Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.7574552424411403,2.117251440406632,0.0,0.008693929111039556,0.009,12/30,6.27%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,ligand-gated channel activity (GO:0022834),0.760450190420309,2.104594061303886,0.001579778830963665,0.006761944864141878,0.013,12/29,6.27%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,retinoid binding (GO:0005501),-0.6616159828935023,-1.960131356080858,0.0,0.10505595450734517,0.086,7/22,6.70%,PTGDS;ALDH1A2;CYP26B1;RBP4;RBP1;RXRA;CRABP2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7831801222940526,1.909614112351408,0.0016339869281045752,0.15327075025388254,0.325,9/17,6.27%,GRIA3;GRIN2B;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6633454615263386,1.8506002324201214,0.0016501650165016502,0.2593688851460135,0.567,10/28,10.62%,CHRNB4;GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIK4;GRIK1;GABRG3;GABRG2
prerank,cGMP binding (GO:0030553),-0.735031470463104,-1.8223751458252426,0.004629629629629629,0.3162290347796855,0.413,3/11,8.51%,PDE5A;RAPGEF2;PDE11A
prerank,amino acid:sodium symporter activity (GO:0005283),0.8100465775553972,1.8082620832120422,0.0016666666666666668,0.3338468778639189,0.727,2/11,1.39%,SLC1A3;SLC6A13
prerank,transmitter-gated ion channel activity (GO:0022824),0.6391562922937997,1.7983160257045154,0.006349206349206349,0.30782949000569687,0.753,13/29,14.49%,GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIA4;GRIK4;GRIK1;GABRG3;GLRA3;GABRG2;GLRA2;GABRB1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6933139054530532,1.7919173844813834,0.008605851979345954,0.2795857203010499,0.771,9/19,10.62%,GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIK4;GRIK1;GABRG3;GABRG2
prerank,signal sequence binding (GO:0005048),0.6132334492019625,1.7782571726203436,0.012403100775193798,0.28267344512421666,0.826,6/35,6.10%,CEMIP;KDELR3;KDELR2;NUP214;KCNIP2;POM121
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.7381896991296208,1.7777842715392855,0.00684931506849315,0.252660606510952,0.827,2/15,0.34%,SLC1A3;SLC1A5
prerank,insulin-like growth factor I binding (GO:0031994),-0.6806362049838968,-1.773380286381071,0.0,0.3622131226111833,0.597,8/13,6.53%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4
prerank,LRR domain binding (GO:0030275),-0.6632037340015466,-1.7696287743069279,0.004545454545454545,0.2812103832772371,0.607,3/14,1.38%,PAWR;ERC1;ROBO1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.686088887095583,1.7676794425130824,0.006711409395973154,0.251351150521388,0.863,13/21,13.66%,POLG;POLQ;POLK;POLA1;POLL;POLE4;POLH;REV3L;POLE3;POLN;POLB;REV1;POLI
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5967000368229085,-1.7607575151521269,0.005154639175257732,0.24979971405079848,0.634,7/23,15.57%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,glutamate receptor activity (GO:0008066),0.6878525416594167,1.756316687225288,0.007874015748031496,0.2566904524400871,0.895,12/19,18.87%,GRID2;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIK1;GRM5;GRM7;GRIA2;GRM1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6469912979190691,-1.748555628670286,0.007444168734491315,0.23770236171358908,0.68,9/17,17.43%,PITPNC1;ATP10A;PITPNM2;PLTP;PITPNA;ABCA3;ATP8B1;ABCB4;PCTP
prerank,ligand-gated calcium channel activity (GO:0099604),0.6979895509772999,1.745656156804632,0.008547008547008548,0.261944864141877,0.918,10/19,17.90%,TRPA1;ITPR1;GRIN2B;RYR2;GRIN2A;P2RX4;TRPM2;RYR3;RASA3;MCOLN1
prerank,CXCR chemokine receptor binding (GO:0045236),0.7789728221083886,1.731336176739969,0.024778761061946902,0.27478760557798526,0.951,2/11,1.25%,CXCL10;CXCL1
prerank,phospholipid transfer activity (GO:0120014),-0.5870451545491109,-1.7125079042141986,0.005063291139240506,0.29091252049003663,0.788,13/21,27.07%,PITPNC1;PITPNM2;CERT1;PLTP;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1;GLTP;PITPNM1;C2CD2L;OSBPL2
prerank,DNA polymerase activity (GO:0034061),0.6546496445053273,1.700066689508571,0.011627906976744186,0.3307143034064492,0.972,13/22,13.66%,POLG;POLQ;POLK;POLA1;POLL;POLE4;POLH;REV3L;POLE3;POLN;POLB;REV1;POLI
prerank,hyaluronic acid binding (GO:0005540),0.7716786158477397,1.699967407156342,0.0071174377224199285,0.30866668317935253,0.972,1/10,0.02%,CEMIP
prerank,cadherin binding (GO:0045296),-0.35258707129284744,-1.6976932831419882,0.0,0.2922200350753553,0.83,106/315,18.05%,PHLDB2;PKP4;PTPRB;TJP1;TMOD3;PICALM;BAIAP2L1;ERC1;PDLIM5;VCL;CALD1;FNBP1L;PTPRJ;BSG;EGFR;AFDN;WASF2;ITGB1;NOTCH3;EZR;CDH1;PACSIN2;ITGA6;AHNAK;PROM1;F11R;BMPR2;RDX;CSNK1D;IQGAP1;FXYD5;KDR;COBLL1;PLEC;EIF5;ANLN;NDRG1;HSPA8;CDH8;MRTFB;S100A11;APC;RPS2;CTNND1;ANXA1;CHMP2B;GIPC1;TRIM25;CAPZB;TJP2;YWHAB;EPN2;NCK1;VAPA;LDHA;SLC3A2;RANGAP1;ZC3HAV1;CLINT1;EEF1G;ACVR1;EHD4;EPS8L2;ARHGAP18;CLIC1;VAPB;PPFIBP1;NIBAN2;IST1;RPL34;TAGLN2;PPL;PTPN1;UBFD1;UBAP2;CD2AP;GAPVD1;USO1;PRDX1;BAG3;RPL29;PKM;MACF1;ENO1;FLNA;RAN;EEF1D;TES;CDH5;PLIN3;LIMA1;PSMB6;BAIAP2;CTNNA1;PAK2;PKN2;EIF3E;RPL23A;EIF4H;RAB1A;EPHA2;ALDOA;SERBP1;CDH4;HNRNPK;DLG1
prerank,tropomyosin binding (GO:0005523),-0.619432011648278,-1.6930691457731015,0.011990407673860911,0.2727210132160374,0.842,3/16,1.20%,NEBL;TMOD3;CALD1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.677312575101447,-1.6893763559913468,0.0045045045045045045,0.25393828195563334,0.853,8/12,26.06%,KDM4C;KDM4A;PHF8;HR;KDM4B;KDM3B;PHF2;KDM1A
prerank,platelet-derived growth factor binding (GO:0048407),0.7426099818911734,1.6872362564107624,0.017094017094017096,0.3217961261238947,0.979,3/11,5.33%,PDGFRA;COL4A1;COL1A2
prerank,chemokine activity (GO:0008009),0.6079874249108141,1.685197359295603,0.014308426073131956,0.3080946643140946,0.98,5/31,10.64%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7502899743953607,1.6835118362817338,0.01436265709156194,0.2954325910881034,0.98,7/11,17.90%,TRPA1;ITPR1;RYR2;TRPM2;RYR3;RASA3;MCOLN1
prerank,protein phosphatase 1 binding (GO:0008157),-0.5637586519504094,-1.679317527942526,0.0026109660574412533,0.2529446397780156,0.876,10/21,17.98%,SHOC2;PPP1R16A;AKAP11;PPP1R3B;SH3RF2;PPP1R16B;PHACTR4;KCNQ1;PPP1R3C;PPP1R11
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.715127505085184,1.66837004573828,0.026578073089700997,0.3168962581819272,0.988,3/14,2.43%,ADH1A;RDH10;RDH11
prerank,exonuclease activity (GO:0004527),0.5470706206044421,1.6631019558804945,0.014044943820224719,0.3137059420900106,0.989,18/46,19.31%,ENPP1;POLG;FAN1;FEN1;PDE12;ENPP3;REV3L;EXOSC9;ISG20L2;CNOT7;EXOSC10;EXOSC8;EXOSC5;APEX2;DXO;WRN;REXO4;TRIR
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6381197328249988,1.6617357604136684,0.028346456692913385,0.30180353914037317,0.989,4/21,2.87%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,glycine binding (GO:0016594),0.7438965295884482,1.657998721111839,0.016853932584269662,0.29686694302898203,0.992,7/11,18.07%,GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRIN3A
prerank,sterol binding (GO:0032934),0.523358283058346,1.6329589736012666,0.008620689655172414,0.34863915724994854,0.997,6/56,3.59%,APOD;RORA;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,phosphatidylinositol binding (GO:0035091),-0.39793605056538867,-1.629378334622156,0.0,0.3607097966628459,0.968,35/91,22.81%,PITPNC1;PICALM;SNX24;PITPNM2;EEA1;MTM1;MCF2L;PARD3;HIP1R;ITPR2;MITD1;PITPNA;WDFY3;SCARB1;MAPT;TNFAIP8L3;PIGU;MYO1E;CCDC88A;GPAA1;SNX17;DENND1A;HIP1;ESYT3;PLEKHF2;BCAS3;DENND1B;NUMA1;EXOC8;FES;WDR45;PIGK;EPB41;PITPNM1;PASK
prerank,calcium-release channel activity (GO:0015278),0.6676712751345102,1.6283207056336526,0.02037351443123939,0.34574468085106386,0.997,9/17,17.90%,TRPA1;MCOLN2;ITPR1;TPCN1;RYR2;TRPM2;RYR3;RASA3;MCOLN1
prerank,chemokine receptor binding (GO:0042379),0.5674622368407515,1.6256448567130255,0.028744326777609682,0.338831397220915,0.997,4/35,5.36%,XCL1;CXCL10;CXCL1;CCL15
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6132841987115869,1.6224598008043716,0.03110419906687403,0.33445619597255594,0.999,4/23,2.87%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,sodium channel activity (GO:0005272),0.5561274676471261,1.6113366582761839,0.021645021645021644,0.3502258109792848,0.999,13/37,14.26%,GRIK5;GRIK2;ASIC2;GRIK4;CACNA1G;GRIK1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.498626296207467,-1.605575442974006,0.03208556149732621,0.406183706005089,0.985,8/27,7.68%,XPR1;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC26A11;SLC39A8;SLC22A8
prerank,anion transmembrane transporter activity (GO:0008509),-0.6473595617257086,-1.6042474408627234,0.02040816326530612,0.3808846835493575,0.985,4/12,5.66%,ABCG2;SLC22A6;SLC26A11;SLC39A8
prerank,sialyltransferase activity (GO:0008373),-0.5544519662987962,-1.5998955621630047,0.024096385542168676,0.36843866065606307,0.988,11/20,16.33%,ST3GAL6;ST6GAL1;ST8SIA4;ST3GAL4;ST3GAL1;ST6GALNAC2;ST6GALNAC3;ST3GAL3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5076384869418714,1.5996313737728698,0.012622720897615708,0.3682154976274809,0.999,10/60,2.95%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6808442024845635,1.5954755486247263,0.02564102564102564,0.3667772162515576,0.999,3/14,8.53%,SLC1A3;SLC7A11;SLC25A22
prerank,potassium channel activity (GO:0005267),0.4734114277285743,1.5735364877748046,0.012953367875647668,0.41473261833403513,1.0,22/89,14.08%,KCNK2;KCNS2;KCNT2;GRIK5;GRIK2;KCNQ3;KCNMA1;GRIK4;GRIK1;KCNG1;KCNH4;TMEM38B;KCNC2;HCN2;TMEM175;HCN1;HCN3;KCND2;KCNK1;KCNN2;KCNH7;KCNH8
prerank,PDZ domain binding (GO:0030165),-0.42455677584839185,-1.572621316610611,0.014652014652014652,0.4242695334491711,0.996,24/61,18.27%,CRIM1;RAPGEF2;ERC1;DOCK4;CXADR;F11R;SLC22A4;USHBP1;FZD4;ATP2B1;FZD7;ATP2B2;SNTG2;CXXC4;CRIPT;MAP2K2;PLEKHA2;CCDC88C;FZD3;KIDINS220;LLGL2;FZD8;SLC26A6;TGFBR3
prerank,outward rectifier potassium channel activity (GO:0015271),0.7091939400105187,1.5687124132841574,0.033271719038817,0.41490919753939676,1.0,4/11,10.75%,KCNK2;KCNT2;KCNIP2;KCND2
prerank,transcription coactivator binding (GO:0001223),0.6234247686282229,1.56583601582631,0.03908794788273615,0.40997309464245907,1.0,4/20,4.29%,RORA;PGR;PPARD;TEAD2
prerank,Wnt-activated receptor activity (GO:0042813),0.6495860914615206,1.5584176470373834,0.03907637655417407,0.4191820365996176,1.0,1/15,0.05%,ROR1
prerank,ligand-gated cation channel activity (GO:0099094),0.4811717054625737,1.5554128932708264,0.017857142857142856,0.4153197900169158,1.0,22/75,19.21%,GRIA3;CHRNB4;GRIN2B;GRIK5;GRIK2;ASIC2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1;ASIC1;P2RX4;KCNK1;TRPM2;KCNN2;KCNJ8;KCNJ10;MCOLN1;GRIN3A;GRIA2;KCNJ3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5944528278812545,-1.554643096228644,0.03773584905660377,0.45530489137051433,0.998,4/15,6.47%,PICALM;EEA1;WDFY3;SCARB1
prerank,hexosaminidase activity (GO:0015929),0.693578149168298,1.5515687642180007,0.034129692832764506,0.4140242241101727,1.0,2/12,4.94%,CEMIP;CEMIP2
prerank,semaphorin receptor binding (GO:0030215),-0.5000359216235849,-1.5285308643434767,0.03305785123966942,0.5163777247642178,0.999,10/23,17.93%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;PLXNB1;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,glucuronosyltransferase activity (GO:0015020),-0.5218931326920488,-1.524048180639029,0.05128205128205128,0.5042797518590216,1.0,3/19,8.24%,CSGALNACT1;EXT1;LARGE1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.47764686242938653,1.5235707552129782,0.02077562326869806,0.48605503678200773,1.0,10/60,2.95%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1
prerank,actinin binding (GO:0042805),-0.5199648286759495,-1.5216946919374668,0.03350515463917526,0.48575114318926516,1.0,6/21,12.28%,CACNA1C;PDLIM5;PROM1;NFKB1;DAG1;CSRP2
prerank,leucine zipper domain binding (GO:0043522),-0.6463237051509768,-1.5215514736093885,0.040268456375838924,0.4630243920879288,1.0,2/10,0.79%,PAWR;ERC1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.599191736216497,-1.5160104420384148,0.043373493975903614,0.46069303099157655,1.0,5/12,14.01%,VEGFD;VEGFC;CCDC88A;ITGB3;CDH5
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6285243131008474,-1.5132551509574568,0.06935123042505593,0.4491061313897663,1.0,3/10,3.97%,SLCO2A1;SLCO1C1;SLC22A6
prerank,insulin-like growth factor binding (GO:0005520),-0.5462860973953899,-1.5079810901653932,0.04116222760290557,0.44600143649646073,1.0,10/15,14.37%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3;IGF2R
prerank,rRNA binding (GO:0019843),-0.4305661744404807,-1.5046111850142563,0.033846153846153845,0.4386457510621838,1.0,21/42,29.13%,CAVIN1;RPS14;RPS9;DDX21;RPL5;RPS5;RPL11;ERI1;RPLP0;NGRN;MRPS7;UTP23;MRPL16;MRPS18A;RPL23;GTF3A;PTCD3;RPF2;FASTKD2;NOP53;MRPL18
prerank,solute:proton symporter activity (GO:0015295),0.6130395544760853,1.4857919071832275,0.0657672849915683,0.6014214744802019,1.0,2/16,0.40%,SLC15A1;SLC2A13
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5195191394090457,-1.4846861076798135,0.04030226700251889,0.48050650831972597,1.0,5/18,5.28%,TMOD3;BAIAP2L1;PDLIM5;S100A11;ANXA1
prerank,voltage-gated potassium channel activity (GO:0005249),0.4537548006266164,1.4846225527410484,0.025435073627844713,0.5896365079841009,1.0,25/80,20.49%,KCNK2;KCNS2;KCNT2;KCNQ3;KCNMA1;KCNIP2;KCNG1;KCNH4;KCNC2;HCN2;HCN1;HCN3;KCND2;KCNE4;KCNK1;KCNN2;KCNJ8;KCNH7;KCNH8;KCNA6;KCNJ10;KCNH1;KCNJ3;KCNS3;KCNJ16
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6088453022440495,-1.4794908138178575,0.05733944954128441,0.47803800025171683,1.0,3/11,3.56%,MAP3K1;EGFR;MAP3K5
prerank,CCR chemokine receptor binding (GO:0048020),0.5358096234391465,1.4757420920759674,0.05732484076433121,0.6076090456493201,1.0,5/28,10.64%,XCL1;MSMP;CCL15;CNIH4;CCL25
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5839308890365102,1.4754736339183434,0.07389162561576355,0.5933365120253634,1.0,4/18,18.11%,HSD11B1;HSD17B8;RDH5;HSD17B2
prerank,calcium ion binding (GO:0005509),0.38375799778548797,1.4748682756308023,0.0,0.5804434622752588,1.0,68/323,14.76%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;MASP1;ITPR1;NRXN1;FKBP9;TCHH;RYR2;LOXL2;KCNIP1;DCHS1;CDH11;CEMIP2;CLEC3B;CDH15;CDH3;ATP2A2;CAMKK2;KCNIP2;NOL3;CAPN3;RASGRP2;S100A7A;ENPP3;CALB1;SYT3;MAN1C1;AMY1C;AMY1B;AMY1A;KCNIP4;MICU3;ITSN1;PVALB;MAN1B1;RCN3;SYT7;PPP3CB;CABYR;S100A2;TRPM2;SYT5;S100A1;HSP90B1;CDH10;TESC;BGLAP;S100G;ASPH;EML1;RYR3;SPARCL1;FBN1;MELK;HSPA5;STIM1;PCLO;NDUFAB1
prerank,cytokine activity (GO:0005125),0.42011972044065365,1.466703158081727,0.020151133501259445,0.5961551390427124,1.0,9/131,2.91%,IL33;IL34;XCL1;CXCL10;NRG1;CXCL1;WNT5A;IL16;TSLP
prerank,tau-protein kinase activity (GO:0050321),-0.4935022704376557,-1.4657499504887777,0.05570291777188329,0.5043595391716268,1.0,13/20,28.57%,ROCK2;MARK1;MARK4;SIK3;GSK3B;MARK3;PRKAA1;MARK2;TTBK1;TAOK2;BRSK1;PHKG2;TTBK2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6163766015075504,1.4600360981054312,0.07807308970099668,0.6067104483251816,1.0,6/14,18.26%,CAPN5;CAPN3;CAPN6;CAPN15;CAPN2;CAPN10
prerank,GTPase inhibitor activity (GO:0005095),-0.5525224406077432,-1.457405980026459,0.08653846153846154,0.5139362177135711,1.0,7/13,20.93%,SLIT2;IQGAP1;CPEB2;ARL2;GPS1;RHOH;IQGAP2
prerank,tau protein binding (GO:0048156),-0.41602539765600555,-1.4565816606221484,0.03048780487804878,0.4991749595985371,1.0,14/40,23.32%,PICALM;ROCK2;MARK1;ACTB;MARK4;GSK3B;APOE;MARK3;PRKAA1;MARK2;HDAC6;TTBK1;BAG2;TAOK2
prerank,cholesterol binding (GO:0015485),0.47863794914114965,1.455660456425847,0.05124450951683748,0.6082018135432546,1.0,5/47,3.59%,APOD;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,phosphatidic acid binding (GO:0070300),-0.5131071901930352,-1.4543952643219136,0.06281407035175879,0.489987270387142,1.0,7/19,5.68%,PITPNC1;RAPGEF2;MARK1;RAPGEF6;PACSIN2;SMPD3;PLTP
prerank,protein tyrosine kinase activity (GO:0004713),0.4258443485762211,1.4536729408672018,0.030456852791878174,0.6011905646512933,1.0,20/108,10.44%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;PEAK1;NTRK2;TXK;ERBB4;EPHB1;FGFR1;JAK1;EPHA6;CAMKK2;PTK2;AXL;EPHB6;FGR;EPHA3
prerank,pentosyltransferase activity (GO:0016763),-0.42695676345467637,-1.447961681157064,0.0423728813559322,0.4944726444630757,1.0,13/36,18.62%,UPP2;ART3;SIRT3;TNKS2;ZC3HAV1;LARGE1;PARP10;PARP9;LACC1;SIRT1;PARP4;QPRT;SIRT5
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5572290434681442,1.4466280141062815,0.06821963394342762,0.6138249949654256,1.0,10/22,17.17%,CPEB1;RBMS3;RBM24;ZFP36L2;ELAVL4;NUDT21;DHX36;EXOSC9;EXOSC8;ILF3
prerank,actin binding (GO:0003779),-0.3279307375220846,-1.437485085331493,0.0072992700729927005,0.5116453297111629,1.0,40/170,14.33%,SORBS1;PAWR;ABLIM1;SYNE2;MICAL2;PDLIM5;VCL;CALD1;MYRIP;ITGB1;EZR;NOS3;TPM1;PARVB;RDX;FXYD5;GSN;ANLN;PHACTR1;GIPC1;COBL;CAPZB;MAPT;EPS8L2;DMD;CAP1;SSH1;PHACTR4;CCDC88A;COTL1;DAG1;SHROOM2;CEACAM1;TRPV4;TMOD1;MYH10;MACF1;TLNRD1;TMSB4X;LIMA1
prerank,ion channel activity (GO:0005216),0.4329317626889301,1.4338008492339827,0.051047120418848166,0.6467214501370466,1.0,15/80,6.41%,GRIA3;NALCN;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;TMC3;GRIK4;GRIN2A;GRIK1;TRPV3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5295478578977912,-1.4336367035232838,0.06382978723404255,0.5091749381559207,1.0,7/15,22.02%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8;SLC26A6;CFTR
prerank,frizzled binding (GO:0005109),-0.42677280088604336,-1.431236008988794,0.04261363636363636,0.5021159199411669,1.0,13/34,18.86%,WNT5B;WNT9A;RNF43;WNT4;DVL1;FZD7;LRP6;WNT6;SFRP1;CCDC88C;WNT16;WNT11;SDCBP
prerank,myosin V binding (GO:0031489),0.5834671500338721,1.4287041483716287,0.08460236886632826,0.6518031852971045,1.0,3/15,6.66%,NPC1L1;RAB8A;RAB3C
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5859186131356676,-1.428433151405422,0.056372549019607844,0.4966871025389355,1.0,4/11,10.48%,SGMS1;SGMS2;AASDHPPT;GNPTAB
prerank,copper ion binding (GO:0005507),0.47944964929854206,1.4240314000383654,0.07111111111111111,0.6561057930714456,1.0,11/42,13.86%,PAM;TYR;LOXL3;LOXL2;CCS;ACR;COMMD1;TP53;P2RX4;HEPH;ATP7A
prerank,AMP binding (GO:0016208),-0.5790941364498792,-1.4224487174834353,0.08705357142857142,0.49981166235312696,1.0,5/11,19.80%,PRKAG2;MPPED2;PRKAG3;PFKL;APRT
prerank,FAD binding (GO:0071949),-0.4693136348335629,-1.4090641552773557,0.06914893617021277,0.5248329635861364,1.0,10/24,17.96%,DDO;MICAL2;PRODH;CYB5R3;NQO2;MTHFR;CYB5R1;MICAL3;AIFM1;NDOR1
prerank,death domain binding (GO:0070513),-0.569012795256981,-1.3985157066328573,0.12761506276150628,0.5423401412174058,1.0,5/11,10.12%,BCL2L1;MCL1;CRADD;DAPL1;BAX
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6260034759617069,1.3980577514852917,0.10582010582010581,0.7403943229385976,1.0,4/12,10.19%,HDAC1;FOS;GTF2A1;TBPL1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.45856562667519407,-1.3890715489627785,0.07049608355091384,0.5564251489487518,1.0,11/25,24.55%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;SIRT1;PARP4;SIRT5;PARP2;PARP1
prerank,triglyceride lipase activity (GO:0004806),0.5481344891579485,1.3875530738774515,0.10679611650485436,0.7699525454548104,1.0,3/20,5.18%,CEL;LIPC;LIPH
prerank,neuropeptide hormone activity (GO:0005184),0.5240428971047688,1.3864342776667054,0.104,0.7598642657221409,1.0,3/22,8.78%,HCRT;SPX;NPY
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3047391792536601,-1.3838015334980924,0.0,0.5588749016203755,1.0,65/196,21.72%,PDE5A;RAPGEF2;RHOBTB1;MRAS;KRAS;MPPED2;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RAB5C;RHOC;GBP2;GCH1;PDE11A;RAB31;MIEF1;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;ARL1;NOA1;TUBB2A;RAB6A;RAP2B;TSR1;RRAGB;RAB4A;DYNC1LI1;RERG;MFHAS1;TUBA1C;RAB1B;ARL4C;RAB8B;SCG5;RHOH;TUBA4A;MTG2;TUBB2B
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5909892837631042,-1.3758199682114267,0.10609480812641084,0.5699752952696489,1.0,6/10,22.87%,KDM4C;KDM4A;RIOX2;PHF8;KDM4B;KDM2B
prerank,histone demethylase activity (GO:0032452),-0.451460932739532,-1.373795783970595,0.08264462809917356,0.5627415857719033,1.0,12/27,26.06%,KDM4C;KDM4A;RIOX2;PHF8;FBXL19;JARID2;HR;KDM4B;KDM3B;KDM2B;PHF2;KDM1A
prerank,"DNA binding, bending (GO:0008301)",-0.5195308756077204,-1.372605930834965,0.10714285714285714,0.5540761016647722,1.0,6/14,17.60%,LEF1;FOXC1;FOXD1;FOXL1;HHEX;HMGB2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4819021463849673,1.372534814471458,0.09984639016897082,0.8024113817893428,1.0,13/34,15.06%,OGT;GAB2;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ARAP2;MYO1G;DAPP1;FERMT2
prerank,nucleotide diphosphatase activity (GO:0004551),0.5734321424504925,1.3721869730389622,0.11221122112211221,0.7888399012541384,1.0,3/14,10.77%,ENPP1;NUDT13;FHIT
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5996874956082477,1.3693836908323656,0.12041884816753927,0.784789564582991,1.0,3/12,5.14%,PIK3R1;GAB2;IRS1
prerank,GDP binding (GO:0019003),-0.36296183079597766,-1.364286272240133,0.05755395683453238,0.5663588909995306,1.0,21/63,20.41%,MRAS;KRAS;RRAS2;RASL12;RAP1A;RAB21;RAB5A;RAB5C;RAB31;MIEF1;RRAGC;RAB35;RALB;RAN;RRAS;RAP2C;RAP2B;RAB4A;DYNC1LI1;RERG;RAB8B
prerank,phospholipase inhibitor activity (GO:0004859),-0.5845362288478133,-1.364224729953011,0.11036036036036036,0.5541851548374952,1.0,6/10,36.78%,ANXA5;ANXA1;ANXA4;ANXA9;APOC1;SNCB
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.38197562635644483,-1.362957945715242,0.05688622754491018,0.5463225727948058,1.0,9/42,5.28%,TMOD3;CD200;BAIAP2L1;PDLIM5;BSG;ESAM;SIRPA;S100A11;ANXA1
prerank,phospholipase binding (GO:0043274),0.5780340115211973,1.361044220442816,0.13937282229965156,0.8058271794091525,1.0,4/13,11.33%,ARHGAP6;PDPK1;DGKQ;FYN
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.37408444552975295,-1.3606729713475139,0.06818181818181818,0.5414405264813532,1.0,14/55,10.42%,SLC13A3;SLC16A2;SLC6A6;SLC38A11;SLC25A32;SLC22A4;SLC16A6;SLC16A11;SLC7A1;SLC16A1;SLC16A4;SLC38A5;SLC38A10;SLC7A5
prerank,transcription corepressor binding (GO:0001222),0.49888103403689715,1.3588983176751577,0.12559618441971382,0.800502420194841,1.0,5/27,9.75%,RORA;PER3;ZBTB16;PER2;WIZ
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5647806383572581,-1.3582750076904084,0.12962962962962962,0.5372341916024967,1.0,6/10,19.54%,SHANK3;GNAS;SQSTM1;SHANK1;SHISA7;IGSF11
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.37475816207551393,-1.3565833355999921,0.06230529595015576,0.5311374378789535,1.0,4/48,1.29%,TRPM3;TRPM6;SLC12A7;PIEZO2
prerank,nuclear export signal receptor activity (GO:0005049),0.6009146873438311,1.3529403655336496,0.1586452762923351,0.8124993060401412,1.0,6/11,19.94%,CSE1L;NUP214;NUP42;EIF4ENIF1;XPO6;XPO1
prerank,MAP kinase activity (GO:0004707),-0.5078010676638535,-1.350327366295744,0.11737089201877934,0.5368694272526283,1.0,3/14,6.43%,MAPK4;MAPK9;MAPK14
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5691413379080252,1.3386972588796848,0.12296564195298372,0.8587178795024532,1.0,7/13,15.07%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GLRB
prerank,protein tyrosine kinase binding (GO:1990782),-0.34820255735829686,-1.334587251054566,0.06172839506172839,0.5711958365696564,1.0,23/71,14.58%,EPHA4;DOCK4;PITPNM2;ITGB1;BMPR2;SIRPA;SQSTM1;PTPN14;GRB14;NEDD9;TJP2;NCK1;ACVR1;PTPN2;PTPN1;RNF41;CEACAM1;PCNA;NOX4;CDH5;CPNE3;ELMO2;TOB1
prerank,voltage-gated cation channel activity (GO:0022843),0.394488204786865,1.333566527324743,0.08483290488431877,0.8653196443167462,1.0,24/97,16.72%,KCNS2;CACNA1E;ITGAV;CACNG3;GRIN2B;KCNQ3;KCNMA1;GRIN2A;KCNG1;CATSPER3;KCNH4;KCNC2;CACNB4;HCN2;HCN1;CACNG4;HCN3;KCND2;KCNK1;KCNH7;KCNH8;CACNA2D1;NCS1;KCNA6
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.48784219613035384,-1.3259756752565095,0.11407766990291263,0.584725385064324,1.0,7/14,22.94%,CASP8AP2;MAL;BAD;CTSH;ATP2A3;BCL2L13;APAF1
prerank,dynactin binding (GO:0034452),-0.5253099389010831,-1.323156421134915,0.1431980906921241,0.5819934808622399,1.0,6/12,24.69%,GSK3B;MAPT;SNX6;BICD2;BICDL1;BICD1
prerank,hydro-lyase activity (GO:0016836),-0.38321316884443135,-1.3207419884038505,0.07352941176470588,0.5777209266874999,1.0,13/41,17.16%,HACD4;HACD1;CA4;ACO1;ECHDC1;L3HYPDH;ACO2;ENO1;PCBD2;HADHA;CDYL;CBS;AUH
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5469740563745638,-1.3203334658245998,0.1554524361948956,0.5684088043654988,1.0,3/10,3.48%,CD200;CXADR;SIRPA
prerank,chloride channel inhibitor activity (GO:0019869),-0.574422311542328,-1.3201961786013356,0.15483870967741936,0.5588649119893664,1.0,4/10,9.55%,WNK4;WNK1;STX1A;STX7
prerank,transforming growth factor beta binding (GO:0050431),-0.42953742733123745,-1.3199924916210544,0.11704834605597965,0.5499977444175032,1.0,13/23,23.94%,LTBP4;THBS1;CD109;ACVR1;ACVRL1;LRRC32;TWSG1;TGFBR3;VASN;TGFBR2;NRROS;TSKU;HYAL2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5036149772591685,1.3194000024730432,0.12786885245901639,0.9127200332311035,1.0,3/21,10.73%,CHRNB4;GRIA1;GRM5
prerank,phosphoric diester hydrolase activity (GO:0008081),0.45703199659927635,1.3189583371302929,0.13943028485757122,0.9000086292100359,1.0,8/35,7.86%,ENPP1;PLCL1;GPLD1;PLCXD3;SMPD4;PLCXD1;ENPP3;ENPP6
prerank,voltage-gated sodium channel activity (GO:0005248),0.5051520941834734,1.3174515088347114,0.12538699690402477,0.8919480605260706,1.0,10/22,21.63%,SCN2B;CACNA1G;HCN2;HCN1;HCN3;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5317570904499768,-1.315682789564093,0.16252821670428894,0.5520968292342865,1.0,6/11,18.29%,ATP10A;ATP8A1;ABCA3;ATP8B1;ABCB4;ATP8A2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2998490975277612,-1.3153752416359978,0.06369426751592357,0.5438679557332274,1.0,45/147,15.78%,PLCE1;DOCK5;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;FNIP1;RAPGEF6;ARHGEF28;DOCK1;CYTH1;RASGRF1;RAP1A;RIN3;DENND3;RAPGEF1;NUCB1;ARHGEF15;LAMTOR5;EPS8L2;NGEF;MADD;SPATA13;RGL2;DENND5B;RAB3IP;CCDC88A;GAPVD1;DENND2C;EIF2B4;ALS2;HERC2;DENND6A;DENND1A;CCDC88C;LAMTOR3;BCR;EEF1D;RAPGEF3;ARHGEF11;MON1A;DENND4C;SBF1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5887283212770131,1.3148064979814,0.1705150976909414,0.8891353751269412,1.0,3/10,3.52%,DPP6;FAP;DPP10
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5879720975724739,1.3120518040306137,0.17345132743362832,0.8876278701112129,1.0,2/12,9.57%,GPR88;GPR52
prerank,ferrous iron binding (GO:0008198),0.4963284994129554,1.3119798523083417,0.15048543689320387,0.8744716878742094,1.0,7/21,13.63%,HIF1AN;DNAJC24;FXN;EGLN2;HEPH;FTO;ALKBH3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4197353113871738,-1.3088221441157797,0.1232876712328767,0.5527832439849976,1.0,8/26,9.65%,ABCG2;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC16A1;SLC16A4;MPC1
prerank,ADP binding (GO:0043531),-0.42738981157153855,-1.3071418675776683,0.12987012987012986,0.5482832268961054,1.0,13/25,29.53%,PRKAG2;GCLC;PGK1;MIEF1;ME1;MYH10;ERN1;ATP5F1D;MYO18A;COQ8A;MYH9;MSH2;ATP5F1A
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.414539486257258,-1.3069122610842427,0.12299465240641712,0.5402877660377752,1.0,9/27,12.69%,SLC9B2;ITPR2;ATP2B1;SLC41A1;MRS2;CNNM2;SLC4A8;CNNM4;ATP2A3
prerank,lipase activator activity (GO:0060229),0.5966805120474821,1.3056697807465685,0.17073170731707318,0.88728539207709,1.0,3/10,11.33%,ARHGAP6;PDPK1;FYN
prerank,BMP binding (GO:0036122),-0.5319656883225671,-1.3053720821704942,0.1391509433962264,0.535543288294309,1.0,2/11,2.81%,NBL1;BMPR2
prerank,ligand-gated anion channel activity (GO:0099095),0.5234128543230485,1.304591731436567,0.15398230088495576,0.8783851613119427,1.0,8/17,15.07%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;GLRB
prerank,mRNA methyltransferase activity (GO:0008174),-0.5197738024186307,-1.3042756137720897,0.1303370786516854,0.529981577493698,1.0,3/12,8.56%,NSUN2;TRMT61B;CMTR1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6008919237392097,1.2998806003700716,0.1936619718309859,0.8849747840517608,1.0,1/10,1.39%,SLC6A13
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.584632532721037,1.2973838192848492,0.17204301075268819,0.8823096057832144,1.0,1/11,0.60%,ROR2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5287175716515418,-1.295380349435309,0.1610738255033557,0.5447988923365296,1.0,6/11,24.70%,NUDT3;NUDT4;NUDT7;DCPS;NUDT16;NUDT16L1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5421984464569239,-1.2949355300352097,0.16818181818181818,0.5379979892515455,1.0,3/10,5.02%,B4GALT1;B3GALT1;B4GALT5
prerank,peptidase activator activity (GO:0016504),-0.4273368711402522,-1.294828696180565,0.13243243243243244,0.5303047305508918,1.0,9/22,13.30%,CAV1;CASP8AP2;PCOLCE2;MAL;VCP;APH1A;APH1B;CLPX;PSME3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.486815935784086,-1.2942908993891344,0.14678899082568808,0.5239725325816499,1.0,3/14,4.07%,SLC26A7;SLC26A2;SLC26A11
prerank,cAMP binding (GO:0030552),0.5793789461153567,1.2900208115428546,0.1986062717770035,0.8999645209826815,1.0,5/11,14.22%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,sequence-specific mRNA binding (GO:1990825),0.5899255471577557,1.2887273820049774,0.1685185185185185,0.8931536340293429,1.0,7/10,25.04%,RBM24;FMR1;LARP6;DHX9;SSB;SHFL;ETF1
prerank,phospholipase activator activity (GO:0016004),0.5856800252983823,1.2881331272769185,0.19686411149825783,0.8834858098912571,1.0,3/10,11.33%,ARHGAP6;PDPK1;FYN
prerank,nuclease activity (GO:0004518),0.4207169332893494,1.2854179359583346,0.13564213564213565,0.8827470995132551,1.0,13/52,20.10%,ENPP1;ANKLE1;FEN1;ERCC5;PDE12;DIS3L2;NME1;RNASEH1;ISG20L2;RNASE12;WRN;REXO4;DDX1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5094796167798694,-1.2853684451408371,0.17488789237668162,0.5389385625816202,1.0,6/12,21.04%,LTBP4;BMPR2;ACVR1;ACVRL1;TGFBR3;TGFBR2
prerank,metalloendopeptidase activity (GO:0004222),0.3903327233333492,1.2836905403614696,0.1356382978723404,0.8780353206350779,1.0,15/76,10.31%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;ADAM19;OMA1;MMP11;ADAMTS12;ADAMTS2;NRDC;PITRM1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.40925052187658184,1.2818105757583362,0.13661971830985917,0.8740957674944302,1.0,7/53,8.53%,SLC1A3;SLC1A5;SLC7A11;SLC43A1;SLC7A8;SLC66A1;SLC25A22
prerank,kinase activator activity (GO:0019209),-0.4009531918929197,-1.2810176772829014,0.14444444444444443,0.5417951843635314,1.0,13/30,24.27%,PRKAG2;RPLP1;GPRC5C;WNK1;MADD;CAB39;WNT11;MARK2;MOB1B;RGCC;DUSP19;BCL10;MT3
prerank,phosphatidate phosphatase activity (GO:0008195),0.5383429723352611,1.2804858607571614,0.20430107526881722,0.8678749234813932,1.0,5/13,15.36%,LPIN3;PLPPR3;PLPPR2;PLPP5;LPIN2
prerank,ribonuclease P activity (GO:0004526),0.5580612484988733,1.2777376431580756,0.19784172661870503,0.86785723131796,1.0,4/11,9.96%,RPP40;POP5;PRORP;POP7
prerank,cytokine receptor activity (GO:0004896),0.38424331241057025,1.2752531693348554,0.1318242343541944,0.8662136965204531,1.0,8/83,5.48%,GHR;IL15RA;IL2RA;IL1R2;IL18RAP;ACKR2;CCR9;IL17RD
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5290835778365248,-1.2747819876013597,0.214123006833713,0.5500846506842934,1.0,3/10,9.25%,MECOM;ASH1L;PRDM16
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4682451920066909,-1.2722335859821734,0.1889168765743073,0.5483638815387548,1.0,7/15,13.77%,HS3ST3A1;HS3ST4;HS3ST1;NDST1;NDST3;HS3ST2;HS3ST3B1
prerank,general transcription initiation factor binding (GO:0140296),0.4752733762638638,1.2720759845685439,0.18459069020866772,0.8685355930943947,1.0,10/25,22.08%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;AR;THAP7;TAF11;GTF2B;GTF2A2
prerank,gated channel activity (GO:0022836),-0.47859027491253314,-1.2682867469819679,0.17317073170731706,0.5511494069799759,1.0,7/14,21.63%,PIEZO2;TMC7;TMC6;TMEM266;PACC1;TMEM63B;PIEZO1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5527803790970087,1.266661764551568,0.20441988950276244,0.878253801816579,1.0,1/11,2.30%,CHRNB4
prerank,phosphatidylglycerol binding (GO:1901611),-0.4834118293015879,-1.2651856836058812,0.21052631578947367,0.5514977770757307,1.0,3/13,6.37%,PITPNC1;PLTP;PITPNA
prerank,monocarboxylic acid binding (GO:0033293),0.5042985031013675,1.265120538317052,0.185,0.8735985109584828,1.0,2/18,1.89%,NR1H4;NR2F2
prerank,serotonin receptor activity (GO:0099589),0.4836021613121696,1.262947501368091,0.18604651162790697,0.8513572699285049,1.0,7/22,20.79%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4836021613121696,1.262947501368091,0.18604651162790697,0.8513572699285049,1.0,7/22,20.79%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4836021613121696,1.262947501368091,0.18604651162790697,0.8513572699285049,1.0,7/22,20.79%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.49798837740149793,1.262048044370762,0.19639934533551553,0.8449959937535966,1.0,6/20,15.09%,CASK;MAGI3;DLG2;AK4;AK8;AK3
prerank,retinoic acid receptor binding (GO:0042974),0.5061845137281457,1.2619440710872911,0.18932874354561102,0.8357053237183949,1.0,8/17,15.24%,NSD1;SNW1;NRIP1;CNOT1;ASXL1;MED1;MED25;PRMT2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4928650152170284,-1.2615544156394238,0.18561484918793503,0.5535962897803325,1.0,6/12,22.94%,CASP8AP2;BAD;CTSH;ATP2A3;BCL2L13;APAF1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.45405792819087665,-1.2614931098933246,0.16581632653061223,0.5464618533550113,1.0,8/18,23.87%,LTBP4;BMPR2;ACVR1;ACVRL1;ACVR2B;TGFBR3;TGFBR2;ACVR2A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5465069631227439,1.2603596845214005,0.1917808219178082,0.831807035755219,1.0,2/12,2.87%,PDE7B;PDE4B
prerank,anion:anion antiporter activity (GO:0015301),-0.46785803461198977,-1.2590595822597372,0.18004866180048662,0.5451563264780922,1.0,6/17,18.08%,SLC26A7;SLC26A2;SLC26A11;SLC4A3;SLC25A5;SLC26A6
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5472558206600844,1.2569846001370546,0.21490467937608318,0.8350404945790616,1.0,6/12,16.86%,SDHB;CISD3;FXN;CISD2;AOX1;ISCA1
prerank,clathrin adaptor activity (GO:0035615),-0.4625367527863211,-1.2565106316683532,0.1721698113207547,0.5446360735781636,1.0,9/15,35.22%,HIP1R;DAB2;AP2A1;HIP1;AP2S1;AP2B1;AP1M1;AP1G1;AP1G2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4534382150340214,1.2563153511052096,0.18370607028753994,0.828123580941058,1.0,8/30,16.81%,SLC25A37;SLC30A10;SLC30A5;SLC39A7;SLC30A3;SLC39A14;ATP7A;SLC39A13
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.4975072644171211,-1.2560854883893233,0.20048899755501223,0.5388760292753658,1.0,5/13,11.11%,EIF5;SH3BP4;ARHGDIB;ITGB1BP1;CCDC88A
prerank,MAP kinase phosphatase activity (GO:0033549),0.5562056063418749,1.2527571991861801,0.20898100172711573,0.8320164466351274,1.0,5/12,23.01%,DUSP1;DUSP8;DUSP6;DUSP10;DUSP7
prerank,titin binding (GO:0031432),-0.48372027587139876,-1.2524682213772933,0.20681265206812652,0.5410401308447862,1.0,4/13,12.94%,ACTN2;CAMK2D;CALM1;TRIM63
prerank,DNA polymerase binding (GO:0070182),0.5023710162780188,1.2513161261776968,0.1945945945945946,0.8281177476552883,1.0,2/18,2.23%,FANCI;NAT10
prerank,phosphatase inhibitor activity (GO:0019212),0.4873328315043973,1.2509818224635085,0.18811881188118812,0.8204077621342274,1.0,2/20,4.64%,PTN;BOD1
prerank,GTPase activator activity (GO:0005096),-0.2609580908819418,-1.2479043164290518,0.014492753623188406,0.5455843786739547,1.0,93/313,16.22%,RANBP3L;PLCE1;DOCK5;TBC1D4;PLCB1;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;CHN2;RGS3;SIPA1L1;FNIP1;RGS6;RAPGEF6;ARHGEF28;DOCK1;RGS5;CYTH1;SIPA1L2;NRP1;RASGRF1;IQGAP1;TBC1D8;RAP1A;RIN3;RAP1GAP2;ARHGAP10;DENND3;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;ARHGAP42;SRGAP2;RAPGEF1;BNIP2;ERRFI1;ARFGAP2;NUCB1;ARHGEF15;RANGAP1;RALBP1;RUNDC1;LAMTOR5;EPS8L2;ELMOD3;ARHGAP18;NGEF;MADD;SGSM2;ELMOD2;SPATA13;RGL2;GMIP;DENND5B;GRTP1;RAB3IP;CCDC88A;ARHGAP28;ARHGAP27;GAPVD1;DENND2C;RP2;PGAM5;TBC1D7;EIF2B4;ALS2;HERC2;TBC1D22A;DENND6A;EVI5L;DENND1A;CCDC88C;LAMTOR3;BCR;EEF1D;ASAP2;TBC1D10B;RAPGEF3;ARHGEF11;TBCK;MON1A;ARHGAP44;ARHGAP15;DENND4C;RAP1GDS1;SBF1;TBC1D13;LLGL2;RGS10
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4749966649365016,1.2469824261038587,0.1870967741935484,0.8265501327778044,1.0,4/21,15.07%,CHRNB4;GRIK2;P2RX4;GLRB
prerank,N-acetyltransferase activity (GO:0008080),0.48677573914519207,1.243592575801566,0.21354166666666666,0.8296855506611375,1.0,4/19,10.58%,NAA10;NAT10;NAA50;NAT8L
prerank,manganese ion binding (GO:0030145),-0.34233977761627343,-1.24283799420938,0.1407942238267148,0.5519369059367277,1.0,12/48,13.86%,B4GALT1;MPPED2;XPNPEP3;SOD2;ADPRM;MGAT1;LARGE1;GYG1;DYRK2;ME1;PRIMPOL;GALNT1
prerank,GTP binding (GO:0005525),-0.27746286975583795,-1.241365141452014,0.029940119760479042,0.5491434928426873,1.0,58/172,21.72%,RHOBTB1;MRAS;KRAS;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;GBP2;GCH1;RAB31;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;ARL1;NOA1;TUBB2A;RAB6A;RAP2B;TSR1;RRAGB;RAB4A;DYNC1LI1;RERG;MFHAS1;TUBA1C;RAB1B;ARL4C;SCG5;RHOH;TUBA4A;MTG2;TUBB2B
prerank,solute:anion antiporter activity (GO:0140323),-0.4790127135796013,-1.240239321260057,0.20930232558139536,0.545466995167549,1.0,4/14,6.36%,SLC26A7;SLC26A2;SLC26A11;SLC4A3
prerank,adenylate cyclase binding (GO:0008179),0.5752325166305098,1.2392845696633392,0.23049645390070922,0.8364384923092165,1.0,4/10,13.71%,ADCY5;AKAP5;ADCY2;AKAP6
prerank,transcription coregulator binding (GO:0001221),0.40813120647092965,1.2379222472090436,0.18347338935574228,0.8329242187733407,1.0,8/50,9.75%,RORA;PER3;PGR;PPARD;TEAD2;ZBTB16;PER2;WIZ
prerank,poly-purine tract binding (GO:0070717),0.45069588586777987,1.2374166264611048,0.2081377151799687,0.8261696921108621,1.0,5/27,6.79%,RBMS1;EIF4A3;RBMS3;FMR1;ELAVL4
prerank,single-stranded DNA helicase activity (GO:0017116),0.481462912919533,1.2362018329770377,0.2,0.8217665721690688,1.0,6/19,17.33%,MCM7;POLQ;PIF1;RFC3;DHX9;HELQ
prerank,death receptor activity (GO:0005035),0.5360852240595764,1.2318716692376843,0.22759856630824374,0.8292172986897185,1.0,3/11,7.99%,EDA2R;NGFR;TNFRSF19
prerank,poly(A) binding (GO:0008143),0.47194921658779304,1.228296641570172,0.21266233766233766,0.8336129454225486,1.0,4/21,6.79%,RBMS1;EIF4A3;RBMS3;ELAVL4
prerank,pyridoxal phosphate binding (GO:0030170),0.4762621966789512,1.2276842199138402,0.21166666666666667,0.8276563690643572,1.0,4/20,6.38%,THNSL2;GLDC;PDXK;ABAT
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5616813987303253,1.227401136896829,0.23297491039426524,0.8126966041661506,1.0,5/10,23.01%,DUSP1;DUSP8;DUSP6;DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5616813987303253,1.227401136896829,0.23297491039426524,0.8126966041661506,1.0,5/10,23.01%,DUSP1;DUSP8;DUSP6;DUSP10;DUSP7
prerank,semaphorin receptor activity (GO:0017154),-0.48625397980448526,-1.2219065687889967,0.23476297968397292,0.5860133182361801,1.0,4/11,3.00%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,GABA-A receptor activity (GO:0004890),0.4787844034782805,1.2212109530217266,0.22984562607204118,0.8262268630732702,1.0,5/18,14.49%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1
prerank,metal ion binding (GO:0046872),0.31125624242436223,1.217163513145587,0.054110301768990635,0.8321475355517348,1.0,86/477,14.76%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;HRG;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;MASP1;ITPR1;PDXK;NRXN1;FKBP9;TCHH;RYR2;FAN1;FEN1;LOXL2;KCNIP1;DCHS1;CISD3;CDH11;CEMIP2;LRRK2;CLEC3B;CDH15;CDH3;ATP2A2;CAMKK2;KCNIP2;NOL3;CAPN3;CLYBL;RASGRP2;S100A7A;ADCY2;ENPP3;CALB1;SYT3;MAN1C1;CDC42BPA;PRKACB;PIF1;PINK1;AMY1C;AMY1B;AMY1A;KCNIP4;MICU3;ITSN1;PVALB;OPA1;MAN1B1;RCN3;SYT7;PPP3CB;DHX36;CABYR;S100A2;TRPM2;SYT5;S100A1;HSP90B1;DIS3L2;CDH10;FIGNL1;YDJC;TESC;BGLAP;S100G;ASPH;EML1;RYR3;SPARCL1;FBN1;MELK;HSPA5;NME1;STIM1;PCLO;NDUFAB1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4467722005426827,1.2155433326737104,0.2251655629139073,0.8303559957600978,1.0,3/26,7.51%,PTN;BOD1;PPP1R14A
prerank,FMN binding (GO:0010181),0.5380326739652714,1.215317230094916,0.2534722222222222,0.8233830640389478,1.0,3/11,6.93%,POR;MTRR;DUS2
prerank,filamin binding (GO:0031005),-0.49430426330863403,-1.2140208393078575,0.23516483516483516,0.5994397868644467,1.0,2/11,0.77%,NEBL;DPYSL3
prerank,miRNA binding (GO:0035198),0.435039101103869,1.2136291351917203,0.21804511278195488,0.8220504347419033,1.0,9/30,11.29%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25946229075407046,-1.2117871162030132,0.03260869565217391,0.5984523542574065,1.0,93/254,25.57%,SNCAIP;SMAD6;FOXO1;VCL;NPLOC4;EGFR;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;TMBIM6;SQSTM1;HSPA8;ACTG1;ARIH1;SKI;GABARAP;APC;DBT;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;PRR5L;GSK3B;SLC22A18;VCP;TPI1;RNF8;PCBP2;SMAD3;RPL11;CASP8;UBE2A;NFKBIA;RALB;OTUB1;PSMA3;PRKAR2A;HERC2;SMG5;SLC25A5;UBE2N;PRKAR2B;CKB;USP25;TRAF3;CDKN1A;UCHL1;HSPBP1;PER1;UBE2L6;FZD8;NEDD8;CUL3;UBC;ISG15;CBS;LAPTM5;MAP1LC3A;ERBB3;APBB1;AMBRA1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;RFFL;UBA52;SMAD7;BCL10;IKBKG;RNF20;RPA2;SUMO1;IKBKE;AXIN2;HSPD1;RB1;MID1;NDUFS2;HSPA1A;CHEK2;BRCA1
prerank,phospholipase C activity (GO:0004629),-0.402525075106033,-1.211292886237091,0.19302949061662197,0.5932305028439964,1.0,7/25,15.57%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.25664177816045786,-1.2106977630043412,0.03529411764705882,0.5882661820741263,1.0,97/269,25.57%,SNCAIP;SMAD6;FOXO1;VCL;NPLOC4;EGFR;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;TMBIM6;SQSTM1;HSPA8;ACTG1;ARIH1;SKI;GABARAP;APC;DBT;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;PRR5L;GSK3B;SLC22A18;VCP;TPI1;RNF8;PCBP2;SMAD3;RPL11;CASP8;UBE2A;NFKBIA;PARP9;SUMO3;RALB;OTUB1;PSMA3;PRKAR2A;HERC2;SMG5;SLC25A5;UBE2N;PRKAR2B;CKB;PTPRN;USP25;TRAF3;CDKN1A;UCHL1;HSPBP1;PER1;UBE2L6;FZD8;NEDD8;CUL3;UBC;ISG15;CBS;LAPTM5;MAP1LC3A;ERBB3;APBB1;AMBRA1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;RFFL;UBA52;SMAD7;BCL10;IKBKG;RNF20;RPA2;SUMO1;IKBKE;AXIN2;HSPD1;RB1;MID1;NDUFS2;DTX3L;HSPA1A;CHEK2;BRCA1
prerank,low-density lipoprotein particle binding (GO:0030169),0.49924348124753687,1.2088559404114183,0.24534686971235195,0.8316138373305293,1.0,3/16,5.39%,COLEC12;LIPC;SORL1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5064002401156015,1.2059085846960695,0.25844594594594594,0.834269089390086,1.0,2/15,3.25%,ACKR2;CCR9
prerank,TBP-class protein binding (GO:0017025),0.46698937012514735,1.2042585247529507,0.228099173553719,0.8328059594283308,1.0,8/21,22.08%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;TAF11;GTF2B;GTF2A2
prerank,growth factor activity (GO:0008083),0.36986992650460426,1.202311267612343,0.19505494505494506,0.8322321344611936,1.0,13/74,15.78%,PTN;NRG1;CXCL1;AMELX;NRG3;IL12A;ENDOU;IGF2;CLEC11A;GDNF;FGF5;AREG;JAG1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4321218463296385,1.200501717825343,0.21864951768488747,0.8314311153754398,1.0,9/28,11.64%,RPP40;POP5;FEN1;PRORP;MRPL44;POP7;DBR1;AGO3;EDC3
prerank,R-SMAD binding (GO:0070412),-0.4311648753503582,-1.1983158801472238,0.235,0.614383174511487,1.0,4/18,8.66%,SMAD6;DDX5;DROSHA;SMAD3
prerank,Toll-like receptor binding (GO:0035325),0.5234186284860877,1.1976813165579918,0.2580071174377224,0.833970399933662,1.0,4/11,17.68%,UNC93B1;TLR6;TIRAP;MYD88
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38069819781309067,-1.1958982611781939,0.20316622691292877,0.6134492626832067,1.0,8/27,16.16%,SLC9A2;SLC8A3;SLC9B2;SLC3A2;SLC41A1;SLC4A8;CNNM4;SLC9A5
prerank,endopeptidase activator activity (GO:0061133),-0.5027527019703827,-1.1957823030556216,0.25790754257907544,0.6072409891356463,1.0,8/10,33.87%,APH1A;APH1B;PSME3;PSME2;ADRM1;VSIR;PSME1;NLRC4
prerank,gamma-tubulin binding (GO:0043015),-0.41470281880280424,-1.1956265288791066,0.22588832487309646,0.6011083612349676,1.0,9/21,21.61%,MARK4;NDRG1;OFD1;TUBGCP5;GIT1;RAD51D;CDK5RAP2;DIXDC1;RAB11FIP5
prerank,histone methyltransferase binding (GO:1990226),-0.4933602032420866,-1.1943444972057262,0.24480369515011546,0.5979979292451594,1.0,4/11,15.02%,LCOR;CBX3;CBX1;LCORL
prerank,single-stranded DNA binding (GO:0003697),0.3558037496513393,1.1927604115741424,0.19584954604409857,0.8444519937787032,1.0,29/93,19.97%,RBMS1;ERCC1;MCM7;ERCC5;MSH3;RTF1;NEIL3;POLA1;HMCES;RPA1;ERCC4;WBP11;XPC;BRCA2;MCM4;DHX36;TOP3A;RAD52;SPRTN;SSBP2;LONP1;MCM10;DHX9;CRY2;FBH1;MCMDC2;SSBP1;REXO4;MLH1
prerank,chloride channel regulator activity (GO:0017081),-0.4702562618331988,-1.1898745566736382,0.2682926829268293,0.6028558130178441,1.0,4/14,9.55%,WNK4;WNK1;STX1A;STX7
prerank,GABA receptor activity (GO:0016917),0.45224352618657243,1.189289934960108,0.24579124579124578,0.8494868682865612,1.0,6/21,16.07%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1;GABBR2
prerank,NF-kappaB binding (GO:0051059),0.43619424997817235,1.1819840243696436,0.24413145539906103,0.868844424050811,1.0,4/24,7.26%,HDAC1;HIF1AN;CDKN2A;BRMS1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.45675689403091196,1.181115584419652,0.264,0.8573341094295692,1.0,8/21,17.06%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.45675689403091196,1.181115584419652,0.264,0.8573341094295692,1.0,8/21,17.06%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,nucleotidase activity (GO:0008252),-0.43216515229680347,-1.1795918231509501,0.23703703703703705,0.6237936609402084,1.0,8/15,31.78%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;BPNT1;NT5C2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4637844572720862,1.1791526807954538,0.26770293609671847,0.8571782999562141,1.0,6/20,16.81%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;SLC39A14;SLC39A13
prerank,metallopeptidase activity (GO:0008237),0.3421475032629734,1.179014282431972,0.1972361809045226,0.8507065060929782,1.0,29/113,18.19%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;EIF3H;ADAM11;ADAM19;METAP1D;OMA1;MMP11;ADAMTS12;ADAMTS2;NRDC;ADAM12;PITRM1;SPRTN;ADAMTS20;ADAMTS10;ADAM2;PSMD14;DPEP1;ADAMTS19;RNPEP;ADAM8;ANPEP
prerank,peptidoglycan binding (GO:0042834),-0.5112824875977313,-1.178912919381834,0.258130081300813,0.6191934288387465,1.0,7/10,41.63%,HK1;PGLYRP1;RNASE7;NOD2;JCHAIN;NLRP3;TLR2
prerank,protein homodimerization activity (GO:0042803),0.30121449270303063,1.1784319777832886,0.07566462167689161,0.8458007132272051,1.0,129/589,18.44%,TBX18;ENPP1;HSD11B1;PDGFRA;ECE1;GHR;XCL1;TENM3;PTPRT;ACOX2;TIMM10;NTRK2;GLDC;NR2F2;MASP1;FAP;HIF1AN;ERBB4;PIP4K2A;ABCD2;PDXK;FGFR1;ODC1;CIP2A;PHETA2;TPST1;RABL3;EPRS1;TYR;POU3F3;JUP;TENM4;RNF40;KMT2A;SOX6;CPQ;MTCL1;FMR1;KYNU;ERCC5;LRRK2;GRHPR;ZBTB16;MSH3;PEX7;MTMR1;MTHFD1L;ACTN1;ADCY8;TENM2;SRF;DSCAML1;QTRT2;TRIM37;PTPRO;GLIPR2;SYNDIG1;TERF1;CIDEA;TRIM8;UXS1;APPL2;CPOX;COMMD1;TENM1;NUDT21;CR2;IRAK1;HOGA1;PTPA;EIF2AK1;PRPS1L1;PRPS1;PYCARD;BCL2L2;ACOT7;SLK;HMGCS1;PDK2;ZNF318;GALE;ACSL6;SLC4A1;S100A1;KCNN2;CISD2;PEX11A;RAB11FIP3;CADM3;SYNE1;TESC;AXIN1;NECTIN3;SDCBP2;TSG101;RDH5;SNF8;RIPK1;ABCB7;BAK1;GDNF;PRMT2;TFAP4;PHETA1;FGFR2;CRPPA;CENPF;ZHX3;AOX1;CYP2R1;HARS1;ZDHHC2;SLC39A13;RRAGA;MMAA;GNPTG;GOLGA5;MMUT;VPS4B;SARS1;DPYD;ADRA2A;LDB1;TOP2A;MSH6;CAMK2A;ALDH3A2;ARNT;WRN
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.31765784200379404,-1.1751274966360903,0.20489296636085627,0.6226395557007107,1.0,24/51,31.98%,SLC16A2;SLCO2A1;SLCO1C1;SLC22A6;SLC22A4;SLC25A3;SLC22A8;SLC35D2;SLC7A5;SLC20A1;MFSD2A;SLC35E4;TMEM241;SLCO5A1;SLC35C2;MCU;SLCO4A1;SLC25A11;SLC5A6;SLCO4C1;SLC5A5;SLC35E2A;SLC35E2B;SLCO1B1
prerank,steroid hydroxylase activity (GO:0008395),0.4854100472836857,1.1743602898855674,0.2914572864321608,0.8532748651086682,1.0,1/16,0.26%,CYP7B1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4980471434362624,-1.1683431520707062,0.2689655172413793,0.6342302255596463,1.0,3/10,6.89%,SLC24A3;SLC8A3;SLC3A2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.421292527207256,-1.167696540408115,0.24121779859484777,0.6296843149849196,1.0,6/16,22.02%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,leak channel activity (GO:0022840),0.46242558818978835,1.1640423405235218,0.27330173775671407,0.8827854259034503,1.0,4/18,11.70%,KCNK2;NALCN;TMEM175;KCNK1
prerank,endodeoxyribonuclease activity (GO:0004520),0.45768152981805255,1.1635528612988617,0.2701342281879195,0.8774428454660292,1.0,5/20,13.83%,ERCC1;FEN1;ERCC5;ERCC4;MBD4
prerank,MHC class II protein complex binding (GO:0023026),-0.47212709458338636,-1.1595384512455493,0.28095238095238095,0.64530656468876,1.0,4/11,17.09%,HSPA8;ANXA11;PKM;CD74
prerank,receptor ligand activity (GO:0048018),0.3095768640403689,1.1582679429310174,0.17516629711751663,0.888842059605205,1.0,13/245,2.91%,IL33;PTN;IL34;EPHA7;CXCL10;NRG1;EDN3;CXCL1;EDA;WNT5A;IL16;SEMA5A;TSLP
prerank,voltage-gated ion channel activity (GO:0005244),0.4940988341361204,1.1536042768960872,0.29533678756476683,0.8980858958957719,1.0,4/14,10.75%,VDAC2;CACNA1E;HCN1;KCND2
prerank,3'-5' DNA helicase activity (GO:0043138),0.4646518219689151,1.1529900319203858,0.2991596638655462,0.8933105765481075,1.0,7/16,18.44%,MCM7;NAV2;RECQL;DHX9;HELQ;FBH1;WRN
prerank,NADP binding (GO:0050661),0.41702112779969863,1.15163816512521,0.2585139318885449,0.8911574567161221,1.0,5/32,8.07%,HSD11B1;GRHPR;MTRR;DUS2;KCNAB1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4473444750123349,1.1503766819741656,0.2840909090909091,0.8888307373437354,1.0,7/21,13.71%,AKAP5;AKAP7;RYR2;WASF3;PRKACA;ACBD3;AKAP6
prerank,hormone activity (GO:0005179),0.3687925083119289,1.1502277459495462,0.25,0.8826387121906404,1.0,7/54,11.41%,HCRT;EDN3;SPX;TRH;NPY;CCL25;ERFE
prerank,vinculin binding (GO:0017166),0.5092702251862892,1.1499557335862265,0.315884476534296,0.876982849216768,1.0,3/11,6.40%,UTRN;CORO2B;ACTN1
prerank,sulfotransferase activity (GO:0008146),0.4049164857661732,1.1464367516218499,0.28173374613003094,0.8825058937349514,1.0,2/33,3.16%,CHST8;TPST1
prerank,nuclear localization sequence binding (GO:0008139),0.44923428923529857,1.146242871258875,0.2857142857142857,0.8766915182589023,1.0,9/18,22.62%,NUP214;POM121;TNPO1;KPNA1;CABP1;TNPO2;KPNB1;KPNA2;IPO4
prerank,ATPase activator activity (GO:0001671),0.4468889450178817,1.146155154806678,0.3197969543147208,0.870614607024788,1.0,5/20,14.21%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15
prerank,G protein-coupled receptor activity (GO:0004930),0.3090626858822421,1.1453451316438488,0.19934282584884994,0.8669532521644425,1.0,29/239,11.18%,ADGRL3;GPR88;RXFP3;ADGRV1;CALCRL;PDGFRL;GPR3;NPFFR1;C5AR1;P2RY1;GPR37L1;ADGRB2;ADGRB1;MRGPRE;ADORA2A;CRHR2;GPR176;GPR22;LPAR3;TRHR;ADGRB3;GPR183;NPY;ADGRL1;TAPT1;GPR52;LPAR1;GRM5;GPR26
prerank,protein kinase activator activity (GO:0030295),-0.30400431070204387,-1.1438452508598262,0.2206896551724138,0.6812410395105605,1.0,20/60,20.81%,PRKAG2;AFAP1L2;RICTOR;IQGAP1;RPLP1;GPRC5C;WNK1;CALM1;MADD;CAB39;MAP2K2;ALS2;ETAA1;CDKN1A;PAK2;ERBB3;WNT11;MARK2;RGCC;DUSP19
prerank,cytokine receptor binding (GO:0005126),0.34131068098427925,1.1437592770003382,0.247682119205298,0.8659699390143435,1.0,11/83,12.27%,IL34;XCL1;IL1RN;TSLP;JAK1;SPRED1;SPRED2;IL1RAP;CCL25;PYCARD;IL12A
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.43301204491347034,-1.1430459440350866,0.2956730769230769,0.6769456338223881,1.0,8/15,29.94%,PLA2G4A;SH3PXD2B;JPH2;SNX3;PLA2G4E;LANCL2;RUBCNL;VEPH1
prerank,beta-tubulin binding (GO:0048487),0.40147254576507313,1.1403126511947552,0.281203007518797,0.8714499878560481,1.0,5/31,10.90%,DLEC1;CCT5;LRPPRC;ARL8B;IFT74
prerank,5'-nucleotidase activity (GO:0008253),-0.4324100611651985,-1.13759763138926,0.27358490566037735,0.6849304616519286,1.0,7/13,31.78%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;NT5C2
prerank,CoA-ligase activity (GO:0016405),0.48026683701782774,1.1364924016436084,0.3016949152542373,0.878197239314818,1.0,1/14,1.11%,ACSS3
prerank,neuropeptide receptor activity (GO:0008188),0.4137627765087172,1.1361844444932094,0.29199372056514916,0.8729759882710744,1.0,2/29,2.15%,SORCS3;NPFFR1
prerank,calcium channel regulator activity (GO:0005246),0.39630504697901536,1.1359755721148623,0.29013254786450665,0.8675153489485198,1.0,9/37,15.68%,ITPR1;NRXN2;NRXN1;STIMATE;NPY;CACNG4;STIM1;PACSIN3;SGK1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4918715540163804,1.1343692580360705,0.3185689948892675,0.8671501881320324,1.0,2/12,7.51%,TRAF4;TRIM37
prerank,ribonuclease P RNA binding (GO:0033204),0.5076575660312802,1.1338005607207613,0.34285714285714286,0.8629261304997564,1.0,5/10,22.35%,RPP40;POP5;POP7;RPP21;POP4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4684340579951262,1.128757554156113,0.3110720562390158,0.8745892825266459,1.0,4/14,9.96%,RPP40;POP5;PRORP;POP7
prerank,protein kinase C activity (GO:0004697),0.4694473477362527,1.128348533827631,0.32926829268292684,0.8699420710097518,1.0,5/14,9.37%,PRKD3;PRKCI;PRKD1;PRKCA;PRKCB
prerank,thyroid hormone receptor binding (GO:0046966),0.41016959755237525,1.1274766371033185,0.28298887122416533,0.8669877878578177,1.0,10/28,20.92%,MED12;NCOA3;BRD8;NSD1;HMGN3;MED1;GTF2H1;PRMT2;TAF11;GTF2B
prerank,lipoprotein particle binding (GO:0071813),0.44642215685486564,1.1230105713524563,0.2996632996632997,0.8757893454349006,1.0,3/20,5.39%,COLEC12;LIPC;SORL1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4572755517612326,1.1191973851447405,0.3293918918918919,0.8829492166753081,1.0,5/16,18.68%,SLC18A3;SLC7A8;SLC25A26;SLC25A17;SLC44A1
prerank,pyrophosphatase activity (GO:0016462),0.3677658962077491,1.118432632725047,0.2951048951048951,0.8793233101330097,1.0,11/50,15.16%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA;NUDT9;TRPM2;ENTPD7;BNIPL;PLPP5;DHX9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4449187119452639,-1.114293765909384,0.32175925925925924,0.7437008527198072,1.0,10/11,55.54%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4952944452095291,1.1124702720582875,0.34594594594594597,0.8930565194790367,1.0,4/10,17.48%,STAMBPL1;ATXN3;YOD1;STAMBP
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4332536994483619,-1.1121955817628912,0.32027649769585254,0.7423636758890603,1.0,8/12,48.05%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A6;SLC2A3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4058012261571694,-1.1109440903200878,0.30238095238095236,0.738928919076916,1.0,3/16,19.46%,PIR;ETHE1;ALOX12
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4198222912061616,-1.1092704902677548,0.3225,0.736959099647578,1.0,8/13,14.71%,PDGFD;PTPRJ;IL1R1;VEGFD;PDGFA;PDGFC;ITGB3;ERN1
prerank,sequence-specific DNA binding (GO:0043565),0.2859738568505856,1.1077004652870226,0.20020429009193055,0.9036729210637126,1.0,92/590,15.33%,TBX18;RORA;ZBTB20;RUNX2;ISL2;PKNOX2;MSC;ATF5;ETV1;PPARA;HOXC10;TEAD1;ETV5;NR1H4;TEF;NR2F2;TCF7L2;TCF4;SMAD5;ZIC4;MEIS2;ZNF740;NFATC3;CXXC1;POU3F3;PPARD;TEAD2;TBX3;FOS;ZIC1;KMT2A;ZNF423;HOXC9;FOXN2;MYCN;DMRTA2;LIN28B;GLIS1;HLF;EPAS1;E2F4;MBD3;BCL6;ZCWPW1;NPAS2;SRF;CSRNP3;PAX9;ZBTB2;NR2C1;ALX4;TERF1;ZKSCAN3;CSRNP2;PIF1;ERH;SOX2;BHLHE22;OLIG2;GLI3;ZBTB43;HOXC8;SOX10;ZBTB26;HOXB9;MSX1;FOXJ2;CREB3L1;RFX2;SOX9;NFIX;TFEB;HOXB4;PRDM5;MYRF;DMRTA1;RFX4;SREBF1;HOXC4;ZFP1;ELK1;ARNT2;LONP1;CUX2;BPTF;ZBTB32;SAFB2;MAFB;HNRNPD;ATF2;FOXJ3;TFAP4
prerank,receptor tyrosine kinase binding (GO:0030971),0.3519214071120568,1.1072699463337103,0.29918032786885246,0.8991113746665286,1.0,10/56,11.60%,PIK3R1;NRG1;CBLB;FLT3LG;GAB2;PIK3R2;IRS1;FIZ1;TP53;NRG3
prerank,mRNA binding (GO:0003729),0.2946093110727389,1.1014144490424704,0.27601809954751133,0.9121788349613876,1.0,57/249,18.31%,RBFOX1;RBMS1;EIF4G3;CPEB1;GNL3;TRA2B;EIF4A3;NANOS3;RBM46;NOVA1;MYEF2;RBMS3;RBM24;SNRNP35;LSM14A;RNF40;FMR1;SF3B6;ZC3H12D;DND1;LARP6;CCT5;BOLL;KHDRBS3;ELAVL4;PCBP3;HNRNPA2B1;CELF4;NUDT21;LUC7L2;TP53;DHX36;RBFOX3;EDC3;CSDC2;RBM20;HDLBP;RBM4B;SLBP;EIF4ENIF1;RC3H2;DHX9;FYTTD1;SNRNP70;HNRNPLL;SRRM2;THOC5;HNRNPL;CALR;IGF2BP3;RBM5;PPP1R8;SRRM3;SRSF6;DXO;KHDRBS1;LSM14B
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4852019410200738,1.1012765013907306,0.3447653429602888,0.9067113681053212,1.0,2/11,10.16%,HCN2;HCN1
prerank,damaged DNA binding (GO:0003684),0.364151014541257,1.0994973725873651,0.32323232323232326,0.9064473781983008,1.0,11/44,15.84%,ERCC1;FEN1;POLQ;ERCC5;NEIL3;RPA1;ERCC4;XPC;XRCC1;ERCC2;CRY2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.49100165373872784,1.0981686790116083,0.35676625659050965,0.9052146062805108,1.0,2/10,9.40%,NAA10;NAA50
prerank,protein phosphatase binding (GO:0019903),-0.25713043312890754,-1.0965236714650735,0.22872340425531915,0.7658569436574031,1.0,37/117,17.98%,FOXO1;EGFR;IQGAP1;SIRPA;SHOC2;MAP3K5;VRK3;FBXL2;MAPK14;PPP1R16A;AKAP11;PPP1R3B;SH3RF2;MVP;PPP1R16B;MTMR9;PPP6R1;ITGA1;VCP;MAPT;CTTNBP2NL;MAP2K7;BAD;PHACTR4;KCNQ1;AP3B1;CEACAM1;SMG5;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;PPP1R11
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4588509805220695,1.0963969622441279,0.3739424703891709,0.9055075659977043,1.0,7/15,20.86%,CXXC1;KMT2A;WDR5;ASH2L;SETD4;KMT2C;RBBP5
prerank,NAD+ binding (GO:0070403),-0.4428612773081363,-1.0953312578487127,0.3503480278422274,0.7626379705991853,1.0,7/12,18.62%,SIRT3;ZC3HAV1;PARP9;CRYL1;HADH;SIRT1;SIRT5
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.3937195959620138,-1.0951432617648977,0.332541567695962,0.7563971876068621,1.0,6/18,22.34%,SMAD6;TGFB2;SMAD3;TGFBR3;TGFBR2;SMAD7
prerank,androgen receptor binding (GO:0050681),-0.35792768385135776,-1.0942464137119678,0.3076923076923077,0.7522107764403636,1.0,5/25,7.73%,FOXP1;DDX5;KDM4C;SMARCA4;TMF1
prerank,Tat protein binding (GO:0030957),-0.45764987542145796,-1.0939818421388667,0.35205183585313177,0.7464222775190933,1.0,3/10,6.11%,ACTB;SMARCA4;GABARAPL1
prerank,adrenergic receptor binding (GO:0031690),-0.3934879954185311,-1.0937248031475229,0.329923273657289,0.7406698551112055,1.0,4/16,3.37%,RAPGEF2;ARRDC3;GNAS;MAGI2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.43961190283812657,-1.0935921516375238,0.33035714285714285,0.7346140991643452,1.0,5/12,21.03%,SLC6A6;SLC3A2;SLC38A5;SLC36A4;SLC38A7
prerank,symporter activity (GO:0015293),-0.4608335425558624,-1.0924502759182688,0.35824175824175825,0.7314735107539395,1.0,10/10,53.95%,MFSD2A;SLC5A6;SLC5A5;SLC4A4;SLC46A2;SLC28A2;SLC5A8;SLC28A3;SLC28A1;SLC5A12
prerank,deoxyribonuclease activity (GO:0004536),0.45499749648991844,1.0917250066767863,0.3684210526315789,0.9152623484123753,1.0,4/14,14.52%,ERCC5;ERCC4;MBD4;NME1
prerank,water transmembrane transporter activity (GO:0005372),-0.44793860778568817,-1.0898661107977419,0.3449074074074074,0.7323430624298626,1.0,8/11,55.14%,PDPN;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7;SLC5A1
prerank,regulatory RNA binding (GO:0061980),0.3755557175378437,1.0898049218065538,0.32794117647058824,0.9156458214648403,1.0,9/38,11.29%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,adenyl nucleotide binding (GO:0030554),-0.4331955369968209,-1.0892500829226748,0.3251833740831296,0.7215964552019668,1.0,6/11,30.76%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4331955369968209,-1.0892500829226748,0.3251833740831296,0.7215964552019668,1.0,6/11,30.76%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,acid-thiol ligase activity (GO:0016878),0.4625994153160853,1.0889701255082618,0.3739565943238731,0.912688558077911,1.0,1/13,1.11%,ACSS3
prerank,transcription cis-regulatory region binding (GO:0000976),0.2846150399003879,1.0873739438563743,0.27848101265822783,0.9121589327667647,1.0,67/406,16.73%,TBX18;RORA;GBX1;ZBTB20;ISL2;BHLHA9;TRPS1;MSC;ATF5;HOXC10;TEAD1;ETV5;NR1H4;HDAC1;TCF7L2;BASP1;ERBB4;THRA;PER3;REST;FOS;SOX6;FOXN2;ZFP37;CREB3L2;EPAS1;PRDX5;ZBTB46;BCOR;ALX4;TWIST1;PER2;MXI1;SOX2;GLI1;GLI3;ZBTB43;HOXC8;SOX10;NFXL1;TP53;ZNF25;DHX36;MSX1;CREB3L1;SOX9;TWIST2;TFEB;PRDM5;CARM1;SREBF1;ELK1;PEG3;LONP1;FOXM1;CUX2;ATF2;TFAP4;AR;PBX2;MYC;CRY2;NONO;KLF11;ZNF3;ATMIN;HNRNPL
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.45105704805596086,-1.0862347579069374,0.39414414414414417,0.7236223276029349,1.0,4/10,13.91%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,carboxylic acid binding (GO:0031406),0.3798007533219275,1.0846837775392923,0.3522388059701492,0.9153990267747122,1.0,11/38,18.07%,THNSL2;GLDC;HIF1AN;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,snoRNA binding (GO:0030515),-0.33344399630287547,-1.0828361931677288,0.3215339233038348,0.7268240283646522,1.0,12/30,30.37%,PRKDC;DDX21;NUDT4;NUDT7;IMP3;NUFIP1;TSR1;NUDT16;NUDT16L1;NHP2;BMS1;RRP9
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3214788511520768,-1.0826686312532035,0.29705882352941176,0.7213462603526022,1.0,11/37,21.05%,SLCO2A1;SLCO1C1;SLC22A6;SLC22A4;SLC22A8;COX15;COX5B;COX4I1;COX6B1;SLCO5A1;UQCRQ
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4349952635062113,1.0824166018009673,0.3547297297297297,0.9111764613164063,1.0,5/17,10.44%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,ephrin receptor activity (GO:0005003),0.4349952635062113,1.0824166018009673,0.3547297297297297,0.9111764613164063,1.0,5/17,10.44%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,tubulin binding (GO:0015631),0.2856931400976311,1.0810392843226553,0.3065049614112459,0.910267180231092,1.0,58/295,14.35%,DLEC1;ATF5;CCDC61;REEP2;MDM1;MAP4K4;GJA1;EFHC1;IRAG2;MTCL1;FMR1;LRRK2;NEFH;CCT5;CENPE;STARD9;CLIP3;CEP295;SUN2;TTLL6;LRPPRC;IFT81;UNC5C;FAM161A;TERF1;SNPH;HAUS8;NAV3;GOLGA2;STMN2;PHF6;OPA1;CCSAP;BRCA2;STMN4;CAPN6;ARL8B;IFT74;TBCE;KATNA1;FYN;DNM1;AGBL4;RMDN1;TUBGCP4;NUSAP1;GAS8;SYBU;KIF5C;POLB;CLIP2;KIF9;TPGS1;MAP9;EML1;STMN1;CLASP2;KIF3C
prerank,kinase activity (GO:0016301),0.3129695290010988,1.0806035818006576,0.33859223300970875,0.9063840466096762,1.0,31/109,18.13%,PDXK;MAP4K4;PKMYT1;PRKD3;CDC7;CDKL5;LRRK2;SCYL3;PSTK;IPMK;NADK;COASY;PAPSS2;PI4KA;DGKQ;PRKD1;PINK1;MTOR;CKM;GK;IRAK1;CHKA;DGKI;AGK;IP6K1;LYN;CDK5;COQ8B;PIK3CG;PANK2;CAMK2A
prerank,poly(U) RNA binding (GO:0008266),0.4220899313098673,1.0800398476761852,0.3617363344051447,0.9028231385190244,1.0,3/20,4.89%,RBMS1;RBMS3;FMR1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2833707111422855,-1.0793267917530773,0.2863070539419087,0.7243520773387675,1.0,25/70,29.85%,B4GALT1;CSGALNACT1;B3GALT1;GXYLT2;EXT1;LARGE1;HEXB;HYAL1;MGAT4B;B3GALNT1;LFNG;MFNG;GCNT1;B3GLCT;B3GNT2;HAS1;GXYLT1;B3GNT9;POMGNT2;RFNG;B3GALT6;HAS2;B3GNT3;B4GALNT3;POMGNT1
prerank,CoA hydrolase activity (GO:0016289),-0.40011919947438634,-1.0786976181032795,0.3378684807256236,0.7202126878819912,1.0,5/16,15.24%,ACOT8;NUDT7;ACAA2;ACOT13;ACOT6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.455523905224009,-1.0783616291592386,0.3747178329571106,0.7153473355735838,1.0,3/10,8.94%,ANO6;ANO1;CLCN5
prerank,intracellular chloride channel activity (GO:0061778),-0.390436728482979,-1.0780792441346423,0.3673469387755102,0.704816684690377,1.0,2/16,2.45%,ANO6;ANO1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.390436728482979,-1.0780792441346423,0.3673469387755102,0.704816684690377,1.0,2/16,2.45%,ANO6;ANO1
prerank,amino acid binding (GO:0016597),0.3883930429431737,1.075732065589883,0.3665644171779141,0.9110220272878485,1.0,10/31,18.07%,THNSL2;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.38311202093193786,-1.075519751121968,0.3518987341772152,0.7006995442820909,1.0,6/16,21.84%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.38311202093193786,-1.075519751121968,0.3518987341772152,0.7006995442820909,1.0,6/16,21.84%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,fibroblast growth factor binding (GO:0017134),0.40862282181292114,1.0752809248502389,0.34210526315789475,0.9070666039184604,1.0,3/21,3.02%,ITGAV;FGFR1;FGFBP3
prerank,alpha-tubulin binding (GO:0043014),0.38463496533769415,1.0751905155583132,0.36037441497659906,0.9021010654593287,1.0,5/31,11.33%,DLEC1;EFHC1;ARL8B;TBCE;FYN
prerank,hexosyltransferase activity (GO:0016758),-0.2599662203975518,-1.0750934923315216,0.31343283582089554,0.6964604673203806,1.0,25/101,17.51%,B4GALT1;TMTC2;CSGALNACT1;B3GALT1;TMTC1;ALG9;B4GALT5;GBE1;EXT1;LARGE1;GYG1;TMTC4;HEXB;HYAL1;MGAT4B;ALG12;MTAP;B3GALNT1;FUT9;LFNG;DPY19L4;MFNG;GCNT1;B3GLCT;B3GNT2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.27500292358636486,1.0750754682298018,0.25175526579739216,0.8972325794524201,1.0,141/831,16.59%,TBX18;RORA;GBX1;ZNF367;ZEB1;ZBTB20;RUNX2;BHLHA9;TRPS1;ZFHX3;PKNOX2;MSC;ATF5;ETV1;PPARA;HOXC10;MEIS1;TEAD1;ETV5;NR1H4;HDAC1;TEF;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;ZFHX4;ZIC4;MEIS2;PGR;ZNF740;NFATC3;POU3F3;PPARD;MYT1;NR1H2;TEAD2;TBX3;REST;FOS;ZIC1;ZBTB24;SOX6;FOXO6;GTF2A1;ZNF423;HOXC9;ZBTB16;MYCN;ZFP37;DMRTA2;GLIS1;HLF;EPAS1;FOXS1;ZBTB46;E2F4;BCL6;NPAS2;SRF;PAX9;ZBTB2;NR2C1;ALX4;ZKSCAN3;TWIST1;CHD2;MXI1;SOX2;BHLHE22;GLI1;OLIG2;GLI3;NSD1;WIZ;ZBTB43;HOXC8;TBPL1;SOX10;NFXL1;TP53;ZNF25;DHX36;ZBTB39;ZBTB26;HOXB9;MSX1;MED8;PROX2;FOXJ2;RFX2;ESR2;SOX9;MYT1L;ZNF112;NRIP1;TWIST2;NFIX;ST18;TFEB;HOXB4;HIVEP3;PRDM5;HIC2;DMRTA1;ZNF628;RFX4;SREBF1;HOXC4;ZFP1;ELK1;PEG3;ARNT2;FOXM1;CUX2;BPTF;ZBTB32;MYNN;ZSCAN18;MAFB;ATF2;ZBTB25;DHX9;HOXC5;FOXJ3;TFAP4;AR;PBX2;MYC;ZKSCAN5;ZBTB7A;KLF11;ZNF467;HOXA9;ZNF3;ZBTB12;ZFP62;NR1D2;CIART
prerank,lysine N-methyltransferase activity (GO:0016278),0.40814079231955025,1.0739300550735829,0.35855263157894735,0.8954523633590754,1.0,7/20,22.04%,EEF1AKMT4;VCPKMT;SETD4;EHMT2;ATPSCKMT;ANTKMT;EHMT1
prerank,zinc ion binding (GO:0008270),0.2871566859608428,1.072589259951142,0.3164277839029768,0.8946086365332927,1.0,64/293,18.45%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;CBLB;HIF1AN;PDXK;GRIN2B;EPRS1;DUSP12;MYT1;SLC30A5;DNAJC24;KMT2A;CHD4;DHX58;ZFP37;GRIN2A;SIRT6;TARS1;ACR;ENPP3;CALB1;MDM4;TRIM8;DPYS;NSD1;BIRC2;SLU7;ZFPM2;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;USP33;P2RX4;PTGR2;KDM1B;RABIF;TRIM2;HDAC10;KDM5C;ZBTB32;TMEM163;KDM2A;ZKSCAN5;SEC23A;SEC24A;ZNF3;CALR;USP16;DPEP1;RNPEP;PEX12;MBD1;ADAM8;ANPEP;SUV39H2;KPNB1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3007717814231819,-1.069906678691734,0.33641975308641975,0.7042800696794064,1.0,19/49,24.96%,SQSTM1;ABRAXAS2;VCP;MINDY1;PARP10;OPTN;BRCC3;TAB2;RNF169;PSMD4;RAD23B;HDAC6;ZFAND2B;TNFAIP3;ZRANB3;IKBKG;ZFAND6;IKBKE;ATRIP
prerank,NADPH binding (GO:0070402),0.4651502291080614,1.0683516471570988,0.38620689655172413,0.9028272784852678,1.0,4/13,8.07%,GRHPR;MTRR;DUS2;KCNAB1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.34341425440885764,-1.068119979008814,0.3573407202216066,0.703819841953515,1.0,11/24,28.52%,DAPK1;CAMK2D;CAMK2B;CAMK2G;EEF2K;PTK2B;MKNK1;CAMK1G;CAMKK1;PHKG2;PHKA2
prerank,methylation-dependent protein binding (GO:0140034),0.34629546048772386,1.063533953783341,0.3654970760233918,0.9127472962353328,1.0,21/57,22.48%,KMT2E;L3MBTL1;PYGO1;CXXC1;FMR1;RRP8;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;BPTF;CHD8;MBTD1;MSH6;THAP7;RBBP5;ING3;KDM5A;ATRX;ZMYND8
prerank,endopeptidase inhibitor activity (GO:0004866),-0.257988753795815,-1.063274655264631,0.3014354066985646,0.7104620761851322,1.0,19/82,20.51%,SPOCK2;APP;CST3;COL4A3;PSMF1;SERPIND1;PTTG1;NGF;RENBP;SERPINE1;SERPINI1;SERPINA2;GAPDH;FURIN;SERPINE2;SPINT2;TIMP3;CAST;AGT
prerank,methylated histone binding (GO:0035064),0.34030037073757846,1.0632620600156129,0.35919540229885055,0.908414626825194,1.0,22/62,22.48%,KMT2E;L3MBTL1;PYGO1;CXXC1;FMR1;RRP8;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;DPF2;BPTF;CHD8;MBTD1;MSH6;THAP7;RBBP5;ING3;KDM5A;ATRX;ZMYND8
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.47973333539211305,1.0629204465658102,0.4076086956521739,0.9043477159754948,1.0,2/11,15.47%,RDH11;AKR1B1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4224578441045478,-1.0628358965385645,0.3880952380952381,0.7063391706753108,1.0,5/12,21.63%,PIEZO2;TMC7;TMC6;TMEM63B;PIEZO1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.4415843865520488,1.0615843159318668,0.40066225165562913,0.8983243752012484,1.0,6/16,10.55%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.4415843865520488,1.0615843159318668,0.40066225165562913,0.8983243752012484,1.0,6/16,10.55%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4303307329712275,1.0604196195047657,0.38341968911917096,0.8970757903543928,1.0,4/16,15.37%,SLC1A5;SLC25A22;SLC25A30;SLC25A14
prerank,phosphatase binding (GO:0019902),-0.25566140623096395,-1.058673614981429,0.3287671232876712,0.7115933555526489,1.0,34/105,18.05%,CTSC;EGFR;MAGI2;IQGAP1;CNST;SIRPA;SHOC2;MAP3K5;VRK3;WNK1;FBXL2;MAPK14;SH3RF2;MVP;MTMR9;PPP6R1;ITGA1;VCP;SMAD3;MAP2K7;BAD;PPP3R1;AP3B1;CEACAM1;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;CHCHD3;DLG1
prerank,calcium channel activity (GO:0005262),0.31452089277179357,1.0573947799276764,0.36772486772486773,0.9015625718744139,1.0,14/84,12.40%,SLC24A5;CACNA1E;ITGAV;CACNG3;RYR2;TRPV3;CATSPER3;TRPC3;CACNB4;CACNG4;P2RX4;TRPM2;TRPC7;CUL5
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.313621494607713,-1.056480509246831,0.3510971786833856,0.7119219814734646,1.0,10/38,12.23%,SORBS1;SHANK3;MAGI2;MAPK8IP3;NCK1;SHANK1;SPAG9;SH2B1;FRS2;DLG5
prerank,protein kinase binding (GO:0019901),-0.2132329466503988,-1.0555916818591469,0.17073170731707318,0.7091622963351555,1.0,108/479,16.44%,PRKAG2;EPHA4;MAP3K1;MAPK4;RHOBTB1;SLC12A7;IL31RA;CAV1;PDLIM5;PTPRJ;BCL2L1;ACTB;TRIB2;ITGB1;PTPRK;EZR;BMPR2;BECN1;ELAVL1;RICTOR;IQGAP1;CSPG4;SIRPA;NEK6;SQSTM1;CAVIN2;CCND2;ATG13;RHOBTB2;SKI;MAPK8IP3;APC;NEDD9;MAVS;DVL1;ACE;CAV2;RAC1;ADAM10;TFRC;SYN1;TJP2;WNK1;RPS7;TRIM5;CDC42;PARN;RPS19;ERRFI1;CALM1;TRIM14;SIK1;PFKFB2;MVP;GSK3B;ACVR1;ANK2;RHOC;ACVRL1;GCH1;MAPT;EXOC2;SMAD3;FRMD5;YWHAG;AP2A1;MAP2K7;BAD;CAVIN3;EEF1A1;PPEF2;PPM1D;ADCY6;SPAG9;PTPN2;KCNQ1;PTPN1;CCDC88A;HSPB1;ACTA2;CEACAM1;SPRED3;MAPKAP1;PLCG2;PRKAR2A;NR3C1;PRKAG3;CYLD;NOX4;SMAD1;TRPV4;NBEAL2;IRAK4;PRKAR2B;CDH5;HINT1;GATA6;CCND1;TICAM1;GRB2;CDKN1A;PRKCD;SIRT1;DACT2;ESR1;PRDX3;PAK2;TRIM27
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4914737214330836,1.054967381195382,0.41847826086956524,0.9037727291368644,1.0,3/10,13.91%,CDKN2A;CDKN2D;CDKN2C
prerank,voltage-gated calcium channel activity (GO:0005245),0.3639179808467813,1.0528271792138213,0.3874425727411945,0.9056123657760944,1.0,7/37,10.36%,CACNA1E;ITGAV;CACNG3;CACNA1G;CATSPER3;CACNB4;CACNG4
prerank,alkali metal ion binding (GO:0031420),0.454373695407978,1.0524975661613065,0.4061433447098976,0.901751036449969,1.0,3/13,6.68%,ATP1A2;PDXK;CAPN3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.46788896979393885,1.052421678090018,0.40037950664136623,0.8971418138759296,1.0,3/10,11.54%,FAN1;DAXX;FAAP20
prerank,protein serine/threonine kinase activity (GO:0004674),-0.21825677224206608,-1.0500505299930114,0.2903225806451613,0.7185885309176927,1.0,105/334,23.87%,DAPK1;MAP3K1;MAPK4;ROCK2;PRKCH;MARK1;EGFR;MYLK;BMPR2;IRAK2;CSNK1D;MARK4;MAP3K5;NEK6;PRKDC;SQSTM1;CAMK2D;TOP1;WNK4;MINK1;SIK3;PRKAA2;TLK1;VRK3;SNRK;MAPK9;WNK1;CDK6;HIPK3;MAPK14;NRBP2;SIK1;HIPK1;GSK3B;RIOK1;ACVR1;CDC42BPB;ACVRL1;TLK2;NEK7;STK38L;RPS6KA5;CDK19;DYRK2;MAST3;CAMK2B;MAP3K8;CDKL2;RPS6KA1;CAMK2G;RIOK3;ATR;FASTK;SRPK1;PRKCZ;HIPK2;CSNK1G3;GAK;BCR;IRAK4;PTK2B;ATM;MAP3K4;CPNE3;ERN1;CDC42BPG;MARK3;STK17B;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;STK32B;MAP3K10;ACVR2B;CSNK2B;AKT1;CDK9;NUAK2;MAP4K3;SBK1;MARK2;VRK2;CSNK1A1;ULK3;MKNK1;PKN3;PIM2;TGFBR2;ALPK1;NEK10;TTBK1;CDKL4;BRD2;PASK;STK39;PLK4;IKBKB;TAOK2;NIM1K;PAK4;CDK16;ACVR2A
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4135262468889299,-1.0486695453680706,0.38848920863309355,0.7169500410523995,1.0,5/12,8.77%,IGF1;GNAS;INSR;SOCS2;YWHAG
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2929789936858464,1.0473784188038675,0.3884297520661157,0.9076038401796297,1.0,29/173,16.41%,TBX18;ZEB1;ZBTB20;TRPS1;ZFHX3;PPARA;NFATC3;PPARD;TBX3;REST;ZBTB16;ZFP37;BCL6;ZBTB2;ZKSCAN3;MXI1;ZNF25;ZBTB39;ZBTB26;CREB3L1;MYT1L;PRDM5;HIC2;PEG3;ZBTB32;ZBTB25;MYC;ZNF3;ZBTB12
prerank,nucleoside-diphosphatase activity (GO:0017110),0.4536791199004927,1.0459629504987318,0.4059233449477352,0.9070717421744362,1.0,3/12,12.34%,ENTPD2;ENTPD5;ENTPD7
prerank,mRNA 3'-UTR binding (GO:0003730),0.3195402477371442,1.0448301155703024,0.3759894459102902,0.905379951004502,1.0,17/79,12.22%,RBMS1;CPEB1;RBMS3;RBM24;RNF40;FMR1;DND1;CCT5;BOLL;ZFP36L2;ELAVL4;HNRNPA2B1;NUDT21;TP53;DHX36;CSDC2;EXOSC9
prerank,potassium channel regulator activity (GO:0015459),0.3385209649781701,1.0432907355323806,0.37700145560407566,0.9053989964632434,1.0,10/49,15.68%,DPP6;DPP10;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNE4;KCNAB3;WNK2;SGK1
prerank,protein kinase regulator activity (GO:0019887),-0.2547977488095983,-1.0417205475040894,0.3514644351464435,0.7290923883411112,1.0,31/95,20.81%,PRKAG2;CCNYL1;RPLP1;CCND2;GPRC5C;APC;WNK1;YWHAB;NCK1;CCNG1;MADD;CAB39;PRKAR2A;PRKAG3;PRKAR2B;CCND1;KIDINS220;CDKN1A;MAPK8IP1;CCNE2;CCNL2;CSNK2B;WNT11;HEXIM1;MARK2;NPM1;RGCC;DNAJC3;GSKIP;ELP3;DUSP19
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4378004613622986,1.0397722943104597,0.4358523725834798,0.9112441405360977,1.0,2/13,4.23%,FAN1;FEN1
prerank,N-acyltransferase activity (GO:0016410),0.3640206240507894,1.037550102923049,0.4161392405063291,0.9133354903029252,1.0,8/32,16.38%,NAA10;NAT10;CERS4;TLCD3B;NAA50;NAT8L;CERS6;GNPNAT1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4315075292158085,1.0372075783974022,0.41450777202072536,0.9096142204512866,1.0,3/15,9.16%,PIK3R1;PIK3R2;CCKBR
prerank,C-C chemokine receptor activity (GO:0016493),0.4013021799231936,1.0362966477397213,0.40842787682333875,0.9076740835012478,1.0,2/21,3.25%,ACKR2;CCR9
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2862728104972658,-1.035189491081518,0.3879003558718861,0.7410039323577198,1.0,6/49,5.28%,ANXA3;ANXA5;MCTP1;SYT9;PLA2G4A;ANXA1
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.3823637348901183,-1.0333618543854737,0.39675174013921116,0.7406159092813852,1.0,5/17,15.24%,ACOT8;PLA2G6;ACAA2;ACOT13;ACOT6
prerank,C-C chemokine binding (GO:0019957),0.39536352922928,1.0315357079331098,0.41798107255520506,0.9170931067792832,1.0,2/22,3.25%,ACKR2;CCR9
prerank,retinoic acid binding (GO:0001972),-0.4113394930301219,-1.0307723753889908,0.39770114942528734,0.7418324015457638,1.0,2/12,6.34%,CYP26B1;RXRA
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.32085103749397903,1.0306644329180774,0.41237113402061853,0.9151493951554812,1.0,12/73,16.10%,RXFP3;SORCS3;CALCRL;NPFFR1;GPR37L1;CRHR2;CCKBR;S1PR2;F2R;LGR5;LHCGR;GPR37
prerank,poly-pyrimidine tract binding (GO:0008187),0.3914401137575459,1.0301292718052142,0.4363929146537842,0.9120878015550675,1.0,3/23,4.89%,RBMS1;RBMS3;FMR1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2642247338688239,1.029566648218236,0.38368580060422963,0.9091059206235189,1.0,129/732,17.59%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;RUNX2;ISL2;ZFHX3;PKNOX2;MSC;ETV1;PPARA;HOXC10;MEIS1;TEAD1;NR1H4;HDAC1;TEF;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;ZFHX4;ZIC4;MEIS2;PGR;ZNF740;NFATC3;POU3F3;PPARD;MYT1;NR1H2;TEAD2;TBX3;REST;FOS;ZIC1;ZBTB24;SOX6;FOXO6;ZNF423;HOXC9;FOXN2;ZBTB16;MYCN;DMRTA2;GLIS1;HLF;FOXS1;E2F4;BCL6;NPAS2;SRF;PAX9;ZBTB2;NR2C1;ZKSCAN3;CHD2;MXI1;SOX2;BHLHE22;GLI1;OLIG2;GLI3;NSD1;WIZ;SOX10;TP53;DHX36;ZBTB39;ZBTB26;HOXB9;MED8;PROX2;FOXJ2;RFX2;ESR2;SOX9;MYT1L;ZNF112;NRIP1;NFIX;ST18;TFEB;HOXB4;HIVEP3;PRDM5;HIC2;DMRTA1;ZNF628;RFX4;SREBF1;HOXC4;ZFP1;ELK1;ARNT2;BPTF;ZBTB32;MYNN;ZSCAN18;MAFB;ATF2;ZBTB25;DHX9;HOXC5;FOXJ3;TFAP4;AR;PBX2;MYC;ZKSCAN5;ZBTB7A;KLF11;ZNF467;HOXA9;ZBTB12;ZFP62;NR1D2;CIART;ONECUT2;DNMT3A;MAZ;ZIC5;ZBTB11;SARS1;ZNF32;SAFB
prerank,lipoprotein particle receptor binding (GO:0070325),0.3753108680245645,1.0293428057937888,0.4022082018927445,0.9052219958435329,1.0,7/27,18.66%,LRP1;HSPG2;RELN;HSP90B1;CLU;LDLRAP1;SYT1
prerank,nuclear receptor binding (GO:0016922),0.29225184859503495,1.0261960300387745,0.3883374689826303,0.9101143090679414,1.0,28/111,16.84%,NR1H4;PPID;TCF7L2;DNAAF4;NCOA2;GRIP1;MED12;JUP;NCOA3;BRD8;NCOA1;PRKCB;NSD1;DAXX;HMGN3;SNW1;NRIP1;CNOT1;ASXL1;MED1;MED25;GTF2H1;PRMT2;MMS19;DCAF1;ZBTB7A;TRIP4;CALR
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.42819999827741306,1.0248683019597873,0.4137353433835846,0.9094935990544885,1.0,4/16,6.29%,PTEN;SACM1L;MTMR4;MTMR1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4097283031880872,1.0248435474506183,0.4223300970873786,0.9051011446969877,1.0,6/17,15.09%,AK4;NME6;NOL9;AK8;NME1;AK3
prerank,5'-3' exonuclease activity (GO:0008409),0.42470475888038256,1.0247711485172288,0.4240400667779633,0.9008804474628765,1.0,5/14,22.99%,FAN1;FEN1;DXO;TRIR;DCP2
prerank,GTPase activity (GO:0003924),-0.22480660016047993,-1.022891625821784,0.36428571428571427,0.757303038416271,1.0,54/192,19.38%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;RASL12;RAP1A;RAB23;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARHGDIB;RAB21;DNM3;GBP4;RAB5A;RAB5C;RHOC;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;NKIRAS1;RAB35;GBP6;RALB;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;GNAZ;ARL1;GNA14;GPN3;RAB1A;GTPBP1;RAB6A;GNG11;RAP2B;TSR1;GSPT2;RRAGB;RAB4A;RERG
prerank,calcium activated cation channel activity (GO:0005227),-0.36695763028276795,-1.0216460245161472,0.4229828850855746,0.7551469108547898,1.0,2/17,2.45%,ANO6;ANO1
prerank,DNA binding (GO:0003677),0.26127657631917206,1.0208336637778261,0.4238143289606458,0.907928420420753,1.0,154/694,20.07%,RORA;C1D;ISL2;RBMS1;ATF5;ARID3A;PPARA;MEIS1;TEAD1;ETV5;NR1H4;NR2F2;TCF7L2;TCF4;POLG;TAF12;ERCC1;ZIC4;MBD6;MEIS2;MCM7;PGR;TIPIN;POU3F3;PPARD;NR1H2;FAN1;FEN1;POLQ;TBX3;SOX6;GTF2A1;ZNF423;ERCC5;CHD4;ZBTB16;MSH3;MYCN;RTF1;HLF;EPAS1;FOXS1;TLR8;E2F4;MBD3;NEIL3;POLA1;ACR;BCL6;NPAS2;HP1BP3;CSRNP3;HMCES;RPA1;LYAR;NR2C1;ERCC4;ALX4;TERF1;ZKSCAN3;CSRNP2;SPTY2D1;POLL;CHD2;WBP11;SOX2;GLI1;APLP2;XPC;SRRT;BRCA2;RFC3;CR2;SOX10;SMARCA1;MCM4;TP53;ZNF292;DHX36;TOP3A;GTF3C4;RFX2;ESR2;SOX9;RAD52;CENPC;CDT1;POLG2;SPRTN;PRDM5;HIC2;MYRF;SREBF1;MBD4;TSG101;ERCC2;SSBP2;LONP1;MCM10;AIFM2;CUX2;BPTF;CHD8;ZBTB32;SAFB2;MAFB;RC3H2;DHX9;FOXJ3;TFAP4;MLF1;MYC;CRY2;WDR76;ZBTB7A;ZNF3;ZCCHC3;CALR;TRIM26;DNMT3A;SMC1A;RBM5;ILF3;NHEJ1;FBH1;SAFB;MBD1;KHDRBS1;TOP2A;MSH6;MCMDC2;ZEB2;ARNT;WRN;CBFB;CARF;ZNF711;HIF1A;HDGFL2;RBM6;ATAD5;CREBZF;SSBP1;NR2C2;REXO4;DEDD2;HIVEP2;GTF3C3;HOXB2;SP1;CNBP;MLH1;DDB1;LRRFIP1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.26177287386034825,1.0202426034325682,0.42338709677419356,0.9052477114323567,1.0,130/731,17.59%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;RUNX2;ZFHX3;PKNOX2;MSC;ETV1;PPARA;HOXC10;MEIS1;TEAD1;NR1H4;HDAC1;TEF;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;ZFHX4;ZIC4;MEIS2;PGR;ZNF740;NFATC3;POU3F3;PPARD;MYT1;NR1H2;TEAD2;TBX3;REST;FOS;ZIC1;ZBTB24;SOX6;FOXO6;ZNF423;HOXC9;ZBTB16;MYCN;CREB3L2;DMRTA2;GLIS1;HLF;FOXS1;E2F4;BCL6;NPAS2;SRF;PAX9;ZBTB2;NR2C1;ZKSCAN3;TWIST1;CHD2;MXI1;SOX2;BHLHE22;GLI1;OLIG2;GLI3;NSD1;WIZ;SOX10;TP53;DHX36;ZBTB39;ZBTB26;HOXB9;MED8;PROX2;FOXJ2;CREB3L1;RFX2;ESR2;SOX9;MYT1L;ZNF112;NRIP1;NFIX;ST18;TFEB;HOXB4;HIVEP3;PRDM5;HIC2;DMRTA1;ZNF628;RFX4;SREBF1;HOXC4;ZFP1;ELK1;ARNT2;BPTF;ZBTB32;MYNN;ZSCAN18;MAFB;ATF2;ZBTB25;DHX9;HOXC5;FOXJ3;TFAP4;AR;PBX2;MYC;ZKSCAN5;ZBTB7A;KLF11;ZNF467;HOXA9;ZBTB12;ZFP62;NR1D2;CIART;ONECUT2;DNMT3A;MAZ;ZIC5;ZBTB11;SARS1;ZNF32;SAFB
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4065936623553076,-1.019746574032602,0.42727272727272725,0.7547237674560867,1.0,6/13,29.78%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,phosphatase activator activity (GO:0019211),-0.396011707196377,-1.0191230650918193,0.41920374707259955,0.7511945291991221,1.0,7/14,29.92%,CALM1;PHACTR4;FRS2;PPP2R5D;PPP2R5B;PPP2R5C;PPP1R15A
prerank,GTPase binding (GO:0051020),-0.22915502940737134,-1.018246909486084,0.43478260869565216,0.748439102652186,1.0,43/194,14.16%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;FNBP1L;RNF152;AFDN;RAPGEF6;BECN1;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;RASIP1;EXOC5;SH3BP4;SRGAP2;ARHGDIB;PPP6R1;RANGAP1;RALBP1;RUSC2;EXOC2;SGSM2;RRAGC;OPTN;RNF41;MYO1C;MAPKAP1;GOLGA4;TBC1D7;ALS2;EVI5L;CCDC186;ENO1;FLNA;BICD2;YBX1;LSM2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.21755325913092988,-1.016990393791197,0.4074074074074074,0.7465835010820978,1.0,57/254,18.46%,NFIB;MECOM;FOXO1;MEF2C;LEF1;RBPJ;ELK3;ERG;FOXC1;MEF2A;ELF1;KLF4;NFKB1;FOXC2;KLF7;MLXIP;ATF6;RUNX1;NFYC;SIX1;PRDM2;ELF4;SOX4;IRF2;PLAG1;SOX17;PLAGL1;SMAD3;PRDM16;MYBL1;NR4A1;IRF1;NR4A2;CASZ1;ETS1;ZNF76;MZF1;RLF;NR3C1;SMAD1;ZIC3;GTF2I;CDC5L;ZNF585A;ZNF585B;ELK4;NFYB;CREB1;ESR1;HHEX;NFKB2;CLOCK;SOX18;CREB3;HOXD3;UBP1;SOX11
prerank,alpha-actinin binding (GO:0051393),-0.34093095583355826,-1.0126954760653617,0.44054054054054054,0.7528061343756319,1.0,14/24,38.32%,CACNA1C;PDLIM5;DAG1;PDLIM3;MAGI1;PKD2L1;TTN;SYNPO2;PPARG;PDLIM2;PDLIM1;NRAP;MYPN;KCNA5
prerank,chemorepellent activity (GO:0045499),0.37337414289811105,1.0115143650601206,0.43788819875776397,0.9261613608441093,1.0,3/25,2.10%,EPHA7;NRG1;SEMA5A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.46519857787053875,1.0110062046324522,0.4654205607476635,0.9232504719576903,1.0,3/10,10.62%,GABRA1;GABRG3;GABRG2
prerank,ubiquitin binding (GO:0043130),-0.2535118316127952,-1.0101110860267855,0.4163568773234201,0.7545206897485273,1.0,26/73,23.75%,NPLOC4;DDI2;MARK4;RNF185;SQSTM1;ASCC2;TOLLIP;SMAD3;HSPB1;OTUB1;UBE2N;USP25;UCHL1;RAE1;UBE2L6;BUB3;RAD23B;FAF2;VPS28;MVB12B;WDR48;TNFAIP3;VPS36;ADRM1;ILRUN;IKBKG
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.27738706851445766,-1.0098238244216495,0.38661710037174724,0.750199528839538,1.0,17/53,17.96%,DDO;MICAL2;NOS3;PRODH;CYB5R3;XDH;ETFDH;PPOX;NQO2;MTHFR;NOS1;NOX4;CYB5R1;SDHA;MICAL3;AIFM1;NDOR1
prerank,chemokine binding (GO:0019956),0.3627818313887708,1.0097148304437027,0.4611872146118721,0.922620005944567,1.0,4/30,8.51%,ITGAV;ACKR2;CCR9;PLP2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.375846454170053,1.0082077402496354,0.4345718901453958,0.9223976846528135,1.0,7/25,13.30%,GAB2;FCHSD2;ADAP2;PLEKHA1;COMMD1;MYO1G;DAPP1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.25943941771247375,1.0080836461028055,0.45528455284552843,0.9183825116502896,1.0,103/597,16.80%,TBX18;ZBTB20;RUNX2;ISL2;PKNOX2;MSC;ATF5;ETV1;HOXC10;TEAD1;ETV5;TEF;TCF7L2;TCF4;BASP1;ERBB4;THRA;SMAD5;ZIC4;MEIS2;PER3;MCM7;ZNF740;NFATC3;PPARD;TEAD2;TBX3;REST;FOS;ZIC1;SOX6;HOXC9;FOXN2;MYCN;CREB3L2;DMRTA2;LIN28B;GLIS1;HLF;E2F4;BCOR;POLA1;BCL6;NPAS2;SRF;PAX9;ZBTB2;NR2C1;ALX4;PER2;SOX2;BHLHE22;GLI1;OLIG2;GLI3;ZBTB43;HOXC8;SOX10;MCM4;TP53;DHX36;ZBTB26;HOXB9;MSX1;FOXJ2;CREB3L1;RFX2;SOX9;CENPC;NFIX;TFEB;HOXB4;PRDM5;CARM1;DMRTA1;RFX4;SREBF1;HOXC4;MBD4;ZFP1;ELK1;ARNT2;MCM10;CUX2;ZBTB32;TSPYL2;ATF2;DHX9;FOXJ3;TFAP4;AR;ORC2;CRY2;NONO;ZBTB7A;KLF11;HOXA9;ZBTB12;NR1D2;ATMIN;HNRNPL;MBD2;ONECUT2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3549349811762573,1.0076715146603665,0.44075829383886256,0.9151333248735165,1.0,11/33,20.92%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;AR;AGO1;LLPH;CDC73;GTF2B
prerank,nuclear import signal receptor activity (GO:0061608),0.4120670207396881,1.0067647576303764,0.4430147058823529,0.9134959194193393,1.0,7/15,22.62%,TNPO1;KPNA1;TNPO2;IPO9;KPNB1;KPNA2;IPO4
prerank,chloride channel activity (GO:0005254),0.31184264718029403,1.0040480889276917,0.4491279069767442,0.9167900175929876,1.0,14/59,15.07%,ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;CLCN6;GLRA2;GABRB1;GLRB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.25964360677955045,-1.0037346679877692,0.41796875,0.7612456721923423,1.0,16/72,13.54%,PLCB1;PICALM;ACTN2;MARK1;SNX18;PARD3;HIP1R;GSN;SNX21;FZD7;VILL;KCNJ2;KCNQ1;RAB35;MAPKAP1;HIP1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.31523886153857456,-1.003253999557967,0.42587601078167114,0.7575667377032109,1.0,9/27,22.50%,CRCP;POLR2B;POLR2G;PRIMPOL;POLR2C;POLR1H;POLR1C;POLRMT;POLR3K
prerank,RNA stem-loop binding (GO:0035613),0.4432300335252357,1.0025539814255315,0.45225225225225224,0.916532423931882,1.0,5/12,15.16%,EPRS1;FMR1;LARP6;RC3H2;DHX9
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3141533403735096,1.000048858914179,0.45234899328859063,0.9193728942725365,1.0,15/71,11.52%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP1;PTPN22;PALD1;DUSP22;PTPN13;PTPRU;PTPRO;TNS2;PTPRA;UBASH3B
prerank,ribosome binding (GO:0043022),0.3327443725394164,0.9994768287714154,0.4697406340057637,0.9166370814378145,1.0,18/46,27.42%,CPEB1;NAA10;FMR1;SEC61B;EIF2S1;BAG6;EFL1;EIF3C;YTHDF1;MRPS27;NAA16;GEMIN5;CCDC47;SHFL;ETF1;SEC61A1;IGHMBP2;MAIP1
prerank,solute:sodium symporter activity (GO:0015370),-0.32110489539694226,-0.999219096912574,0.4444444444444444,0.7627372485754726,1.0,22/27,56.22%,SLC4A10;SLC4A8;SLC20A1;SLC4A7;SLC5A6;SLC4A9;SLC4A5;SLC4A4;SLC34A3;SLC5A3;SLC28A2;SLC13A5;SLC5A10;SLC5A8;SLC17A7;SLC28A3;SLC28A1;SLC5A1;SLC34A2;SLC5A2;SLC5A9;SLC17A1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.19832530118859207,-0.996860086168128,0.5087719298245614,0.7640838598235438,1.0,116/431,20.85%,PRKAG2;DAPK1;RHOBTB1;MARK1;MRAS;KRAS;RRAS2;ABCD3;MARK4;GBP7;MAP3K5;RASL12;NEK6;RAP1A;INSR;DRG1;ABCD4;HSPA8;TOP1;RHOQ;RHOBTB2;WNK4;MINK1;SIK3;TLK1;RAC1;SNRK;GBP5;SYN1;WNK1;PEX1;CDK6;CDC42;ARL6;PRAG1;SIK1;PGK1;RAB21;ADSS2;ABCC6;GBP4;RAB5A;ACVR1;CDC42BPB;RHOC;GBP2;ACVRL1;GCH1;TLK2;RAB31;STK38L;RPS6KA5;ABCF1;DYRK2;DRG2;EEF1A1;RRAGC;RAB13;SMARCA5;TAP2;ARL2;ABCF2;RAB35;REM1;SYN3;GBP6;RTEL1;RALB;SRPK1;TGM2;CLPX;MYH10;GUK1;PSMA6;PMVK;RAN;RAB38;RRAS;PFKL;GNL1;TBCK;ERN1;RAP2C;CDC42BPG;ABCB8;P2RX7;STK17B;ATL3;ARL1;NOA1;ATP5F1D;TUBB2A;RAB6A;RAP2B;AKT1;NUAK2;TSR1;RRAGB;MAP4K3;MCM6;CLP1;RAB4A;MARK2;DYNC1LI1;RERG;TRNT1;MFHAS1;ABCB9;TUBA1C;MKNK1;RAB1B;ARL4C;SCG5;MLKL;TWF2;RHOH
prerank,nuclear receptor coactivator activity (GO:0030374),0.32272682118246593,0.994559513517277,0.44832826747720367,0.925807741428689,1.0,11/52,14.08%,NCOA2;MED12;NCOA3;ACTN1;BRD8;NCOA1;PRKCB;ENY2;CARM1;MED1;ELK1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4449380513373938,0.9944359406301495,0.4664310954063604,0.9218932536664411,1.0,3/11,7.85%,RPA1;HNRNPA2B1;TERF1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3237030473674157,-0.9935136780925153,0.4477211796246649,0.7675290516011314,1.0,4/25,4.40%,MICAL2;CYP26B1;NOS3;FMO2
prerank,cell adhesion mediator activity (GO:0098631),0.3732588931637039,0.9935061510223614,0.4723127035830619,0.9204361113439098,1.0,8/24,11.25%,DSCAM;CNTN4;PALLD;DSCAML1;JAM3;NEXN;CNTN6;LRRC4C
prerank,potassium ion leak channel activity (GO:0022841),0.41541137571465014,0.9934083913581817,0.466996699669967,0.916511372361817,1.0,4/15,16.28%,KCNK2;TMEM175;KCNK1;KCNK13
prerank,small GTPase binding (GO:0031267),-0.22725727480708455,-0.9911884188629821,0.4697986577181208,0.7684214711999043,1.0,37/169,14.16%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;RNF152;AFDN;RAPGEF6;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;EXOC5;SH3BP4;SRGAP2;ARHGDIB;PPP6R1;RANGAP1;RALBP1;RUSC2;EXOC2;SGSM2;OPTN;RNF41;MYO1C;MAPKAP1;GOLGA4;TBC1D7;ALS2;EVI5L;CCDC186;FLNA;BICD2;LSM2
prerank,vitamin D receptor binding (GO:0042809),0.4155537617841287,0.9910521191615123,0.46935201401050786,0.9189907057861909,1.0,5/14,20.39%,MED12;SNW1;MED1;TAF11;MED14
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2736965202696838,0.9910340965020251,0.4878048780487805,0.9148989724869644,1.0,42/181,19.71%,PPARA;MIER2;PTPRT;NR1H4;HDAC1;TCF7L2;HIF1AN;CDKN2A;NCOA2;JUP;PPARD;MDFIC;TBX3;FOS;NCOA3;CHD4;BRMS1;FIZ1;PIAS2;NCOA1;ZFPM2;TP53;SNW1;NRIP1;ATN1;MED1;ELK1;ARNT2;ATF2;DHX9;DMAP1;AR;TRIP4;BBS1;LDB2;LDB1;ARNT;HIF1A;DDRGK1;MTA3;RERE;SP1
prerank,protein phosphatase activator activity (GO:0072542),-0.3919200981763016,-0.9907033698572866,0.4823529411764706,0.7648590809122832,1.0,5/13,18.31%,IGFBP3;CALM1;PHACTR4;PPP2R5D;PPP2R5B
prerank,receptor antagonist activity (GO:0048019),0.400551529326806,0.9904736843355165,0.45563139931740615,0.9122690996147027,1.0,1/17,0.67%,IL1RN
prerank,amyloid-beta binding (GO:0001540),0.30268241295110365,0.9891886981023491,0.4800531914893617,0.9117326908719053,1.0,15/79,11.72%,LRP1;HSPG2;GRIA3;GRIN2B;GRIA4;GRIA1;NGFR;ATP1A3;TLR6;SORL1;GRIN2A;C1QA;TLR4;IAPP;GSAP
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.434055499543038,0.9882118982228147,0.5037174721189591,0.9104067900164301,1.0,4/12,14.49%,GABRA1;GABRG3;GABRG2;GABRB1
prerank,aspartic-type peptidase activity (GO:0070001),-0.4169396579822111,-0.9880453806579378,0.49336283185840707,0.7666995292150017,1.0,1/10,2.51%,DDI2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29280827416742616,0.9876439229398418,0.46589446589446587,0.907985578726166,1.0,21/100,15.06%,ZFYVE28;OGT;GAB2;MYO10;WDR45B;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ZFYVE26;ARAP2;GSDMD;PLEKHA5;MYO1G;ARFIP1;DAPP1;CLVS1;SNX12;FERMT2
prerank,phosphotyrosine residue binding (GO:0001784),0.3359130375264451,0.9869997373941108,0.48005908419497784,0.9056665536602461,1.0,13/37,23.06%,PIK3R1;PIK3R2;IRS1;FGR;CRK;LDLRAP1;SH3BP2;NCK2;PIK3R3;PTPN11;BCAR3;ABL1;VAV2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3461155905855576,0.9865930675424512,0.47832817337461303,0.9027747178612074,1.0,12/34,22.04%,EEF1AKMT4;KMT2E;VCPKMT;DOT1L;N6AMT1;SETD4;EHMT2;ATPSCKMT;CAMKMT;MEN1;ANTKMT;EHMT1
prerank,SH2 domain binding (GO:0042169),0.35252321308139944,0.9839306048516346,0.48,0.9061090484074433,1.0,5/31,7.60%,DLC1;PAG1;IRS1;RUFY1;PTK2
prerank,double-stranded DNA binding (GO:0003690),0.2542345952639031,0.9831764483668566,0.5209397344228804,0.9042862265892292,1.0,90/531,18.43%,TBX18;ZBTB20;RUNX2;ISL2;RBMS1;PKNOX2;MSC;ETV1;HOXC10;TEAD1;ETV5;TEF;TCF4;SMAD5;ZIC4;MEIS2;ZNF740;NFATC3;PPARD;FEN1;TEAD2;TBX3;FOS;ZIC1;ERCC5;HOXC9;FOXN2;MSH3;MYCN;DMRTA2;LIN28B;GLIS1;HLF;E2F4;NEIL3;BCL6;NPAS2;SRF;PAX9;ZBTB2;NR2C1;ALX4;TERF1;BHLHE22;OLIG2;GLI3;ZBTB43;HOXC8;SOX10;ZBTB26;HOXB9;MSX1;FOXJ2;CREB3L1;RFX2;SOX9;POLG2;NFIX;SPRTN;TFEB;HOXB4;DMRTA1;RFX4;SREBF1;HOXC4;ZFP1;ELK1;ARNT2;CUX2;ZBTB32;ATF2;DHX9;FOXJ3;TFAP4;ZBTB7A;KLF11;HOXA9;ZBTB12;NR1D2;ONECUT2;ZCCHC3;ZIC5;ZNF32;FBH1;SAFB;MBD1;MSH6;SKOR2;NFAT5;ARNT
prerank,carboxy-lyase activity (GO:0016831),0.3674199138848157,0.98162701155834,0.47299509001636664,0.9046202602292068,1.0,3/23,9.41%,ODC1;UXS1;GGCX
prerank,RNA polymerase II complex binding (GO:0000993),0.34913899893490113,0.9811311452397672,0.46141479099678456,0.9020492741393403,1.0,10/32,20.92%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;SCAF1;DHX9;AGO1;CDC73;GTF2B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3879015189364154,0.9808795872065723,0.48006644518272423,0.898783117812663,1.0,3/18,9.16%,PIK3R1;PIK3R2;CCKBR
prerank,potassium ion antiporter activity (GO:0022821),0.4069089657893353,0.9793410586789923,0.4924114671163575,0.8991074893286768,1.0,3/15,5.55%,SLC24A5;SLC9A9;SLC9A1
prerank,DNA replication origin binding (GO:0003688),0.37407775103853624,0.9780872297268205,0.4779874213836478,0.898594647465575,1.0,9/23,21.36%,MCM7;POLA1;MCM4;MCM10;DHX9;ORC2;MCMDC2;KAT7;ORC5
prerank,estrogen receptor binding (GO:0030331),0.34149790752087095,0.9738487834977518,0.4946401225114854,0.9060801458601927,1.0,12/32,18.60%,PPID;DNAAF4;NCOA1;NSD1;NRIP1;CNOT1;MED1;PRMT2;MMS19;DCAF1;TRIP4;TAF10
prerank,syntaxin binding (GO:0019905),0.304597839555871,0.9726488648913241,0.5083798882681564,0.9056074259429555,1.0,24/61,23.86%,VAMP2;LRRK2;NAPB;SNAP23;SYT3;SNPH;SYP;GOLGA2;SNAP29;SYNPR;SCFD1;SYT5;UNC13A;VPS52;STXBP5;TMED9;UNC13C;SYT1;SYT6;NAPG;CACNA1A;ABL1;BLOC1S6;STXBP4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.32364075576116424,-0.9726058144855959,0.4735376044568245,0.8007257687353705,1.0,8/24,22.49%,OSBPL8;PLA2G4A;CERT1;GOLPH3L;JPH2;SNX3;PLA2G4E;LANCL2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.34656005479211777,0.970509153037497,0.5015479876160991,0.9071071918228071,1.0,3/32,4.79%,SLC1A5;SLC43A1;SLC7A8
prerank,mannosyltransferase activity (GO:0000030),-0.32318631538178366,-0.9684614140052231,0.46005509641873277,0.8062948482205303,1.0,5/21,10.02%,TMTC2;TMTC1;ALG9;TMTC4;ALG12
prerank,RNA polymerase core enzyme binding (GO:0043175),0.34261115980877815,0.9676519269592465,0.48705501618122976,0.9109386560283514,1.0,16/33,28.28%,NCOA3;ERCC5;SPTY2D1;UVSSA;ELP4;ZNF326;DHX9;AGO1;CDC73;GTF2B;MAF1;RPRD2;RRN3;ELP2;CTR9;WDR43
prerank,syntaxin-1 binding (GO:0017075),0.37721799109160925,0.9659944593173115,0.523102310231023,0.9112887944913679,1.0,9/22,18.66%,VAMP2;LRRK2;SNPH;SYP;SYNPR;UNC13A;STXBP5;UNC13C;SYT1
prerank,bHLH transcription factor binding (GO:0043425),-0.334922093507478,-0.9645805166117168,0.491183879093199,0.8109742514331788,1.0,8/19,26.06%,LMO2;PSMD9;SMAD3;SIRT1;MAP3K10;BHLHE40;BHLHE41;KDM1A
prerank,endoribonuclease activity (GO:0004521),-0.29414288536670763,-0.963457759211506,0.4940828402366864,0.8088633206265256,1.0,10/32,22.32%,KHNYN;SMG6;NYNRIN;DICER1;RNASEL;ERN1;ENDOV;AGO2;LACTB2;YBEY
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.30144293091471797,0.9628894928890539,0.4978601997146933,0.9154959874687215,1.0,8/55,12.40%,SLC24A5;ITPR1;RYR2;ATP2A2;TRPV3;TRPC3;TRPM2;CUL5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.319486208498355,0.9608217865903431,0.5058309037900874,0.9171177120459156,1.0,14/42,23.06%,PIK3R1;PIK3R2;IRS1;NEDD4;FGR;CRK;LDLRAP1;SH3BP2;NCK2;PIK3R3;PTPN11;BCAR3;ABL1;VAV2
prerank,omega peptidase activity (GO:0008242),0.2829830528818027,0.959456061846942,0.5110533159947984,0.9168457834397943,1.0,31/89,25.13%,GGT5;STAMBPL1;GGT7;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;PSMD14;USP21;USP16;USP13;STAMBP;USP14;USP49;USP46;USP45;USP48;USP31;USP24;USP22;UFD1;OTUD7A;JOSD2;USP2;USP36
prerank,endopeptidase activity (GO:0004175),0.25907123880012684,0.9587201528334688,0.5682074408117249,0.9149410233182134,1.0,30/257,10.57%,ECE1;ECE2;ADAMTS14;MASP1;FAP;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;PCSK2;HTRA3;USP1;CASP4;CASP6;ADAM19;OMA1;MMP11;ADAMTS12;ACR;USP42;PSMA5;PSMB5;PLAU;ADAMTS2;LGMN;RHBDL3;NRDC;PITRM1;PSMA4
prerank,translation initiation factor activity (GO:0003743),0.33879572876178704,0.9574679581936834,0.5068702290076336,0.914368715806735,1.0,9/36,20.34%,EIF4G3;EIF3H;EIF2B1;EIF4A2;EIF2S1;EIF5B;EIF3C;EIF3G;EIF4A1
prerank,histone deacetylase activity (GO:0004407),0.3739399084148456,0.9551172815617813,0.5160744500846024,0.9169189382181886,1.0,3/19,5.87%,MIER2;HDAC1;SIRT6
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.38962867968575954,0.9542009623468685,0.5513698630136986,0.9156158297559467,1.0,5/17,17.71%,BLVRB;DHCR24;PTGR2;PECR;DPYD
prerank,phosphoric ester hydrolase activity (GO:0042578),0.31500781791094185,0.9535205304927424,0.5425383542538355,0.9135714702336198,1.0,8/49,7.86%,ATP1A2;SACM1L;DUSP12;PLCXD3;PTPN22;PLCXD1;PTPRO;ENPP6
prerank,transition metal ion binding (GO:0046914),0.2508980070378338,0.9524854959336099,0.602357984994641,0.9123543439355719,1.0,81/397,18.45%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;CBLB;HIF1AN;PDXK;GRIN2B;EPRS1;TYR;DUSP12;LOXL3;MYT1;FEN1;LOXL2;SLC30A5;DNAJC24;KMT2A;CHD4;DHX58;ZFP37;GRIN2A;SIRT6;CCS;TARS1;ACR;ADCY2;ENPP3;CALB1;MDM4;TRIM8;COMMD1;DPYS;NSD1;BIRC2;AGMO;SLU7;ZFPM2;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;USP33;P2RX4;PTGR2;ENDOU;HEPH;KDM1B;RABIF;B4GALT7;TRIM2;ATP7A;HDAC10;PIM1;KDM5C;ZBTB32;TMEM163;KDM2A;AOX1;ZKSCAN5;SEC23A;CYP2R1;SEC24A;ZNF3;CALR;USP16;DPEP1;GALNT2;RNPEP;PEX12;MBD1;ADAM8;ANPEP;SUV39H2;WRN;KPNB1
prerank,tRNA binding (GO:0000049),0.3255476133174393,0.9509930147689537,0.51698670605613,0.9125379833056746,1.0,19/43,26.94%,NAT10;ELP1;CTU1;PSTK;CARS1;TRNAU1AP;PTCD1;SARS2;SARS1;SEPSECS;MRPS27;TRMT10A;AIMP1;AARS1;TRMT10C;SSB;NSUN6;YARS2;IGHMBP2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3684717564497305,-0.9507697363346106,0.49772727272727274,0.8365545439147325,1.0,3/12,8.59%,PARN;PAN3;CNOT8
prerank,microtubule binding (GO:0008017),0.25563978189036546,0.9492176569127998,0.5891032917139614,0.9132589598014451,1.0,54/222,19.21%,CCDC61;REEP2;MDM1;MAP4K4;IRAG2;MTCL1;FMR1;LRRK2;NEFH;CENPE;STARD9;CLIP3;CEP295;SUN2;LRPPRC;FAM161A;TERF1;SNPH;HAUS8;NAV3;GOLGA2;OPA1;CCSAP;CAPN6;KATNA1;DNM1;RMDN1;TUBGCP4;NUSAP1;GAS8;SYBU;KIF5C;POLB;CLIP2;KIF9;TPGS1;MAP9;EML1;CLASP2;KIF3C;STIM1;TUBGCP6;KIFC2;KIF2A;CLASP1;ALMS1;CDK5;CEP44;MAST1;KIF21A;SPEF1;KIF13B;SVBP;PEX14
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3417740137662872,0.948121079884634,0.5304212168486739,0.9122453950247277,1.0,6/28,18.02%,EDA;TRAF4;TRIM37;RIPK1;MYD88;FEM1B
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.41752562884990563,0.9477749557858666,0.5268630849220104,0.9094529480969408,1.0,5/11,22.55%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,growth factor receptor binding (GO:0070851),-0.22931160995250632,-0.9471568776905855,0.589041095890411,0.840797123598706,1.0,19/95,15.55%,PDGFD;PTPRJ;FER;ERAP1;IL1R1;VEGFD;VEGFC;IL6ST;PDGFA;FGF1;PDGFC;CCDC88A;FRS2;ITGB3;TRIP6;HIP1;ERN1;GRB2;ESM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.33076352459172714,-0.9469699470521363,0.48894348894348894,0.8362850654707178,1.0,7/20,29.78%,LPGAT1;AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,phosphatase activity (GO:0016791),0.29402044424062523,0.9455811583427522,0.5238726790450928,0.9115162526760789,1.0,13/73,15.88%,LPIN3;ATP1A2;SACM1L;DUSP12;PTPN22;PLPPR3;PTPRO;PLPPR2;PLPP6;DUSP8;PLPP5;LPIN2;ACP2
prerank,microtubule minus-end binding (GO:0051011),-0.3759643580208427,-0.9451802683093956,0.5225653206650831,0.8355436434420476,1.0,5/13,19.93%,TUBGCP5;CEP290;MACF1;CAMSAP2;NUMA1
prerank,anion channel activity (GO:0005253),0.2893032559075279,0.9438713942206686,0.5427769985974754,0.9123284198379523,1.0,14/61,15.07%,VDAC2;ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;LRRC8A;GABRB1;GLRB
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.42472175951812924,0.9429503801645442,0.5422297297297297,0.9109796266997746,1.0,4/11,11.80%,CASP4;CASP6;PYCARD;CASP12
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.36943924554666885,-0.9423089166244494,0.5258215962441315,0.8381130592919314,1.0,5/12,25.84%,AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,muscle alpha-actinin binding (GO:0051371),-0.34862379718889347,-0.9403827263516442,0.5325581395348837,0.8383501162629386,1.0,9/15,37.39%,PDLIM5;PDLIM3;PKD2L1;TTN;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN
prerank,histone methyltransferase activity (GO:0042054),-0.28530264402592426,-0.9393386755272081,0.5508982035928144,0.836011693417771,1.0,6/32,10.72%,SMYD3;KMT5B;PRMT7;NTMT1;SMYD2;PRMT8
prerank,protease binding (GO:0002020),0.2769265246792734,0.939113783741572,0.5697969543147208,0.91670773153187,1.0,21/99,16.65%,SLC2A13;NTRK2;PTEN;FAP;POLG;ITGAV;ITGA3;BFAR;COL1A2;NOL3;PINK1;BRCA2;TP53;PYCARD;ATP9A;BAG6;STIM1;COL3A1;TRIP4;SERPINC1;DVL3
prerank,epidermal growth factor receptor binding (GO:0005154),-0.30349042431624657,-0.9387578375576021,0.5391566265060241,0.8325471240364889,1.0,11/25,28.76%,FER;CCDC88A;HIP1;GRB2;EGF;EFEMP1;LINGO1;CNOT9;FAM83B;ARF4;SNX2
prerank,E-box binding (GO:0070888),0.3274645801949862,0.9359166221767422,0.5557206537890045,0.9209199793322617,1.0,6/34,16.59%,ZEB1;TCF4;TWIST1;TFAP4;MYC;CIART
prerank,MHC class I protein binding (GO:0042288),-0.3592018581353931,-0.9353919985448171,0.5375854214123007,0.8361053720619409,1.0,3/13,10.46%,ATP5F1B;TAPBP;TAP2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.30750266507712654,0.9330459011986899,0.5497076023391813,0.9242754365732594,1.0,6/47,7.49%,SLC1A5;SLC6A13;SLC7A11;SLC43A1;SLC7A8;SLC66A1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.1967239259304258,-0.9327915414184533,0.7115384615384616,0.8378219951755475,1.0,73/248,21.64%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;MYL6;RASL12;RAP1A;RAB23;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ATP2B1;ARHGDIB;ABCA3;RAB21;DNM3;GBP4;RAB5A;VCP;RAB5C;RHOC;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;NKIRAS1;MYO1E;RAB35;GBP6;RALB;CLPX;SMCHD1;RAN;RAB38;TOR1A;RRAS;GNL1;RAP2C;ATL3;GNAZ;CHD3;ARL1;DYNC1I1;GNA14;GPN3;RAB1A;GTPBP1;RAB6A;GNG11;ABCB10;RAP2B;KIF1C;TSR1;GSPT2;RRAGB;RAB4A;RERG;CHD1L;RAB1B;RAB8B;RHOH;RUVBL2;MYO18A;MTG2
prerank,exoribonuclease activity (GO:0004532),0.4060010547667406,0.9324096095346747,0.5557491289198606,0.9222772645084586,1.0,5/12,15.78%,EXOSC9;CNOT7;EXOSC10;EXOSC8;EXOSC5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3862800896516767,0.9322416717574266,0.5686274509803921,0.9192173784061328,1.0,2/15,5.21%,ALDH1A1;ALDH3B1
prerank,G protein-coupled receptor binding (GO:0001664),0.2673888035867868,0.9317849144401046,0.5953827460510328,0.9167523341028119,1.0,17/132,13.15%,XCL1;NPB;RTP4;WNT5A;REEP2;PTCH2;PDYN;TUB;CALCA;NPY;GNA11;WNT3;CCL25;USP33;PSMC5;GNAO1;S1PR2
prerank,GTPase regulator activity (GO:0030695),0.25421312215650854,0.9317408663896908,0.6052934407364787,0.9133877919201921,1.0,39/212,13.17%,DLC1;CHN1;ARHGAP32;ARHGAP22;PREX2;ALDH1A1;TAGAP;IQGAP3;RABGAP1L;TBC1D16;SIPA1;ABR;RGS20;NPRL2;ARHGAP24;HTR2B;GARNL3;LRRK2;NF1;SIPA1L3;LLGL1;GPSM2;ARHGEF6;TBC1D1;ADGRB3;GNB5;ELMOD1;RGS8;TBC1D8B;OPHN1;ASAP1;RIMS1;RANBP3;ARHGAP31;ARHGAP35;RTKN;ARHGAP1;PREX1;SMAP1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.39835016900611,0.9311404598155318,0.5542168674698795,0.9113513644357277,1.0,3/14,6.29%,PTEN;MTMR4;MTMR1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.37251471585888013,-0.9269169077405777,0.5542452830188679,0.8470076038333246,1.0,5/12,14.81%,PIK3C2B;PIK3CB;PIK3CD;ATM;PIK3R6
prerank,protein tyrosine kinase activator activity (GO:0030296),0.37081254370233185,0.9262082626479079,0.5468998410174881,0.919591694243631,1.0,4/19,11.60%,NRG1;DGKQ;GRM5;NRG3
prerank,histone deacetylase binding (GO:0042826),0.28005981782849926,0.9261868783506537,0.5688073394495413,0.9161854243018439,1.0,29/88,24.44%,MIER2;HDAC1;TOP2B;CHD4;BCOR;GMNN;BRMS1L;BRMS1;PHF6;GLI3;KAT2A;NUDT21;TP53;DHX36;ZMYND15;HDAC10;TFAP4;TOP2A;THAP7;NACC1;MTA3;SP1;MTA1;MEF2B;KPNA2;NCOR2;USF1;NACC2;YWHAE
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4011791716839032,0.922830149619084,0.5596491228070175,0.9209414346054503,1.0,5/12,21.30%,CDK8;CDK13;CCNK;CDK7;MAPK1
prerank,exopeptidase activity (GO:0008238),0.305442889049317,0.9219618425902404,0.5807407407407408,0.9194298613193167,1.0,7/50,7.15%,DPP6;FAP;DPP10;METAP1D;BLMH;DPEP3;CPM
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.22883412333615344,-0.9216034040450953,0.6049382716049383,0.8553040336658607,1.0,26/85,24.35%,PLA2G4A;MGLL;PON3;NDST3;GDPD3;PAFAH2;LIPA;LIPE;ENPP2;ABHD2;PLA2G6;TARS2;PAFAH1B2;PTRH2;PLAAT3;ESD;DDHD2;PLA2G4E;PNPLA3;PLA2G4C;MRPL58;LYPLA1;FAAH;GDPD1;PGLS;AOAH
prerank,phospholipase activity (GO:0004620),0.28520262860615303,0.9196704090993466,0.5691275167785235,0.9214667095505417,1.0,10/67,12.05%,PLCL1;GPLD1;PRDX6;LIPC;LIPH;SMPD4;PNPLA7;ABHD16A;LYPLA2;ABHD12
prerank,double-stranded RNA binding (GO:0003725),0.28516138817470227,0.9195640572266229,0.5947075208913649,0.91825422380744,1.0,25/70,21.57%,AGO4;ADARB2;FMR1;DHX58;ZNF346;ACTN1;TLR8;DUS2;MRPL44;DHX30;STAU2;EIF2AK2;DHX36;AGO3;RC3H2;DHX9;ADAR;PRKRIP1;ILF3;AGO1;FXR1;LRRFIP1;EIF4A1;DHX15;DHX33
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2527063806876863,0.9186342030233499,0.645422943221321,0.9171221898234388,1.0,33/188,16.73%,TBX18;ZBTB20;ATF5;ETV5;TCF7L2;BASP1;ERBB4;THRA;PER3;REST;FOS;SOX6;CREB3L2;BCOR;PER2;SOX2;GLI1;SOX10;TP53;DHX36;CREB3L1;TFEB;PRDM5;CARM1;ELK1;DHX9;TFAP4;AR;CRY2;NONO;KLF11;ATMIN;HNRNPL
prerank,cyclic nucleotide binding (GO:0030551),0.3559674831260053,0.9182627028567585,0.5582137161084529,0.9146382774743168,1.0,5/21,14.22%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,acetylcholine receptor activity (GO:0015464),0.344050824549141,0.9175941289947529,0.5626016260162602,0.9127882495727343,1.0,1/22,2.30%,CHRNB4
prerank,ubiquitin-dependent protein binding (GO:0140036),0.40986249720801576,0.9161616108824112,0.5666666666666667,0.9128273014721662,1.0,5/10,25.75%,FAN1;FAAP20;ANKRD13B;IDE;DNAJC2
prerank,motor activity (GO:0003774),0.29193859184033316,0.9160778579872668,0.5768115942028985,0.9096976151928718,1.0,21/60,24.02%,GPR88;CENPE;STARD9;MYO6;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;KIF3A;SMC3;KIF7;KIF11;KIF1B;KIF15;KIFC1;KIF14;KIF23
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.3967252959336775,0.9157612786885287,0.5640569395017794,0.9071121035474634,1.0,3/11,11.77%,ITPR1;TRPC3;TRPC7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.30845925387423984,-0.9154107121088585,0.5822454308093995,0.865409007158651,1.0,5/22,13.14%,PICALM;MESD;APOE;AP2A1;SNX17
prerank,channel activity (GO:0015267),0.30804162349225567,0.9114276499559166,0.5725190839694656,0.9138703968168311,1.0,3/41,6.41%,TRPA1;SLC14A1;TRPV3
prerank,calcium-activated potassium channel activity (GO:0015269),0.4085438329495272,0.9113881853222844,0.5843920145190563,0.9106734378182442,1.0,2/11,12.48%,KCNMA1;KCNN2
prerank,histone acetyltransferase binding (GO:0035035),0.35242787011872323,0.9106477780561923,0.5730897009966778,0.9091786297080797,1.0,9/21,22.56%,EPAS1;GLI3;KANSL1;TP53;ZBTB7A;TRIP4;HIF1A;TRIM68;STAT1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.25717787727164393,0.9103839621027924,0.6357056694813028,0.9065594580536498,1.0,9/134,4.79%,SLC1A3;SLC1A5;SLC6A13;SLC16A12;SLC6A8;SLC25A21;SLC35B3;GJA1;SLC7A8
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2628123921958938,-0.9099328241468292,0.608955223880597,0.8734684399979247,1.0,11/38,23.22%,APP;SERPIND1;SERPINE1;SERPINI1;SERPINA2;FURIN;SERPINE2;SPINT2;AGT;SERPINB8;TFPI
prerank,sterol transfer activity (GO:0120015),0.3642237355838816,0.9083995240193576,0.5833333333333334,0.9080360337362986,1.0,4/17,19.96%,GRAMD1B;MTTP;NPC2;OSBP
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2824698554144015,-0.9083127764128858,0.6005586592178771,0.8726306021449339,1.0,5/29,9.97%,PTPRJ;ACE;MAPK14;GCH1;PPM1D
prerank,galactosyltransferase activity (GO:0008378),0.41260617809782996,0.9047056572851071,0.5815972222222222,0.9132119580655073,1.0,5/11,13.50%,B4GALT2;A3GALT2;B4GALT3;B4GALT4;B4GALT7
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.37809534812235834,-0.9045184362597051,0.5879828326180258,0.8769906219644639,1.0,1/10,0.87%,CACNA1C
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.37875682339501227,0.9040222663859706,0.5845896147403685,0.911715654350041,1.0,1/15,1.37%,PLA2G2C
prerank,ion channel inhibitor activity (GO:0008200),-0.2734317471420227,-0.9040184296558861,0.6198347107438017,0.873413912381579,1.0,7/35,9.55%,CAMK2D;WNK4;WNK1;CALM1;STX1A;MCUB;STX7
prerank,chemokine receptor activity (GO:0004950),0.34201688241548067,0.9031831605456031,0.5922953451043339,0.9104475763505313,1.0,2/24,3.25%,ACKR2;CCR9
prerank,metalloaminopeptidase activity (GO:0070006),-0.3280713808359895,-0.9029150771699279,0.6111111111111112,0.8712621937809025,1.0,4/16,20.17%,ERAP1;XPNPEP3;MMP15;TRHDE
prerank,phospholipase A2 activity (GO:0004623),0.3360635653916669,0.9024753133805351,0.5859872611464968,0.9088630103234704,1.0,3/26,7.89%,PLA2G2C;PRDX6;PLA2G7
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27794147455805696,0.9021463422381144,0.627906976744186,0.9064248608993859,1.0,9/75,9.08%,ADH1A;RDH10;RDH11;MDH1;H6PD;GRHPR;KCNAB1;PRXL2B;HSD17B8
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.4000659445024248,0.8983543303155727,0.5928571428571429,0.9117417365298557,1.0,3/11,17.41%,NEIL3;HMCES;APEX2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4006617629325439,0.8974683903993524,0.6044362292051756,0.9105482005300571,1.0,4/11,15.24%,PRMT3;NDUFAF7;CARM1;PRMT2
prerank,MAP-kinase scaffold activity (GO:0005078),0.40238786528311804,0.8972824792527186,0.5924006908462867,0.9078153313774657,1.0,1/11,0.33%,SH3RF1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39637084944453393,0.8956368667250504,0.5979020979020979,0.9081358572688986,1.0,2/11,9.40%,NAA10;NAA50
prerank,mRNA 5'-UTR binding (GO:0048027),0.33289580003996444,0.8950206194039061,0.613747954173486,0.9063263419132058,1.0,4/24,5.70%,GNL3;FMR1;LARP6;CCT5
prerank,ATPase binding (GO:0051117),-0.2314706484969796,-0.8935768117378416,0.6407407407407407,0.8889500832154793,1.0,25/71,25.24%,CAV1;EGFR;EZR;PTPN3;ATP6V0A4;SNTA1;RDX;ATP1B3;ANK2;TMTC4;RALB;PEX26;USP25;ESR1;NUFIP1;CHMP4A;ATP6V0A2;CLPP;SELENOS;ATP6V0A1;TOR1AIP1;PLN;ATP6V1G1;DNAJB1;SRC
prerank,sodium:proton antiporter activity (GO:0015385),-0.36209642178133344,-0.8929000743677896,0.5981524249422633,0.8858026692168054,1.0,2/11,3.09%,SLC9A2;SLC9B2
prerank,NAD binding (GO:0051287),0.32596971083931586,0.8925813900401026,0.622154779969651,0.9084395036829509,1.0,5/26,9.08%,ALDH1A1;GRHPR;SIRT6;UXS1;HSD17B8
prerank,metalloexopeptidase activity (GO:0008235),-0.24937334925983498,-0.8919539535282625,0.6964285714285714,0.8833223780009086,1.0,6/51,5.36%,AEBP1;CPE;CPD;ERAP1;XPNPEP3;ACE
prerank,cholesterol transfer activity (GO:0120020),0.3645406391019248,0.8909198228003242,0.6060070671378092,0.9089491346436799,1.0,1/16,1.26%,GRAMD1B
prerank,methyl-CpG binding (GO:0008327),0.33964766041593475,0.8899868506980362,0.6,0.907868311667173,1.0,7/22,22.58%,MBD3;ZCWPW1;ERH;MBD2;MBD1;CHTOP;CXXC5
prerank,transferrin receptor binding (GO:1990459),0.40429575734210077,0.8898883742449055,0.6143344709897611,0.9050363831844324,1.0,2/10,13.40%,RGMA;CD81
prerank,myosin II binding (GO:0045159),-0.3767893709625676,-0.889341982494596,0.621978021978022,0.8846876955488095,1.0,4/10,16.03%,SHROOM4;GSN;SHROOM1;LLGL2
prerank,adenyl ribonucleotide binding (GO:0032559),0.23599106639304895,0.8886275413839585,0.7358695652173913,0.9047788995990765,1.0,53/291,15.42%,ENPP1;RAPGEF4;ATP1A2;PEAK1;ABCD2;EIF4A3;PDXK;PDE4B;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;CNBD2;MTHFD1L;CARS1;TARS1;RHOBTB3;MYO6;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;GCK;HCN1;PTPA;NOL9;PRPS1L1;PRPS1;DHX36;HSPA13;P2RX4;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;ATP7A;MAP4K1;LONP1;PIM1;PDE4A;HSPA5;WNK2;CHD8;NME1;SYN2;HSPA4;DHX9;BRSK2
prerank,nucleosomal DNA binding (GO:0031492),0.34886119253870657,0.8881407035347133,0.6290322580645161,0.9027602955970925,1.0,4/21,10.90%,HDAC1;CHD4;MBD3;RCC1
prerank,cation channel activity (GO:0005261),0.2639303150990021,0.8874281284580158,0.6550387596899225,0.901280375930688,1.0,14/94,12.40%,TRPA1;SLC24A5;NALCN;CACNA1E;RYR2;TRPV3;KCNG1;TRPC3;TMEM38B;TMEM175;HCN1;KCNK1;TRPM2;CUL5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.33928793030424975,-0.886075339873978,0.6219512195121951,0.8876471789123193,1.0,7/13,22.95%,PIK3C2B;PIK3CB;PIK3CD;PIP4K2C;PIP5K1A;PIK3C2A;PIP5K1B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3715666627471144,0.8858530514499077,0.6046099290780141,0.9017584933538233,1.0,2/14,4.10%,RSAD1;SDHB
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.27841150770709694,-0.8853993888017521,0.6700507614213198,0.8845227385590371,1.0,9/27,22.50%,CRCP;POLR2B;POLR2G;TERT;POLR2C;POLR1H;POLR1C;POLRMT;POLR3K
prerank,sulfuric ester hydrolase activity (GO:0008484),0.39247468863281565,0.8846203185121377,0.6066433566433567,0.9013286107051742,1.0,4/12,19.62%,SULF1;GNS;ARSK;ARSJ
prerank,deubiquitinase activity (GO:0101005),0.25987326296842667,0.8820944181088757,0.6550836550836551,0.903796351513828,1.0,32/88,25.13%,STAMBPL1;EIF3H;USP1;UCHL3;USP42;MINDY4;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;PSMD14;USP21;USP16;USP13;STAMBP;USP14;USP49;USP46;USP45;MINDY2;USP48;USP31;USP24;USP22;UFD1;OTUD7A;JOSD2;USP2;USP36
prerank,iron ion binding (GO:0005506),0.29044007215624107,0.8801314877053531,0.6422413793103449,0.9050290642408547,1.0,10/48,16.18%,HIF1AN;DNAJC24;FXN;EGLN2;AGMO;HEPH;FTO;ALKBH3;AOX1;CYP2R1
prerank,single-stranded RNA binding (GO:0003727),0.29242536306793876,0.8772356292672611,0.6616314199395771,0.9080867936197926,1.0,14/43,19.81%,AGO4;ADARB2;FMR1;DHX58;TLR8;AGO3;LONP1;DHX9;EXOSC10;SRA1;ILF3;AGO1;FXR1;CNBP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.28117355899614316,0.8756965540273872,0.6448736998514116,0.9081914763253711,1.0,10/54,13.97%,MIER2;HDAC1;NIT1;SIRT6;ASPA;ACR;ACY1;AGA;PIGL;HDAC10
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2640633111355472,-0.8747033204998362,0.6835820895522388,0.9044921140138771,1.0,7/34,12.97%,RICTOR;IQGAP1;CALM1;CAB39;MAP2K2;ALS2;ETAA1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2936200915912657,-0.8738033893235837,0.6351351351351351,0.9016455491635477,1.0,3/26,2.96%,AEBP1;CPE;CPD
prerank,ubiquitin protein ligase activity (GO:0061630),-0.18809753148825628,-0.8719879115760388,0.8991596638655462,0.9010615172183812,1.0,41/228,13.62%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF185;RNF43;PELI1;KCMF1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIM25;TRIP12;TRIM5;CDC42;TRIM11;TRIM14;VPS18;SH3RF2;MSL2;RNF8;UBR1;SMURF2;RC3H1;RNF125;RNF144B;RNF11;RNF41;RNF114;RCHY1;UBR2;NEURL2;VPS11;HERC2;TRIM63;UBE3D;RING1;AMFR
prerank,protein kinase C binding (GO:0005080),-0.24787923806149065,-0.8711774960086112,0.7305194805194806,0.8981632562222409,1.0,14/43,20.83%,PDLIM5;SQSTM1;CAVIN2;YWHAG;CAVIN3;ADCY6;CCDC88A;HSPB1;TRPV4;HINT1;DACT2;PKP2;TWF2;ADAM9
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.35315638899110335,-0.8692208023669719,0.628175519630485,0.8979149826199488,1.0,2/11,9.62%,LEF1;GATA2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.2697852928637495,-0.8690147134710775,0.6827195467422096,0.893903457924892,1.0,7/32,9.59%,KDM4C;KDM4A;TET3;EGLN3;RIOX2;PHF8;ALKBH5
prerank,MAP kinase kinase activity (GO:0004708),-0.32741491966237907,-0.8681640080486828,0.59375,0.8911293918896858,1.0,5/15,14.84%,MAPK14;MAP2K4;MAP2K7;MAP2K2;MAP2K5
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3712342074605741,0.8670568160577896,0.5905096660808435,0.9232002559737009,1.0,4/14,19.21%,KCNIP2;KCNE4;KCNJ8;KCNJ3
prerank,neuropeptide binding (GO:0042923),0.34741092380418603,0.8660046732765712,0.6418918918918919,0.9222288920522014,1.0,2/18,16.10%,SORL1;GPR37
prerank,ATP binding (GO:0005524),0.23138525938674492,0.8655088192362487,0.7779005524861878,0.9202192002572752,1.0,77/266,23.62%,ENPP1;ATP1A2;PEAK1;ABCD2;EIF4A3;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;MTHFD1L;CARS1;TARS1;RHOBTB3;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;GCK;PTPA;NOL9;PRPS1L1;PRPS1;DHX36;HSPA13;P2RX4;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;ATP7A;MAP4K1;LONP1;PIM1;HSPA5;WNK2;CHD8;NME1;SYN2;HSPA4;DHX9;BRSK2;HARS1;SARS2;ABCA2;MSH6;MAST1;PEX6;KSR1;STK26;NVL;PDK3;PXK;LATS2;PPIP5K1;TRIP13;PI4K2A;HSPA9;BMPR1B;MYO9B;BMPR1A;ABL1;NLK;MVK;BCKDK;KIFC1;TDG;MAP4K5;AARS1;BTK;KIF14;PIP4K2B
prerank,protein phosphatase regulator activity (GO:0019888),0.2773144518206451,0.8639662390572634,0.6638418079096046,0.9202925415307452,1.0,8/53,10.63%,PTN;BOD1;PPP6R2;PPP2R2A;RCAN3;PPP2R3A;PTPA;EIF2AK2
prerank,WW domain binding (GO:0050699),0.32129407591228437,0.8637848903145416,0.6391096979332274,0.9176831387120923,1.0,4/26,10.42%,TRAF4;WBP11;TCEAL5;NDFIP2
prerank,histone acetyltransferase activity (GO:0004402),0.3144759447935245,0.8631560360280822,0.6547987616099071,0.915978660283182,1.0,12/30,24.09%,NCOA3;NAA50;BRCA2;KAT2A;EPC1;ATF2;KAT7;TAF10;MCM3AP;CREBBP;USP22;SRCAP
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.29119243459567,-0.8614279601405658,0.6480582524271845,0.9013383969545739,1.0,10/22,24.96%,SQSTM1;PARP10;OPTN;TAB2;RNF169;TNFAIP3;ZRANB3;IKBKG;IKBKE;ATRIP
prerank,antiporter activity (GO:0015297),0.3370191078044867,0.8611449832952722,0.6305418719211823,0.9171862255846864,1.0,8/20,21.98%,ATP1A3;CLCN3;SLC25A30;SLC35E1;SLC25A14;SLC35E3;SLC25A16;SLC35A1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.33890937869217824,-0.860977355426726,0.6561085972850679,0.8976758516607117,1.0,2/12,3.09%,SLC9A2;SLC9B2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.358221886813604,0.8580221368317738,0.6218905472636815,0.9204914175315185,1.0,4/14,14.52%,AK4;NME6;AK8;NME1
prerank,I-SMAD binding (GO:0070411),-0.32628483914057144,-0.8549343969057785,0.634020618556701,0.9056163493237868,1.0,7/13,26.27%,SMAD6;SMAD3;SMAD1;TGFB1I1;SMAD7;SMURF1;SMAD4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.26334860839745017,0.854660064832401,0.7120622568093385,0.9238156111196003,1.0,24/78,22.87%,CAPN5;USP1;CASP4;CASP6;CAPN3;USP42;LGMN;CAPN6;PYCARD;USP33;CASP12;USP34;CAPN15;USP16;USP13;USP14;USP49;CAPN2;CAPN10;CTSK;USP46;MALT1;USP48;USP24
prerank,phosphate ion binding (GO:0042301),-0.3559673933856632,-0.8540211066643583,0.6605504587155964,0.9030567402601084,1.0,5/10,36.82%,ADSS2;PNP;RELA;MTHFD2;CHST14
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.325881037512578,-0.8538932475379085,0.6442307692307693,0.8987698195575624,1.0,6/15,29.78%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,acylglycerol lipase activity (GO:0047372),-0.3487794795541945,-0.8536268707660809,0.6537530266343826,0.8948457963209656,1.0,3/11,9.84%,MGLL;LIPE;ABHD2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2572187826470087,0.8523263310962084,0.7209908735332464,0.9256942545792334,1.0,22/91,17.95%,SVIL;STXBP6;WDR45B;GBF1;MYO1B;GRAMD2A;SLC9A1;ADAP2;COMMD1;GSDMD;SYT7;EXOC1;PLEKHA5;MYO1G;CLVS1;SDCBP2;TIRAP;AMER2;LDLRAP1;WIPI2;SYTL2;FCHO2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.26966429425618416,0.8519669754089981,0.6973125884016973,0.9234547369588114,1.0,8/60,11.56%,CDC14B;PTEN;DUSP1;LRRK2;PPP6C;PPP3CB;PDP1;LRRC39
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3315150159345931,-0.8473973774105622,0.6554054054054054,0.9029521913677291,1.0,5/13,17.61%,FTSJ1;TRMT5;TRMT11;THUMPD2;TRMT10B
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2589228697457493,0.8466771957123523,0.7181467181467182,0.930886257797933,1.0,14/74,12.28%,PDXK;ADK;IPMK;NADK;COASY;PAPSS2;PI4KA;DGKQ;GK;CHKA;NOL9;FGGY;DGKI;AGK
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3237961286848207,-0.8465688201189518,0.678743961352657,0.9002217484198182,1.0,5/13,13.85%,EZR;GSK3B;KCNQ1;PRKAR2A;PRKAR2B
prerank,neurexin family protein binding (GO:0042043),0.38693042386229326,0.8457929835738471,0.6538461538461539,0.929555631902853,1.0,1/10,2.00%,CEL
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3017714476113331,0.8446973667980079,0.7067082683307332,0.9285280326988568,1.0,5/29,15.37%,SLC1A5;SLC25A21;SLC25A22;SLC25A30;SLC25A14
prerank,cardiolipin binding (GO:1901612),0.38526638605398145,0.8444082438192064,0.6426174496644296,0.926135106744032,1.0,3/10,20.06%,OPA1;GSDMD;GSDME
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2857292632339894,0.8443841092771793,0.6892086330935252,0.923292252867015,1.0,17/44,22.04%,KMT2E;CXXC1;KMT2A;SETD5;WDR5;NSD1;SMYD5;DOT1L;N6AMT1;ASH2L;SUV39H2;SETD4;EHMT2;KMT2C;RBBP5;MEN1;EHMT1
prerank,protein heterodimerization activity (GO:0046982),0.23460460728851515,0.843886240266435,0.7795823665893271,0.9213668985310115,1.0,39/178,18.78%,BHLHA9;TENM3;ATP1A2;TCF4;ITGA3;TOP2B;PIK3R2;TENM4;FMR1;GTF2A1;TLR6;EPAS1;ADCY8;TENM2;QTRT2;TENM1;TLR4;SAE1;CYBA;IRAK1;TP53;RCC1;BCL2L2;KATNA1;IL12A;SDCBP2;ARNT2;BAK1;HEXA;MTTP;ZHX3;GABBR2;RRAGA;SMC1A;ADRA2A;TOP2A;ARNT;RRAGD;HIF1A
prerank,serine-type peptidase activity (GO:0008236),0.25391281133772725,0.8423399891085919,0.7381578947368421,0.9214904863083424,1.0,9/96,12.50%,MASP1;FAP;PCSK2;HTRA3;ACR;PLAU;RHBDL3;HTRA2;ENDOU
prerank,cysteine-type peptidase activity (GO:0008234),0.260315681363177,0.842187307217438,0.7330677290836654,0.9189037457903195,1.0,22/73,22.87%,ATG4A;USP1;CASP4;CASP6;OTULINL;BLMH;CAPN3;USP42;LGMN;USP33;USP34;USP21;USP16;USP13;USP14;USP49;CAPN2;CTSK;USP46;MALT1;USP48;USP24
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.28940522476846253,0.8419379392597599,0.7101669195751138,0.9165237860653114,1.0,12/42,23.02%,CDKN2A;CCNJ;CDKN2D;CCNB2;CDKN2C;CCNA2;CCNK;CCNE1;CCND3;CDK5R1;CCNT2;CCNQ
prerank,Hsp70 protein binding (GO:0030544),0.2969051730579014,0.8417656578033268,0.7007874015748031,0.9140128303569217,1.0,8/31,19.11%,PPID;DNAJB12;DNAJC10;GPR37;TSC1;DNAJB14;DNAJC8;SACS
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.29612848467312897,0.8414793712103704,0.6822840409956076,0.9117424799025164,1.0,7/35,14.20%,PEAK1;TXK;PTK2;FGR;FYN;LYN;MELK
prerank,lipid phosphatase activity (GO:0042577),0.3456674016589206,0.8406916837425176,0.6449912126537786,0.9103752007938816,1.0,3/14,10.79%,PLPPR3;PLPPR2;PLPP6
prerank,RNA methyltransferase activity (GO:0008173),-0.29231475085413555,-0.8396527699974127,0.7219387755102041,0.910039764779961,1.0,7/19,25.34%,TRMT9B;FTSJ1;TRDMT1;TRMT5;MEPCE;MRM2;TRMT12
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2736450758332598,-0.8384269535349094,0.7076923076923077,0.9080947280755535,1.0,7/22,21.84%,ATP6V0A4;ATP5F1B;ATP2A3;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,carboxypeptidase activity (GO:0004180),-0.25904106027438734,-0.8365502350562374,0.7369942196531792,0.9074962296761706,1.0,9/35,19.16%,AEBP1;CPE;CPD;MINDY1;SCPEP1;AGBL1;CTSZ;ACE2;VASH1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.32237706334387706,-0.8357948362762386,0.7074829931972789,0.904495443599807,1.0,2/13,3.09%,SLC9A2;SLC9B2
prerank,methyltransferase activity (GO:0008168),0.27846160913267787,0.831304674221581,0.7291666666666666,0.925246693485685,1.0,7/46,12.14%,EEF1AKMT4;PRMT3;RRP8;COQ3;GAMT;NDUFAF7;AMT
prerank,DNA-binding transcription factor binding (GO:0140297),0.22684722268547158,0.8303409520965647,0.8029279279279279,0.9242019535611578,1.0,50/189,22.58%,PPARA;MIER2;HDAC1;TCF7L2;PPARD;YWHAZ;TBX3;FOS;RUNX1T1;CHD4;TLE2;CRTC2;SRF;LYAR;DGKQ;FIZ1;PIAS2;TWIST1;NOC2L;TLE1;ZFPM2;TP53;PSMC5;PRDM5;ATN1;ELK1;ATF2;DHX9;DMAP1;AR;MYC;ZBTB7A;BBS1;LDB2;LDB1;CRTC3;DDRGK1;MTA3;RERE;SP1;FHL2;MTA1;BBS4;CREBBP;TCF12;DDIT3;HMGB1;ZMYND8;STAT1;CXXC5
prerank,ion gated channel activity (GO:0022839),0.30887960738900155,0.830160117403096,0.6869983948635634,0.921781883932331,1.0,2/24,3.22%,KCNT2;ANO4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.25976132725968526,-0.8281385691535801,0.7647058823529411,0.9151662782959703,1.0,11/30,27.26%,XIAP;CST3;PTTG1;RPS6KA1;TNFAIP8;PRDX3;CAST;BIRC3;MT3;CD27;RPS6KA3
prerank,chemoattractant activity (GO:0042056),0.3038731180106876,0.8272818597756808,0.6784,0.9241859688615145,1.0,2/26,5.36%,CXCL10;CCL15
prerank,cytochrome-c oxidase activity (GO:0004129),-0.30821940893200883,-0.824273902939023,0.7281553398058253,0.9180394677788327,1.0,4/15,18.44%,COX15;COX5B;COX4I1;COX6B1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.30343719290757315,-0.8236190989808932,0.7106598984771574,0.9148654137812559,1.0,11/16,36.75%,CD38;OARD1;SARM1;MACROD1;NEIL1;ADPRH;NTHL1;SMUG1;RPS3;NEIL2;BST1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.3292031876540991,0.8222462519081919,0.7271214642262895,0.9307043147946603,1.0,5/18,18.39%,ALDH1A1;ALDH3B1;AKR1B1;ALDH3A2;ALDH9A1
prerank,ephrin receptor binding (GO:0046875),0.31673678322668,0.821927077503158,0.7022653721682848,0.9284431683559814,1.0,10/21,22.42%,CHN1;ANKS1B;FYN;CRK;LYN;EFNA1;PIK3CG;EFNB3;CBL;ABL1
prerank,cation:chloride symporter activity (GO:0015377),-0.3475542640494019,-0.8195435122724138,0.6969026548672567,0.9182985632768259,1.0,2/10,10.65%,SLC12A7;SLC12A8
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.37154509140608327,0.8192301161609403,0.668918918918919,0.9308057157426163,1.0,3/10,11.80%,CASP4;CASP6;CASP12
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3546559784009183,0.8190332577263136,0.6881533101045296,0.928419355184546,1.0,5/12,22.55%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30083453965203055,-0.8189215116607856,0.6982543640897756,0.9152627007354249,1.0,4/15,13.91%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,potassium:proton antiporter activity (GO:0015386),0.37639969763931913,0.8166073277708912,0.6967509025270758,0.9300520414987385,1.0,2/10,5.55%,SLC9A9;SLC9A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.37149856367494294,0.8164819237487951,0.6751361161524501,0.9275272916845666,1.0,3/11,19.21%,KCNE4;KCNJ8;KCNJ3
prerank,heme binding (GO:0020037),0.25548571848094126,0.8164645278350235,0.7716643741403026,0.9248117077483239,1.0,5/65,4.27%,HRG;SLC48A1;PGRMC2;RSAD1;PTGES2
prerank,RNA binding (GO:0003723),0.20414851361265574,0.8143664389128976,0.978,0.9259362199700185,1.0,298/1321,21.12%,DCN;C1D;LRP1;RBFOX1;RBMS1;EIF4G3;GNL3;TEP1;TRA2B;NAT10;BICC1;FNDC3A;EIF4A3;AGO4;NANOS3;CDKN2A;RBM46;FNDC3B;ARL6IP4;ISY1;RPP40;NOVA1;EPRS1;SPOUT1;ELP1;CTU1;WDR36;AFF2;HTATSF1;MYEF2;SPTBN1;EIF3H;POP5;BZW1;RBMS3;YWHAZ;GTPBP10;FSCN1;ADARB2;SNRNP35;LSM14A;EIF1AX;LRRC59;SPATS2L;MTCL1;ZMAT3;FMR1;SF3B6;ZC3H12D;RRP8;DND1;RRBP1;CAPRIN1;LARP6;ZC3H7B;ADK;PSTK;IFIT2;DHX58;TBL2;RTF1;LIN28B;ZNF346;NOL3;KHDRBS3;TRIM56;ACTN1;LSM4;CARS1;TLR8;LRPPRC;ZFP36L2;TAF15;DUS2;SRF;STAU1;UTP11;KRR1;PCBP3;LYAR;HNRNPA2B1;SEC63;MPHOSPH10;MRPL44;SRSF11;EIF4A2;TRNAU1AP;DDX19B;NMD3;CDK13;NOC2L;CHD2;TENT4B;WBP11;ERH;RALYL;DHX30;SNUPN;MRM3;PNO1;DDX17;PHF6;EDF1;GPATCH8;CELF4;ALG13;TENT5A;DDX19A;MRPS31;CFAP65;RP9;SRRT;STAU2;MRPS24;DDX41;POP7;NUDT21;SRPRA;CWC22;LUC7L2;FAM32A;DBR1;RCAN3;SEC61B;NOC3L;EIF2AK2;MRPS26;DHX36;ZC3H8;NUP42;NAP1L1;RBFOX3;NTPCR;RPL37;RIMS1;AGO3;TEFM;MTREX;SNW1;MKI67;DNAJC21;DNM1;TNPO1;EDC3;CASC3;PRPF38B;NUSAP1;CSDC2;R3HDM2;NDUFV3;EXOSC9;SRSF10;HSP90B1;UTP15;PPAN;ENDOU;SYF2;DDX18;RBM20;HDLBP;CISD2;SSRP1;MRPL28;PPIL4;FAM98B;CLNS1A;LGALS1;CNOT1;MRPS30;SYNE1;RBM18;DIMT1;DDX31;DAP3;EIF2S1;MRPL10;CDC42EP4;RBM4B;TDRD9;MRTO4;PRR3;SLBP;EIF4ENIF1;YARS1;LONP1;ZNF326;PUS7;NME1;RRS1;HNRNPUL1;SAFB2;UTP6;RC3H2;HNRNPD;DHX9;TNRC6B;DUS3L;RNASEH1;SNRPF;ZCCHC9;ISG20L2;DDX59;ERAL1;EXOSC10;ZCCHC24;FYTTD1;SNRNP70;CSNK1E;NOL4;NONO;HEATR6;PTCD1;ADAR;HNRNPLL;EIF5B;SRSF9;SRRM2;PRKRIP1;SUGP2;CHERP;THOC5;HNRNPL;MRPL3;ZCCHC3;MTIF2;CALR;MRPS23;IGF2BP3;MAZ;SMC1A;DMGDH;RBM5;ILF3;SF3A3;PPP1R8;SRRM3;SARS2;SARS1;AGO1;SRSF6;SAFB;EIF3C;DXO;RPP21;HABP4;KHDRBS1;RPS17;TOP2A;LSM14B;RRP1B;KPNB1;SEPSECS;MRPS5;YTHDF1;RBM6;SSBP1;CANX;FKBP3;EIF3G;HSPE1;REXO4;BYSL;DHX29;ZCRB1;NVL;PPIG;RBM28;CHTOP;FXR1;LLPH;ZC3H14;CCDC86;CNBP;SUMO2;NOL12;RO60;LRRFIP1;DDX1;ZC3H7A;PRPF8;MRPS27;URB1;EIF4A1;NOL10;ZNFX1;FLNB;LUC7L3;KMT2C;UTP20;DHX15;HEATR1;RAVER2;DDX39B;TRMT10A;GANAB;UTP4;RBPMS;RPL35
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2641350018869496,-0.8129742060619126,0.7438692098092643,0.9216272372689827,1.0,2/26,1.43%,CSGALNACT1;B3GALT1
prerank,sodium channel regulator activity (GO:0017080),0.2796599957016461,0.8126846019359634,0.7631975867269984,0.9263637171610031,1.0,8/37,15.73%,GPLD1;SCN2B;NEDD4;COMMD1;FXYD4;FGF12;SGK1;FGF14
prerank,3'-5' exonuclease activity (GO:0008408),0.2692390466362718,0.8106548333544766,0.7521865889212828,0.9272192959014958,1.0,13/45,21.38%,POLG;PDE12;REV3L;EXOSC9;DIS3L2;CNOT7;EXOSC10;EXOSC5;WRN;REXO4;TRIR;REXO2;PNLDC1
prerank,glutamate receptor binding (GO:0035254),-0.28655739928870577,-0.8095397096172547,0.7531486146095718,0.9233374504818929,1.0,6/17,15.41%,SHANK3;GNAS;SQSTM1;SHANK1;HIP1;SHISA7
prerank,peptidase inhibitor activity (GO:0030414),-0.24386228307642188,-0.8058503434243708,0.8193146417445483,0.9256066294851699,1.0,5/33,6.69%,CST3;GPC3;PSMF1;SERPIND1;RENBP
prerank,pre-mRNA binding (GO:0036002),0.28891290465300884,0.804566364931911,0.7376,0.9354136710264502,1.0,8/28,17.55%,TRA2B;RBM24;ZRSR2;CELF4;SLU7;SLBP;HNRNPL;SRSF6
prerank,cation transmembrane transporter activity (GO:0008324),-0.22037614811768075,-0.8039289176514304,0.8389057750759878,0.9244170907366752,1.0,20/48,27.32%,SLC6A6;SLC7A1;SLC3A2;SLC41A1;SLC38A5;SLC7A5;SLC1A1;SFXN1;SLC6A7;SLC36A4;SLC22A2;SLC38A6;SLC38A7;SLC38A2;PKD2L1;MMGT1;MFSD12;SLC39A1;PKD1L3;SLC8B1
prerank,voltage-gated anion channel activity (GO:0008308),0.33344171346753676,0.8026207875487733,0.7238421955403087,0.9361336730324996,1.0,4/15,12.88%,VDAC2;CLCN3;CLCN2;CLCN6
prerank,disordered domain specific binding (GO:0097718),0.3007277804034046,0.8017235198160733,0.7246376811594203,0.9349596264830455,1.0,5/23,11.33%,TEAD2;NCOA3;TP53;BCL2L2;FYN
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3547172180026362,0.8011146335878131,0.6927175843694494,0.9333583895392854,1.0,11/11,64.55%,SLC2A9;SLC5A11;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC5A3;SLC23A2;SLC23A1;SLC17A5
prerank,Notch binding (GO:0005112),-0.2708261297350391,-0.7988963658604424,0.7268041237113402,0.928982419701593,1.0,5/22,16.69%,SNED1;CCN3;DNER;GALNT11;CUL3
prerank,kinase binding (GO:0019900),0.2055313918580978,0.7982276511476194,0.9303534303534303,0.9354572799397067,1.0,54/434,11.57%,PTN;GHR;IL15RA;RND3;UTRN;ATF5;TCF7L2;ERCC6L2;PTPRR;CDKN2A;DLG3;SPRED1;YWHAZ;FBXO5;RAC3;PTPN22;DLG2;NEFH;MYCN;TBL2;DCTN2;SGO1;CDKN2D;LLGL1;MTCP1;CADPS;SIKE1;POLA1;TEX14;CEP68;RHOBTB3;PTK2;JTB;UNC5C;DGKQ;SPRED2;LRRC14;GOLGA2;PFKM;CEP192;PRKACA;SP100;CACUL1;RB1CC1;DAXX;TNS2;FGR;CNKSR2;IRAK1;TP53;TTC28;DLG4;DNM1;FBXW5
prerank,acetylation-dependent protein binding (GO:0140033),0.30993863060946336,0.7971285487352366,0.738562091503268,0.9320574863535463,1.0,11/20,26.45%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;ZMYND8;BRD9;BRDT;YEATS4
prerank,lysine-acetylated histone binding (GO:0070577),0.30993863060946336,0.7971285487352366,0.738562091503268,0.9320574863535463,1.0,11/20,26.45%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;ZMYND8;BRD9;BRDT;YEATS4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.24475391580541844,-0.7939317863382255,0.8212121212121212,0.9332056332514236,1.0,15/33,27.76%,RNF185;ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;DCUN1D3;SIAH2;ANKIB1;RNF5;RNF19A;FOXL2;PARK7;DCUN1D1
prerank,kinesin binding (GO:0019894),-0.25423787056115643,-0.7916294498797302,0.7727272727272727,0.9329094171400882,1.0,7/27,15.24%,ACTB;NEK6;MAPK8IP3;SPAG9;TOR1A;CROCC;MAPK8IP1
prerank,kinase inhibitor activity (GO:0019210),-0.24135631239683542,-0.7890687254035902,0.8027027027027027,0.9330048177893516,1.0,13/33,23.15%,YWHAB;NCK1;LRP6;CDKN1A;MAPK8IP1;HEXIM1;NPM1;DNAJC3;GSKIP;DUSP19;RHOH;SOCS3;QARS1
prerank,endonuclease activity (GO:0004519),0.25901636928841165,0.7888364168353141,0.8002832861189801,0.9435888562649,1.0,11/49,19.73%,ANKLE1;FEN1;ZC3H12D;ERCC5;ERCC4;AGO3;ENDOU;MBD4;AGO1;REXO4;NOB1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2344441842755189,0.788103250091332,0.833116036505867,0.9421045182246975,1.0,29/83,25.13%,STAMBPL1;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;PSMD14;USP21;USP16;USP13;STAMBP;USP14;USP49;USP46;USP45;USP48;USP31;USP24;USP22;UFD1;OTUD7A;JOSD2;USP2;USP36
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.23226536753431593,-0.7859598269809278,0.8140243902439024,0.9340075686082321,1.0,13/38,22.49%,PARD3;PLA2G4A;SNX21;SH3PXD2B;ATG2B;DENND1A;HIP1;JPH2;ATG2A;SNX3;PLA2G4E;WDR45;LANCL2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.35797283587643086,0.7855356397602559,0.7176258992805755,0.9433477268911841,1.0,3/10,14.59%,DSE;GALE;GNE
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3112857056007677,-0.7815146045992631,0.7610837438423645,0.9370094618894017,1.0,7/12,34.95%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.2947870467416662,0.780832922394433,0.7269681742043551,0.9485850551561238,1.0,6/23,17.66%,WDR45B;GBF1;COMMD1;PLEKHA5;CLVS1;WIPI2
prerank,microtubule motor activity (GO:0003777),0.25411176341419867,0.7804562966311155,0.7953216374269005,0.9465026166409001,1.0,19/51,24.02%,CENPE;STARD9;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;KIF3A;SMC3;KIF7;KIF11;KIF1B;KIF15;KIFC1;KIF14;KIF23
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.31343296202035725,-0.7794174223264562,0.7538126361655774,0.9359862108490585,1.0,8/12,47.23%,DDI2;BACE2;SPPL3;CTSE;HM13;NAPSA;SPPL2A;PSEN1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.30217231573350495,0.7784145107645806,0.7450331125827815,0.9470324814326742,1.0,6/22,23.01%,DUSP12;DUSP1;DUSP8;DUSP6;DUSP10;DUSP7
prerank,serine-type endopeptidase activity (GO:0004252),0.2400009217212058,0.777581068123828,0.8346456692913385,0.9457090099609871,1.0,7/80,12.35%,MASP1;FAP;PCSK2;ACR;PLAU;RHBDL3;HTRA2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3538388005484746,0.7775026107776819,0.7525597269624573,0.9431664893408294,1.0,2/10,11.22%,ADARB2;DCTD
prerank,delayed rectifier potassium channel activity (GO:0005251),0.2781033796571502,0.7744073402845757,0.802731411229135,0.9454871141729423,1.0,7/32,20.46%,KCNQ3;KCNG1;KCNC2;KCNE4;KCNA6;KCNH1;KCNS3
prerank,pseudouridine synthase activity (GO:0009982),-0.3046277623213496,-0.7727910573871476,0.7662037037037037,0.9418531614397906,1.0,7/13,36.72%,PUS10;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,MHC protein binding (GO:0042287),-0.27047701910026856,-0.7725346623136905,0.7880434782608695,0.9380800872105995,1.0,5/20,20.02%,ATP5F1B;TAPBP;TAP2;CD74;ABCB9
prerank,lysophospholipase activity (GO:0004622),-0.2640478695557697,-0.7709518092373311,0.7915632754342432,0.9363457293602199,1.0,5/20,11.39%,PLA2G4A;MGLL;GDPD3;ENPP2;PLA2G6
prerank,ATP hydrolysis activity (GO:0140603),0.260680633680663,0.7696524776512059,0.7804154302670623,0.9503041954998688,1.0,9/41,17.28%,ABCD2;VWA8;RHOBTB3;ABCB6;ABCA4;TDRD9;CLU;DHX9;VPS4B
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2313190309200474,-0.7693296799816292,0.870253164556962,0.9345707340563708,1.0,7/34,16.11%,UBE2G1;UBE2D3;UBE2H;UBE2F;UBE2A;UBE2N;UBE2L6
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.265435675962173,0.7686680401947724,0.7818991097922848,0.9491774026147678,1.0,8/37,17.36%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS2;SARS1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.22844440730483273,-0.7678835624666087,0.8668639053254438,0.9326629549549799,1.0,14/35,26.84%,TRMT9B;FTSJ1;TRDMT1;TARS2;PTRH2;TRMT5;MTFMT;ELAC2;MRPL58;GATC;PUS10;DUS1L;TRMT12;TRPT1
prerank,myosin binding (GO:0017022),0.2484588266796161,0.767277855764497,0.8014084507042254,0.9485666988664041,1.0,8/55,13.19%,NPC1L1;LARP6;RAB8A;LLGL1;RAB3C;NKD2;PYCARD;TRIOBP
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.31973767534320763,0.7658442042321147,0.725752508361204,0.9481547176457648,1.0,3/14,9.32%,RECK;SPOCK3;LXN
prerank,glucose transmembrane transporter activity (GO:0005355),-0.27664988673205754,-0.7656224515029428,0.8181818181818182,0.9319067571039569,1.0,13/17,55.80%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A6;SLC2A10;SLC2A3;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.319213493901995,0.759465121768374,0.7597173144876325,0.9551794160338819,1.0,3/14,15.93%,BLVRB;PYCR1;AASS
prerank,ribosomal small subunit binding (GO:0043024),0.3027551983198792,0.7526422573886685,0.7779661016949152,0.9629238344176095,1.0,6/17,22.44%,PIM1;NME1;ERAL1;MTIF2;DHX29;EIF4B
prerank,SH3 domain binding (GO:0017124),0.23747184036199456,0.7513157198151507,0.855755894590846,0.962311268846577,1.0,9/62,11.34%,WIPF1;AKAP5;CBLB;ELMO1;PTPN22;RUFY1;CYBA;ADAM12;CABYR
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3078460618582648,-0.74971498740134,0.7905982905982906,0.9502857519479836,1.0,4/11,25.53%,PPP1R1A;PABIR1;PPP1R11;PPP1R2
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3165231159253184,-0.7493709899539959,0.7742616033755274,0.9465647618237565,1.0,3/10,17.16%,ECHDC1;HADHA;AUH
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.28925925493135624,-0.7464602374885916,0.8141176470588235,0.946191302411193,1.0,3/13,21.22%,SREBF2;MIF;EBP
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.23457719954403417,-0.7444940804520714,0.8666666666666667,0.9445512573861642,1.0,8/28,18.05%,PRKAA2;MAPK14;MAP2K4;MAP2K7;RPS6KA1;MAP2K2;MAP2K5;AKT1
prerank,SUMO binding (GO:0032183),-0.2947855213455883,-0.7428215026343838,0.7949886104783599,0.942672295338249,1.0,4/13,17.54%,CASP8AP2;HERC2;USP25;SERBP1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.32357110697155744,0.742605614785483,0.7883333333333333,0.9724100163238079,1.0,4/13,19.77%,BMP7;PYCARD;BMP2;BMP5
prerank,lipase activity (GO:0016298),0.25072453916471843,0.7411012805964519,0.8527777777777777,0.9718962884219408,1.0,5/43,12.05%,CEL;LIPC;LIPH;ABHD16A;ABHD12
prerank,purinergic nucleotide receptor activity (GO:0001614),0.30857090013212607,0.7404295062835521,0.7888513513513513,0.9701272014486709,1.0,2/15,11.26%,P2RY1;P2RX4
prerank,death receptor binding (GO:0005123),-0.2756656473858689,-0.7398875362591882,0.8096446700507615,0.9423560487001957,1.0,4/15,12.01%,CASP8AP2;NGF;MADD;BID
prerank,nucleotidyltransferase activity (GO:0016779),0.29239175360071384,0.7388828409280696,0.7878260869565218,0.9696854683338735,1.0,5/19,15.81%,PAPSS2;TENT4B;TENT2;REV1;CRPPA
prerank,magnesium ion binding (GO:0000287),-0.17025400442889327,-0.7372595275446041,0.9833333333333333,0.9418365050808097,1.0,22/135,15.59%,EYA2;MARK1;MAP3K5;NEK6;GCLC;SIK3;SNRK;AASDHPPT;NUDT3;SIK1;CDC42BPB;STK38L;DYRK2;MAP2K7;RRAGC;RP2;SRPK1;RAN;PGP;ERN1;CDC42BPG;ENDOV
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.24284608388894174,0.7353184289149244,0.8575539568345324,0.9719870339168555,1.0,8/46,15.44%,OGT;PIGQ;GCNT2;PIGP;B3GNT8;PIGA;B3GALT5;HEXA
prerank,Hsp90 protein binding (GO:0051879),-0.21936332083386806,-0.73504434791749,0.8991596638655462,0.9406792741762862,1.0,8/33,16.77%,PTGES3;KDR;MAPT;PPEF2;HDAC8;NR3C1;ERN1;UNC45B
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.33910628063799875,0.7340196167822434,0.7946902654867256,0.971198037757372,1.0,5/10,20.34%,CXCL10;PKIG;PRKAR1A;PKIB;PRKAR1B
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.25774793924626377,0.7323829162627322,0.8287461773700305,0.9708689516084613,1.0,6/35,10.84%,HDAC1;FOS;GTF2A1;TBPL1;TAF1B;TP53
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2670501261114332,0.7314870452378411,0.8170347003154574,0.9694691757426515,1.0,6/31,11.70%,SLC12A6;KCNG1;TMEM38B;TMEM175;HCN1;KCNK1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2847809299740731,0.7306149859756509,0.8210702341137124,0.9680613666301684,1.0,4/20,16.98%,EIF3H;OTULINL;YOD1;USP21
prerank,SUMO transferase activity (GO:0019789),-0.26526663050931626,-0.7263283011149458,0.8633093525179856,0.9475371321393435,1.0,1/16,1.89%,HDAC4
prerank,telomerase RNA binding (GO:0070034),0.2825377866489566,0.7262509279364271,0.8297520661157025,0.9710364619972235,1.0,4/22,15.52%,TEP1;TENT4B;DHX36;EXOSC10
prerank,endopeptidase regulator activity (GO:0061135),-0.20716411818084798,-0.7255254738892672,0.9183673469387755,0.9445441148873147,1.0,12/40,23.22%,CST3;PSMF1;SERPIND1;RENBP;APH1A;APH1B;PSME3;SPINT2;PSME2;CAST;ADRM1;TFPI
prerank,H4 histone acetyltransferase activity (GO:0010485),0.32990828037392633,0.7251040167097467,0.7982142857142858,0.9700750501572833,1.0,3/10,15.05%,NAA50;BRCA2;ATF2
prerank,adenylyltransferase activity (GO:0070566),0.2789679600893218,0.7249713440872905,0.8213716108452951,0.9676492110010324,1.0,4/21,12.03%,NMNAT3;COASY;TENT4B;TENT2
prerank,BMP receptor binding (GO:0070700),0.323583508992342,0.724722242065511,0.8136752136752137,0.9654104783241104,1.0,4/12,19.77%,BMP7;PYCARD;BMP2;BMP5
prerank,microtubule plus-end binding (GO:0051010),0.2802652825829546,0.7241150973340431,0.8297520661157025,0.9637151420149958,1.0,5/20,15.99%,CLIP3;CLIP2;CLASP2;STIM1;CLASP1
prerank,transaminase activity (GO:0008483),-0.2986062631119488,-0.7232249579848747,0.8241758241758241,0.9432051200412381,1.0,4/11,20.51%,GOT2;OAT;PSAT1;AGXT
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.26763292546060025,0.7224159314629921,0.8325508607198748,0.9633439286829732,1.0,10/29,20.34%,CDKN2A;SPRED1;CDKN2D;SPRED2;CDKN2C;PKIG;PRKAR1A;PKIB;SPRY2;PRKAR1B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.31459467023383264,0.7199180855465842,0.7885304659498208,0.9640626812864773,1.0,4/12,19.29%,TENT4B;TENT5A;TENT2;PAPOLB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.32654368019249175,0.715822283465755,0.7962264150943397,0.9665778037126629,1.0,3/10,17.03%,DPYSL2;DPYS;DPEP1
prerank,thioesterase binding (GO:0031996),0.32406308351087065,0.7147349967715675,0.8066666666666666,0.9653599296507709,1.0,1/11,1.98%,TRAF4
prerank,translation elongation factor activity (GO:0003746),-0.2751985282198439,-0.7112945945439533,0.8305084745762712,0.9527256941254019,1.0,5/14,30.68%,EEF1A1;EEFSEC;GTPBP1;GTPBP2;TUFM
prerank,protein kinase inhibitor activity (GO:0004860),0.23746278289386114,0.709298576637066,0.8676470588235294,0.9693012139604972,1.0,4/42,7.82%,SPRY4;SPRED1;DUS2;SPRED2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.29687207995630455,0.7067775991302935,0.8241379310344827,0.9697152180912986,1.0,1/13,1.55%,ALDH1A1
prerank,RNA polymerase binding (GO:0070063),-0.24671443663745088,-0.7055269060540539,0.8519417475728155,0.9550934345241282,1.0,2/18,4.21%,PHRF1;STOM
prerank,ribonuclease activity (GO:0004540),0.22477814039397467,0.7027175792820868,0.9035460992907801,0.9719762564733213,1.0,14/56,17.83%,RPP40;ZC3H12D;AGO3;EXOSC9;ENDOU;DIS3L2;RNASEH1;CNOT7;EXOSC10;EXOSC8;EXOSC5;PPP1R8;AGO1;RNASE12
prerank,hormone receptor binding (GO:0051427),0.2951163531626132,0.7007270558961752,0.8441330998248686,0.9717104965112247,1.0,1/14,3.13%,JAK1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21133347619083503,-0.7005187903419025,0.9487179487179487,0.9564327847073948,1.0,9/34,19.06%,PARN;PAN3;CNOT8;ERI1;DIS3L;EXOSC2;ANGEL2;EXOSC3;ANGEL1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.24075341445259518,-0.6982907399541158,0.8878048780487805,0.9547032956732433,1.0,7/19,26.75%,LCOR;VCP;AMFR;SELENOS;RHBDD2;SUMO1;PARK7
prerank,DNA secondary structure binding (GO:0000217),0.2476193691562047,0.6977216165065024,0.888208269525268,0.9725394033966595,1.0,10/31,22.42%,KMT2A;ERCC5;NEIL3;XPC;MSH6;WRN;MEN1;LIN54;HMGB1;ABL1
prerank,N-methyltransferase activity (GO:0008170),0.2713258078329123,0.6963360786004823,0.8513986013986014,0.9715067434319302,1.0,5/20,23.51%,HNMT;DIMT1;N6AMT1;METTL15;METTL5
prerank,protein phosphatase 2A binding (GO:0051721),0.26448842115362436,0.6946075032919286,0.8576,0.9708791992816089,1.0,5/23,12.93%,BOD1;ADCY8;PTPA;TP53;ANKLE2
prerank,GABA receptor binding (GO:0050811),0.31276771039260937,0.6944983138092417,0.8464223385689355,0.9685111336784485,1.0,1/11,1.64%,AKAP5
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.1881527630989459,0.6943480956705478,0.9875,0.9661947100322739,1.0,39/232,19.46%,PDZRN3;SH3RF1;MYCBP2;CBLB;SH3RF3;RNF220;DTX4;BFAR;NEDD4;RNF180;TRIM56;RNF150;TRIM37;PIAS2;BIRC2;FBXO17;RNF128;RNF181;ASB1;TRIM59;HECTD1;AREL1;TRIM44;TRIM2;UBE2D1;RNF122;RC3H2;TRIM3;RNF167;HACE1;RNF145;TRIM26;HECW1;RNF24;RNF187;RNF19B;RNF217;RNF144A;RNF13
prerank,RNA cap binding (GO:0000339),-0.24669145632701392,-0.6939577060523573,0.8838383838383839,0.9547349177668012,1.0,6/16,25.84%,EIF3D;AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,actin monomer binding (GO:0003785),-0.22593181015313862,-0.6907859261434736,0.8871391076115486,0.9540445155062203,1.0,11/22,36.85%,NOS3;COBL;TMSB4X;LIMA1;TWF2;MYL4;PRKCE;PFN2;CORO1A;MRTFA;TMSB10
prerank,calcium channel inhibitor activity (GO:0019855),0.3096429873318984,0.6893138674118718,0.8422876949740035,0.9689590992565752,1.0,1/11,2.28%,ITPR1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.2797461524100734,-0.6891990137672506,0.8614718614718615,0.9517978765338608,1.0,3/11,20.96%,AMFR;ANAPC11;PRPF19
prerank,carbohydrate kinase activity (GO:0019200),-0.2798976694055599,-0.6890789466252719,0.8606194690265486,0.9481160322566262,1.0,2/11,8.02%,HK1;HK2
prerank,fatty acid synthase activity (GO:0004312),-0.2857380445807191,-0.6888938146551826,0.8702830188679245,0.9445230683240379,1.0,3/10,12.95%,ELOVL4;CBR4;ELOVL7
prerank,mannose binding (GO:0005537),0.30031772350293384,0.6881972892481222,0.8407079646017699,0.96762914826873,1.0,2/12,9.35%,ACR;MBL2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2405867163598913,0.6860045935676569,0.8938461538461538,0.9649943391795557,1.0,12/34,25.16%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2405867163598913,0.6860045935676569,0.8938461538461538,0.9649943391795557,1.0,12/34,25.16%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8
prerank,CARD domain binding (GO:0050700),0.2872832929200224,0.6843882454798383,0.8440207972270364,0.9641138054310223,1.0,2/14,6.99%,CASP4;CARD19
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.31486406798153954,0.681271899468929,0.8421985815602837,0.9648655381764043,1.0,2/10,9.61%,SETD5;NSD1
prerank,acetyltransferase activity (GO:0016407),0.2379483167341479,0.673004637086751,0.90625,0.9702031695146278,1.0,4/31,10.58%,NAA10;NAT10;NAA50;NAT8L
prerank,tRNA methyltransferase activity (GO:0008175),0.27226133942180564,0.6697695358012586,0.8538732394366197,0.970962503973753,1.0,7/16,22.28%,TRMT13;TYW3;TRMT44;THUMPD3;METTL2B;METTL2A;LCMT2
prerank,four-way junction DNA binding (GO:0000400),-0.24077126305121166,-0.6661280395658911,0.9120603015075377,0.9603007993381177,1.0,8/17,31.32%,RAD51D;RAD51C;HMGB2;XRCC2;MSH2;GEN1;YY1;XRCC3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.1735574539678237,-0.6646135094193818,0.9927007299270073,0.9576607390614851,1.0,16/69,21.32%,LPGAT1;KAT6B;ZDHHC21;PLA2G4A;DBT;ESCO1;ZDHHC16;ZDHHC14;SOAT1;PLAAT3;ZDHHC18;PLA2G4E;PLA2G4C;ELP3;CERS2;ZDHHC3
prerank,diacylglycerol kinase activity (GO:0004143),0.29437626841697834,0.6550302123147946,0.8788927335640139,0.9818271493324747,1.0,3/11,12.28%,DGKQ;DGKI;AGK
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.30084056884152405,0.6547996821918591,0.8642857142857143,0.9795762371249693,1.0,1/10,4.23%,FEN1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.2784675400254369,0.6534470993804383,0.8836805555555556,0.9781703525076424,1.0,3/13,13.20%,SLC66A1;SLC7A3;SLC25A29
prerank,retinoid X receptor binding (GO:0046965),0.2886767781104775,0.6529801357860434,0.8711340206185567,0.9761458272575971,1.0,3/11,14.80%,NSD1;NRIP1;MED25
prerank,cAMP response element binding (GO:0035497),0.2979751229769477,0.6527716756980989,0.8754448398576512,0.9739137370750426,1.0,3/10,15.05%,CREB3L2;CREB3L1;ATF2
prerank,P-type ion transporter activity (GO:0015662),-0.2648888081949527,-0.6507352961694982,0.9155844155844156,0.9644830369726917,1.0,3/12,12.69%,ATP2B1;ATP2B2;ATP2A3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.16986663910735567,0.6465284704054166,0.9989224137931034,0.9766705104529888,1.0,59/346,19.60%,PDZRN3;SH3RF1;MYCBP2;FBXO9;CBLB;SH3RF3;RNF220;DTX4;BFAR;RNF40;SEL1L;NEDD4;RNF180;TRIM56;BCOR;UBE2QL1;RNF150;TRIM37;TTC3;UBE2G2;TRIM23;RNF168;BIRC2;FBXO17;RNF128;RNF181;ASB1;TRIM59;HECTD1;CUL5;RNF182;AREL1;TRIM44;TRIM2;UBE2D1;RNF31;UBE2Q2;RNF122;RC3H2;TRIM3;RNF167;HACE1;RNF145;RNF208;TRIM26;HECW1;PEX12;RNF24;RNF187;RNF19B;TRAIP;UBE2E3;RNF217;CUL4A;UBE2E2;FBXO4;RNF144A;RNF13;UBE2J1
prerank,aminopeptidase activity (GO:0004177),-0.20283559345213395,-0.6439550918877617,0.9607329842931938,0.9653817513688565,1.0,4/26,13.51%,ERAP1;XPNPEP3;CTSH;MMP15
prerank,ankyrin binding (GO:0030506),-0.21901197779457857,-0.6414421688278527,0.9354005167958657,0.9632230698409044,1.0,2/19,4.01%,CDH1;PLEC
prerank,O-methyltransferase activity (GO:0008171),0.2891326480892377,0.6395896684520989,0.8790035587188612,0.9797896316357356,1.0,1/10,5.67%,COQ3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2403689566751057,0.6387361705590301,0.9193037974683544,0.9780848258296058,1.0,6/24,15.09%,AK4;NME6;AK8;IP6K1;NME1;AK3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.1944360467956253,-0.6367606352728353,0.9726027397260274,0.9624989114894066,1.0,8/33,19.06%,PARN;CNOT8;ERI1;DIS3L;EXOSC2;ANGEL2;EXOSC3;ANGEL1
prerank,gap junction channel activity (GO:0005243),0.2462709235190953,0.6328403805121469,0.9278846153846154,0.9800037444943549,1.0,4/22,15.41%,GJA1;GJC3;GJA4;GJA5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.22544060084466785,0.6311381073223356,0.9340329835082459,0.9788050996583993,1.0,9/31,20.76%,UBE2QL1;UBE2G2;UBE2D1;UBE2Q2;UBE2E3;UBE2E2;UBE2J1;BIRC6;UBE2K
prerank,wide pore channel activity (GO:0022829),0.24171338448364105,0.6262050447782482,0.9281150159744409,0.9799071221832028,1.0,4/23,15.41%,GJA1;GJC3;GJA4;GJA5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.25765165028878795,0.61746552257244,0.9263157894736842,0.9833470768297307,1.0,5/14,21.57%,MINDY4;ATXN3;YOD1;USP13;MINDY2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.24475133565635143,0.6168767988256119,0.9178743961352657,0.9814104831667997,1.0,3/18,9.74%,NOL3;PRDX5;BIRC2
prerank,ATPase regulator activity (GO:0060590),0.21128176768816676,0.6166416427008404,0.9532846715328467,0.9791932361479806,1.0,7/38,16.50%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15;BRSK2;TSC1
prerank,ribosomal large subunit binding (GO:0043023),0.27347856646046226,0.6160384911136008,0.9144385026737968,0.9772316984697407,1.0,3/11,21.57%,NMD3;MALSU1;DHX33
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2247356326223416,0.6065393786665461,0.9330218068535826,0.9806938252601718,1.0,6/27,19.33%,PPARA;RNF180;DCUN1D5;RNF19B;RNF217;RNF144A
prerank,store-operated calcium channel activity (GO:0015279),0.2692191396327784,0.6010079684341171,0.9089285714285714,0.9814224543630644,1.0,3/10,19.93%,TRPC3;TRPC7;TRPC1
prerank,proton transmembrane transporter activity (GO:0015078),-0.17515534073698036,-0.6005581268593104,0.9909638554216867,0.9790192602094709,1.0,12/39,29.11%,CLCN5;COX15;SLC33A1;NNT;COX5B;COX4I1;COX6B1;UQCRQ;SLC11A2;ATP6V1B2;UQCRC1;NDUFA4L2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.23576482415027133,-0.5966297736937795,0.9420935412026726,0.9769932306768354,1.0,5/12,25.34%,NQO2;CBR4;CRYZ;CBR1;NQO1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.26144100875846016,0.5823987842460134,0.9384057971014492,0.9889767130144497,1.0,2/11,13.20%,SLC25A20;SLC25A29
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18581000641652445,0.5786173565837825,0.979108635097493,0.9884317969385243,1.0,17/57,25.16%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;UQCRH;COX7A2L;CYBRD1;NDUFS4;NDUFB3;COX5A;UQCR11;NDUFA10;NDUFS1;NDUFB6;NDUFB8
prerank,inward rectifier potassium channel activity (GO:0005242),0.21795454952309257,0.5722680919438842,0.9666110183639399,0.9889361654835958,1.0,8/24,24.76%,KCNK1;KCNN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9;KCNJ6
prerank,snRNA binding (GO:0017069),0.19181340550372072,0.5623691328760839,0.9804804804804805,0.9905467232344105,1.0,4/42,8.34%,SNRNP35;LSM4;LSM11;SNRPB2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19064209825745415,0.5621691629518659,0.9912280701754386,0.9882466545778902,1.0,9/40,20.99%,RRP8;HNMT;GAMT;METTL9;N6AMT1;DNMT3A;THUMPD3;METTL2B;METTL2A
prerank,neuropeptide receptor binding (GO:0071855),0.23933609369263892,0.5494417074762797,0.9523809523809523,0.9905493829283636,1.0,2/14,14.71%,NPY;NMU
prerank,palmitoyltransferase activity (GO:0016409),-0.17339760066797108,-0.5464556726686405,0.9862258953168044,0.9916747832396868,1.0,11/28,32.76%,ZDHHC21;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;GLUL;ZDHHC5;GOLGA7;ZDHHC23;ZDHHC12;ZDHHC20
prerank,telomeric DNA binding (GO:0042162),0.19431099604031926,0.5445662500800333,0.985981308411215,0.9898587515390613,1.0,4/32,8.31%,RPA1;HNRNPA2B1;TERF1;PIF1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.18514721369746256,-0.5398108987050874,0.9828009828009828,0.9897830020055078,1.0,7/21,37.74%,FGF1;FRS2;NPTN;FGF2;FGF18;KLB;FGF22
prerank,glutathione transferase activity (GO:0004364),0.19979557457235106,0.5276015531609817,0.9860681114551083,0.9927482826417244,1.0,2/23,7.70%,PTGES;GSTA3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.19026515291420482,-0.5058503806607891,0.9897172236503856,0.9933132182239831,1.0,5/14,26.20%,NOX4;AIFM1;CYBB;CYB5R4;NCF2
prerank,peptide hormone receptor binding (GO:0051428),-0.2030649564678002,-0.49891472354246885,0.990632318501171,0.9907086760875993,1.0,3/11,27.42%,PTHLH;GNRH1;CCK
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.1762148776168792,0.4846098762573837,0.9860248447204969,0.9997518434713939,1.0,10/29,26.75%,ENGASE;PGGHG;GUSB;IDUA;NEU3;GANAB;CTBS;GLA;PARG;MGAM
prerank,O-acyltransferase activity (GO:0008374),0.17273329821912498,0.4837383053233623,0.9983922829581994,0.9975750771938993,1.0,4/30,14.23%,PRDX6;SOAT2;MBOAT7;GPAT3
prerank,U6 snRNA binding (GO:0017070),0.19921711439946505,0.4710032070611322,0.9896193771626297,0.9972070164683877,1.0,6/14,28.64%,LSM4;PRPF8;DDX39B;LSM3;TUT1;EIF5A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.21268698832037686,0.4628536694268464,0.9863013698630136,0.9959739911308357,1.0,2/10,17.26%,CYBA;NOX1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.1705985956548643,0.45503467199094305,0.988976377952756,0.9946206172892325,1.0,6/24,20.29%,ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
